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CHAPTER 1
Introduction
1.1

Protein-RNA Interactions
According to the central dogma of molecular biology, genetic information is

transformed from DNA to RNA during a process called transcription (1). In
eukaryotes, after transcription the pre-mRNA undergoes several processing
events including 5’ end capping, splicing, editing and 3’ end polyadenylation
before entering the ribosome for protein synthesis (Figure 1.1). RNA has
structural, catalytic and regulatory roles in the cell (2). Perhaps in the cell, most
functional RNAs interact with proteins to carry out functions, such as processing,
nuclear

export,

transport

and

localization

(2-4).

For

example,

during

posttranscriptional regulation of gene expression, RNA interacts directly with
proteins to form ribonucleoprotein particles (RNPs) (5). These RNPs are
important for recognition of specific sequence elements present in RNA in order
to control the function of the RNA molecule (6). Since there are many RNAs and
a very large number of RNA-binding proteins, the biogenesis of RNPs must be
performed with high fidelity. Incorrect formation of RNP complexes or aberrant
expression of RNA binding proteins can cause genetic disorders that may lead to
diseases, such as neuromuscular and neurodegenerative disorders and cancers
(7, 8). Therefore, understanding the molecular mechanism of protein-RNA
interactions and their applications to function is an important aspect of structural
and biological research (9).

2
RNA molecules can adopt different secondary and tertiary structures from
standard Watson-Crick base pairs to non-cannonical base pairs, creating a
platform that allows for interaction with a wide variety of ligands. These structures
include single-stranded RNA (ssRNA), double-stranded RNA (dsRNA), hairpin
loops, bulge loops, internal loops, junction loops, and pseudoknots and are
recognized by various proteins to form protein-RNA complexes (10). These
protein-RNA complexes have a wide variety of structural and functional roles.

Figure 1.1 Central dogma of molecular biology representing the general cellular
processes in eukaryotic cells.
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Despite their functional importance in biology, the actual mechanisms of
protein-RNA interactions are poorly understood. Over the last several years,
much work has been done to understand the structural and functional
relationships of different types of protein-RNA interactions (4, 9, 11-13). Several
biophysical methods have been used to characterize protein-RNA interactions.
For example, X-ray crystallography can be useful to obtain information
concerning the detailed molecular interactions of a structured system, while,
cryo-electron microscopy (cryo-EM) can provide the overall shape of a proteinRNA complex. However, both of these methods have certain restrictions for a
system with structural heterogeneity (9, 14). Recent advances have made
nuclear magnetic resonance (NMR) one of the best techniques to study proteinRNA interactions in solution by using specific isotope-labeling strategies. Several
solution-based protein-RNA structures have been reported in the Protein Data
Base (PDB). Furthermore, computational modeling has also added insight into
the structural analysis of protein-RNA complexes on the basis of different
experimental interpretations. The recent advancement on single-molecule
spectroscopic techniques have been added an effort to understand both the
structural and dynamic behavior of protein-RNA interactions.
In this chapter, a comparison of structural and functional aspects of
important known RNA-binding proteins will be discussed. Some important
examples of common RNA-binding domains are summarized in Table 1.1 with
their PDB entry numbers.
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Table 1.1 Common RNA binding domains and their properties (4)
Domain

Topology

RNA-recognition
Motif
! sheet makes a
flat, solventexposed RNAbinding surface
A cleft formed by
GXXG loop and
variable loop

RRM

!"!!"!

KH

!""!!"
"!!""!

TRAP

!sandwich

Edges of !-strand

Sm/LSm
Proteins

"!!!!!

Loops formed by
!2-!3 and !4-!5

Pumiliohomology

"

Helix "2 provides
the RNA interacting
pocket

ZincFinger

"!

Amino acid
residues in "
helices

PAZ

"!
(!-barrel)

dsRBM

"!!!"

Hydrophobic pocket
formed by !-barrel
and inserted "!
motif
"1 helix and !1-!2
loop

SAM

""""""

Hydrophobic core
packed with
electropositive
regions

Protein-interaction
Interacts with ssRNA
through stacking,
electrostatic interactions
and hydrogen bonding
Recognizes at least 4
nucleotides of ssRNA
through hydrophobic
interactions, backbone
contacts from the loop
and hydrogen bonding
with bases
Bind GAG triplet through
protein-base interactions,
stacking or hydrogen
bonding
Recognizes poly U of
ssRNA through stacking
and hydrogen bonding
Stacking interactions and
two amino acids in "2
makes hydrogen bonds
with Watson-Crick edge
of a base
Sequence-specific
(UAUU-Tis11d (23, 24)),
hydrogen bonding to the
protein backbone, and
shape determines the
specificity
Single-stranded RNA
(ssRNA), and the 5’phosphate and 3’-OH
contribute to specificity
Shape specific
recognition of RNA minor
groove of A-form helix
(stem-loop), and
sequence-specific (G-XnA/G) contact with the 2’OH of sugar and
phosphate backbone
Shape-specific
recognition of RNA stemloop, and interaction with
phosphate backbone and
a single nucleotide G at
position 3 of the
pentaloop

Examples
(PDB ID)
PTB (2ADC)
(15)
Fox-1 (2ERR)
(16)
Nova-1 (1EC6)
(17)
NusA (2ATW)
(18)

TRAP (1C9S)
(19)
Sm core
protein (1M8V)
(20), Hfq
(1KQ2) (21)
Pumilio 1
(1M8Y) (22)

Tis11D
(1RGO) (24)

PAZ (1SI3)
(25)

ADAR2 (2L3C)
(26)
Staufen
(1EKZ) (27)

Vts1p (2ESE)
(28)
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1.2

RNA-binding proteins are modular
Most RNA binding proteins have a modular structure formed by RNA

binding domains. These RNA binding domains are encoded by sequences of 70150 amino acids that are important for RNA recognition and interaction (4, 29).
Most of the RNA binding proteins (RBPs) consists of one or more RNA binding
domains (Figure 1.2). These include the RNA binding domain (RBD), often
called RNA recognition motif, (RRM); K-homology (KH) domain; zinc finger
(ZnF); Pumilio/FBF (PUF) domain; Piwi/Argonaute/Zwille (PAZ); sterile alpha
motif (SAM) domain; double-stranded RNA binding domain (dsRBD); and the Sm
domain. These modular architectures allow RBPs to recognize RNA with high
specificity and affinity, as well as, create functional diversity within the RBPs (2,
4, 30). Proteins with multiple domains can bind long RNA strands or also interact
with multiple RNAs; furthermore, modulation of RNA binding domains with other
auxiliary functional domains help to recognize RNA as well as perform enzymatic
activity. For example, adenosine deaminases that act on RNA 2 (ADAR2) and
protein kinase R (PKR) have similar dsRBD but different auxiliary functional
domains. ADAR2 converts adenosine to inosine while PKR have a kinase activity
in its target RNA (31, 32).
Frequently, RNA binding domains are connected with interdomain linkers
of variable length. The importance of these linkers is in recognition of the discrete
target and they may act as spacers to regulate the catalytic action of each
domain (4). In some cases, linkers can interact with the RNA binding domains to
allow two domains to function synergistically as observed in polypyrimidine tract
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binding protein domains 3 and 4 (PTB34) (15). Eukaryotic genomes have been
shown to have higher numbers of modular RBPs, which might reflect the
evolution of highly specific gene expression and modification patterns (2, 33).

Figure 1.2 Different modular structures of RNA binding proteins (RBPs).
Examples are taken from the most common RBPs. Each RBP contains many
domains as shown by the colored boxes. This Figure is adapted from (2, 4).

1.3

Single-stranded RNA recognition
In most cases, RNA binding proteins (RBP) recognize ssRNA as their

target. Many ssRNA binding domains have been identified and have been shown
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to recognize RNA by conserved RNA binding domains (RRM and KH) and by
repeats

of

RNA

binding

domains

(TRAP

and

Sm).

The

oligonucleotide/oligosaccharide binding protein (OB-fold) domains recognize
structured RNAs (34). Many of ssRBPs are sequence-specific RNA binding
proteins with a hydrophobic binding surface to maximize intermolecular contacts
with the RNA bases. The most common ssRBPs and their structures are
discussed in detailed.
1.3.1 RNA recognition motifs (RRM)
The RNA recognition motif (RRM) domain is the most abundant and the
best characterized RNA binding domain in higher eukaryotes. It has been
estimated that about 2% of human gene products are associated with RRM (30).
These domains, also known as ribonucleoprotein domain (RNP) or RNA-binding
domain (RBD), consists of 80-100 amino acid residues (30, 35) and are often
found in multiple copies. Single RRMs recognize a minimum of two to a
maximum of eight nucleotides in the RNA (36, 37). RRM has four antiparallel !sheets packed against two "-helices with a topology of !"!!"! (Figure 1.3A and
Figure 1.3B). An unusual fifth !-strand is present in RRM3 of polypyrimidine tract
binding protein (PTB) (Figure 1.3C) (15, 38). Most of the studied structures of
RRM protein in complex with RNA has led to two proposed primary conserved
sequence stretches that contribute to the RNA binding known as RNP1 ([R/K]-G[F/Y]-[G/A]-[F/Y]-[I/L/V]-X-[F/Y]) and RNP2 ([I/L/V]-[F/Y]-[I/L/V]-X-N/L) (Figure
1.3A) (35). These RNA binding sequences often rely on the surface of the central
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Figure 1.3 Structures for common single-stranded RNA binding protein RRM and
KH domains. (A) The secondary structure for RRM domain with conserved
sequences RNP2 (red) and RNP1 (green). (B) The RRM for Fox-1 domains
(PDB: 2ERR) (C) The RRM domain 3 of PTB (PDB: 2ADC) showing the extra !strand (red). (D) The secondary structure for type I KH domain. (E) Type I KH
domain of Nova-1 (PDB: 1EC6) with GXXG conserved loop. (F) Type II KH
domain in NusA (PDB: 2ATW). RNA nucleotides are represented in color and
protein secondary structures are shown in grey. Figures were generated with
PyMOL.
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!-strands; !1 and !3 (15, 39-41). To form these RRM-RNA complexes, solventexposed charged residues (Arg or Lys) form a salt bridge to the phosphodiester
backbone of the RNA and two aromatic residues can form a ring stacking
interaction or hydrogen bonds with the RNA nucleobases (7, 35). The wide range
of RNA structures and recognition sequence elements have associated RRM
proteins with diverse biological functions. These motifs in eukaryotes are
implicated in post-transcriptional gene regulation, like pre-mRNA splicing,
alternative splicing, capping, mRNA stability and export, RNA editing and poly(A)
recognition (9, 30). During alternative splicing many ssRBPs associate with premRNA (RNPA1, U2AF65, U2AF35, PTB, Fox-1, sex-lethal) to regulate splicing
(42). For example, SR proteins recognize exonic splicing sites to promote
alternative splicing whereas Fox-1 does the same activity by interaction with
intronic splicing elements (43, 44). Recent studies have shown that RRMs are
also involved in protein-protein interactions for the recognition and interaction
with RNA with very distinct mechanisms from protein-RNA interactions (30).
1.3.2 KH-homology domain
The heterogeneous nuclear ribonucleoprotein K-homology (KH) domain is
highly expressed and most abundant in gene expression and regulatory systems
in bacteria, archaea and eukaryotes (45). The KH domain consists of nearly 70
amino acid residues with a signature sequence of (I/L/V)IGXXGXX(I/L/V) at the
center of the domain (45, 46). All KH domains are composed of three !-sheets
packed against three "-helices. KH domains are divided into two sub families:
type I has !""!!" topology (Figure 1.3D and Figure 1.3E) (Nova) whereas type
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II has !""!!" topology (Figure 1.3F) (NusA) (46). An important feature of the
KH domain is the presence of a variable length loop that connects !2 and !3 in
type I and !3 and "2 in type II (47). In both type I and II, the consensus
sequence is formed by a GXXG loop recognized four nucleotides. Hydrophobic
interactions between bases and non-aromatic residues, backbone contacts with
the GXXG loop, as well as hydrogen bonding with bases are the prevalent
interactions observed between protein and RNA (4). This ssRNA binding protein
domain can also found in multiple copies (14 copies in chicken vigilin, three KH
domains in hnRNP K) that can increase the RNA binding affinity and
cooperativity of this protein (48).
The KH domain is the most abundant RNA binding domain in eubacteria
and eukaryotes, suggesting the evolutionary importance of this ancient RNA
binding domain. Like RRM, KH protein domains are also involved in a myriad of
biological processes like splicing (splicing factor 1, SF1) (49), alternative splicing
(Nova family protein) (50), transcriptional and translational gene control (hnRNP
K) (51) and mRNA stability, transport and localization (9). Unusual expression of
this protein has been linked to many diseases, such as human fragile X mental
retardation syndrome which is caused by a loss of FMR-1 expression where a
mutation on the conserved KH motif has an RNA binding defect (52).
1.3.3 RNA recognition by modular RNA binding repeats
In some cases, RNA binding domains oligomerize to form modular RNA
binding repeats. The numbers of modular repeats varies; for example, eleven
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repeats are observed in TRAP proteins, seven in Sm core proteins and six in
Lsm proteins Hfq (19-21, 53).
The tryptophan RNA binding attenuation protein (TRAP) is comprised of
70 amino acids in each of the eleven monomers that fold into four antiparallel !strands to form a !-sandwich-like structure. Tryptophan is inserted between the
interfaces of two !-strands. Each monomer oligomerizes into an 11-mer
symmetric ring as observed in the crystal structure of Bacillus subtilis TRAP
bound with a 53-nucleotide ssRNA containing GAG triplets (Figure 1.4A) (19).
Each monomer contains an RNA binding pocket created by two !-strands to
allow for binding to the GAG triplet through protein-base interactions (19).

Figure 1.4 RNA recognition by modular RNA binding repeats. (A) The crystal
structure of the 11-mer TRAP (PDB: 1C9S) protein with GAUGU ssRNA repeats.
The surface in magenta is a L-tryptophan inserted in the !-sandwich. (B)
Structutre of Hfq (PDB: 1KQ2) showing the hexameric ring from S. aureus. The
central core contains a bound 5’-AU5G-3’ RNA. For clarity, each protein subunit
is colored differently and RNA is in yellow sticks. Figures were generated from
PyMOL.
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The outer edge of the 11-mer oligomeric structure has a symmetrical ring
with an 80 Å diameter. TRAP regulates the expression of L-tryptophan
biosynthesis genes in several bacilli, which is activated by bound L-tryptophan.
For regulation, TRAP binds to the 5’ ssRNA leader sequence of an mRNA
operon and terminates transcription by preventing the formation of the
antiterminator stem-loop structure (9, 54).
The classical Sm fold is characterized by an N-terminal !-helix followed by
five "-strands with a topology of !""""" (Figure 1.4B) (55). The Sm proteins
consist of nearly 80 residues and recognize the uridine-rich site (Sm-site) present
in small nuclear RNAs (snRNAs). Each Sm proteins oligomerizes to form a
heptameric ring (~70 Å diameter) structure around the poly(U) RNA (55). The
central hole of this ring can accommodate the U small nuclear RNP (UsnRNP)
during pre-mRNA splicing (56, 57). It has been proposed that the intersubunit
interaction during oligomerization is manifested by hydrophobic contacts between
adjacent "-strands and each U-rich RNA is recognized by three conserved
residues in the loops of !2-!3 and !4-!5 (20). The interactions between Sm
protein domains and the RNA include stacking and hydrogen bonding. Unlike Sm
proteins, LSm proteins, such as bacterial host factor for Q-! bacteriophage (Hfq),
form a hexameric doughnut-shape with a 12 Å central cavity in the absence of
RNA (21, 58, 59). The crystal structure of S. aureus Hfq with a short RNA (5’AU5G-3’) showed that the RNA is bound around the basic central pore (Figure
1.4B) (21). Hfq is known to play a role in post-transcriptional gene regulation
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where it helps small non-coding RNAs (ncRNA) to identify its target mRNA (6062).
1.3.4 Other ssRNA binding proteins
Several recent studies have shown other proteins that can bind RNA
through different structural arrangements than the traditional RRM and KH
domains. These protein domains include zinc fingers, pumilio homology domain
(PUF), PAZ domain and OB-fold. Their structures, RNA recognition motifs and
protein interactions are summarized in Table 1.1 and are mentioned in many
research and review articles (34, 35, 63-65).
1.4

Double-stranded RNA recognition
Double-stranded RNA binding motifs (dsRBM) recognize perfectly duplexed

RNA and are distributed in eukaryotes, bacteria and viral proteins (66). This motif
adopts an !/" sandwich global fold with an !"""! topology that contains 70-90
amino acid residues (Figure 1.5A) (4, 10, 67, 68). Previous structural studies of
dsRBM protein-RNA complexes proposed that these proteins bind in a shapespecific rather than sequence-specific. Many of the solved structures suggested
that dsRBM recognizes the A-form helix of dsRNA, and intermolecular
interactions involve the direct contact with the 2’-OH sugar and phosphate
backbone (4, 27, 69-71). But the recent solution NMR structure of an adenosine
deaminase (ADAR2) in complex with a stem-loop pre-mRNA encoding the R/G
editing site of GluR-2 has revealed that dsRBM recognizes shape as well as
sequence of the RNA (26). The minor groove of the A-form helix in the stem-loop
is specifically recognized by the N-terminal helix (!1) and "1-"2 loop of ADAR2
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(Figure 1.5A). The two domains of ADAR2, dsRBM1 and dsRBM2 preferentially
recognize G-X9-A and G-X8-A RNA sequences respectively in a long stem-loop
pre-mRNA. The sequence-specificity of ADAR2 dsRBM is important for the
proper editing function of the enzyme (26).

Figure 1.5 Structure of RNA (yellow sticks) bound with dsRBM and SAM proteins
(grey). (A) USL (upper stem-loop of GluR-2 R/G) RNA recognition by dsRBM1 of
ADAR2 (PDB: 2L3C). Shown in red is a !1-!2 loop that is important for sequence
specific recognition of RNA (26). (B) The structure of Vts1p-SAM (PDB: 2ESE)
domain in complex with SRE RNA. Figures were generated from PyMOL.

The double-stranded RBM is involved in several biological processes from
RNA editing to protein phosphorylation in translational control (66). For example,
the RNaseIII domain is involved in RNA processing in the RNA interference
(RNAi)/microRNA (miRNA) pathway (72-74). Drosophila melanogaster staufen
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contains multiple copies of dsRBM domains that control RNP localization (74).
Furthermore, ADAR1 and ADAR2 are RNA editing proteins that regulate gene
expression at the RNA level (75) by converting adenosine-to-inosine (A-to-I) by
hydrolytic deamination in many mRNA and pre-mRNA transcripts (26, 76).
1.5

SAM binding domain
The sterile alpha motif (SAM) domain is the most copious of the eukaryotic

protein motifs, initially identified as a protein-protein interaction module involved
in transcription regulation and signal-transduction (28, 77). Later, it was reported
that the SAM domain also interacts with RNA to control post-transcriptional gene
expression (78). The SAM domain from Saccharomyces cerevisiae (Vts1p) and
its homolog from Drosophila melanogaster (Smaug) specifically interact with the
RNA stem-loop (78). The RNA stem-loop recognized by Smaug contains a
CNGGN pentaloop in the Smaug recognition element (SRE) present at the 3’
untranslated region (UTR) of the nos transcript (78, 79). The solution NMR
structure of Vts1p-SAM in complex with a 23 nucleotide SRE stem-loop RNA with
a CUGGC pentaloop was recently solved (Figure 1.5B). This study revealed that
the SAM domain recognizes RNA in a shape-specific rather than sequencespecific manner specifically recognizing the G in position three of the pentaloop
(28). Two intermolecular hydrogen bonds specifically recognize the identity of the
third G in the pentaloop, which also occupies the hydrophobic cavity formed by
Leu465 and Ala495 (28). This protein consists of six !-helices that adopt a
globular protein fold and recognize the major groove of the RNA pentaloop
through contacts with the RNA sugar-phosphate backbone (28).
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1.6

Protein-RNA interactions in the ribosome
The ribosome is a protein-RNA complex with a catalytic role in protein

synthesis. This complex macromolecule consists of more than 50 different
ribosomal proteins that interact with RNA. How all of these proteins interact with
RNA to form an active structure of the ribosome was a question that proved
elusive. The recent X-ray crystal structures of the ribosomal subunits offered a
clear picture to explain the interactions between ribosomal proteins and the RNA
(80, 81). The majority of the ribosomal proteins recognize ribosomal RNA by
shape rather than by sequence. Hydrogen bonding, stacking, hydrophobic
interactions, as well as interactions with the phosphate backbone were observed
among the characterized protein-RNA interactions.
Ribosomal proteins contain globular domains with similar !/" sandwich
folds (80, 82). The topologies of some of the ribosomal proteins are similar to
other RNA binding proteins as described before, reflecting the similar RNA
binding properties among them. Most of these proteins have extended structures
like extended !-hairpin (S2), "-hairpin (S5, S10), N-terminal extension (S3) and
C-terminal tail (S6) (81, 82). These extensions are associated with basic amino
acid side chains and have extensive contacts with ribosomal RNA that stabilize
the tertiary structure of the ribosome and also participate in protein-protein
interactions (82). In the crystal structure, most of the primary binders are
globular, surface-oriented, and have a direct interaction with RNA helices during
assembly. For example, S15 is a primary binder with four !-helices and without
any extensions that recognizes the junction of helices h20, h21 and h22 as well
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as helix h23a in the 16S ribosomal RNA (83). Proteins with multiple extensions
are buried in the RNA and are secondary or tertiary binders. Except for very few
(h10, h14 and h33a), most of the RNA helices in the 16S RNA contact proteins
and many proteins can recognize a single RNA helix. Most of proteins in the
large subunit, except L12, have a direct interaction with RNA (80). Therefore, it
can be theorized that RNA binding proteins may function in the proper folding of
RNA. But some of the ribosomal proteins from large subunit (L1, L10 and L11)
are directly involved in protein synthesis. Ribosomal proteins also have
significant protein-protein interactions that influence the proper assembly of the
ribosomal subunits (82).
1.7

Conclusions
RNA molecules can adopt different secondary and tertiary structures that

not only allow it to perform structural, catalytic and regulatory roles but also
create a platform to interact with many proteins to form protein-RNA complexes.
These protein-RNA complexes have a wide variety of structural and functional
roles in the cell. Most of the RNA-binding proteins are modular and their mode of
RNA recognition is also different. Several methods including single-molecule
techniques have been used to explore the structural and dynamics of proteinRNA interactions. This will finally led to characterize the mechanistic importance
of protein-RNA interactions and their roles in cellular functions. Therefore,
understanding the molecular mechanism of protein-RNA interactions and their
applications to function is an important aspect of structural and biological
research.
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CHAPTER 2
Methods
2.1

Methods used to study protein-RNA interactions
RNA folding and conformational changes are important for proper RNA-

protein interactions and ribonucleoprotein (RNP) assembly and function. To
understand the detailed mechanisms and to obtain a clear picture of RNA-protein
interactions, several methods have been used; each method has its own
advantages and disadvantages. For example, native gel Electrophoresis Mobility
Shift Assay (EMSA) can show binding of protein with RNA, characterized by gel
shift, but lacks any kind of kinetic information (84, 85). X-ray crystallography can
provide specific structural information of a large RNP complex (86) as well as
discrete intermediates formed during the protein-RNA interaction (87) but cannot
provide details of conformational dynamics of the interaction. Cryo-Electron
Microscopy (cryo-EM) is another method that can be used to determine the
three-dimensional structure of large RNP complex (88-90), but like X-ray
crystallography, it does not offer details of conformational dynamics. Nuclear
Magnetic Resonance (NMR) spectroscopy can provide insight into both structure
and conformational dynamics of RNA-protein interactions (15, 41, 91, 92);
however, this technique has a size limit due to technical challenge (93). Chemical
probing can capture intermediates but lacks any detailed structural information
(94, 95). Hydroxyl radical footprinting can be used to capture the detailed
mechanistic information of protein-RNA interactions (96, 97) because of its
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higher time resolution but it also cannot provide structural information. Pulsechase mass spectrometry can provide kinetic information of protein-RNA
interactions, such as kinetics of 30S ribosome assembly (98), but this method is
not able to observe kinetics of transient interactions (99).
Unlike

the

aforementioned

techniques,

fluorescence

spectroscopic

techniques have been developed to understand both the structural and dynamic
behavior of protein-RNA interactions. This study focuses on the characterization
of protein-RNA interactions using Fluorescence Resonance Energy Transfer
(FRET) in combination with single-molecule FRET (smFRET).
2.2

Fluorescence spectroscopy
Fluorescence is defined as the ability of a molecule to emit light from its

electronically excited singlet state upon excitation by light of a certain
wavelength. According to the Jablonski diagram (Figure 2.1A), the electronic
state of a molecule changes from the ground state (S0) to the vibrational levels of
the excited states upon excitation. The relaxation of a molecule from a singletexcited state (S1) down to the singlet ground state results in the emission of light
at a certain wavelength. This phenomenon has a lifetime of 10-9 s (100). A
fluorescence spectrum can be generated by plotting fluorescence emission
intensity as a function of wavelength. The emission spectrum can be used to
obtain both qualitative and quantitative information from a molecule of interest.
The nature of those spectra depends on the nature of the fluorescent compound
(chromophore) and solvent used.
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2.3

Fluorescence resonance energy transfer
The phenomenon of fluorescence resonance energy transfer (FRET), also

known as FÖrster resonance energy transfer, was discovered by Theodor FÖrster
in the 1940s (101). FRET is a long-range non-radiative energy transfer process
from one fluorophore called the donor to other fluorophore called the acceptor,
when they are within 10-100 Å of each other (Figure 2.1A). FRET can be used
as a molecular ruler to measure the distance between a fluorophore pair directly
(102) as the rate of energy transfer (kT) and efficiency (ET) of energy transfer
both depend on the distance between donor and acceptor (Equations 2.1 and
2.2)

!

6
1 # R0 &
kT = % ( ,
"D $ R '

(2.1)

R06
ET = 6
,
R + R06

(2.2)

where, !D is the fluorescence lifetime of the donor in the absence of acceptor, R0

! defined as the distance at which 50 % of energy is
is the Förster distance (103)
transferred from the donor to the acceptor, typically 20-80 Å (Figure 2.1B). R0
depends on the spectral overlap between donor and acceptor and the relative
orientation of their transition dipoles (Equation 2.3) (104).
R06 = 8.79 " 10 #5

$ 2% D J
,
n4

(2.3)

where, "2 is the orientation factor (2/3 in average), #D is the quantum yield of the
donor in the absence!of acceptor, n is the refractive index of the solution (1.33 for
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aqueous solution) and J is the spectral overlap between donor emission and
acceptor excitation calculated by Equation 2.4 (Figure 2.1C).

Figure 2.1 A Jablonski diagram showing the simplified energy levels. (A)
Diagram showing the possible photophysical transitions after a molecule is
excited by a certain wavelength. S and T represent the singlet and triplet states
respectively. The black arrow represents the fluorescence resonance energy
transfer (FRET) from donor to acceptor fluorophores when two molecules are in
close proximity. !EX and !EM are excitation and emission for both donor (D) and
acceptor (A). (B) FRET efficiency as a function of distance between two
fluorophores for a FRET pair Cy3 and Cy5. R0 is the Förster distance (60 Å)
represented by a line where the energy transfer efficiency is 50% (C) Spectrum
overlap for Cy3 and Cy5 fluorophores. Absorption and emission spectra are in
blue and red for both fluorophores, respectively. The area in green represents
the spectral overlap between donor emission and acceptor absorption (105).
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In this equation, FD(!) is the emission spectrum of the donor and "A(!) is

! of the acceptor fluorophore normalized to the extinction
the absorption spectrum
coefficient. The value of J from Equation 2.4 is used to calculate R0 in Equation
2.3. In general, FRET can be calculated simply by measuring the emission
intensities of the donor (ID) and acceptor (IA) as in Equation 2.5.

FRET =
2.4

IA
,
IA + ID

(2.5)

Steady-state FRET
!
For steady-state FRET experiments (ssFRET), a sample is excited with a

continuous light source and emission intensity is recorded. A commercially
available spectrophotometer (Carry Eclipse fluorescence spectrophotometer) is
used to measure emission spectra throughout this study. This spectrometer uses
a xenon lamp to generate a continuous light source to excite a sample in a quartz
cuvette (Quartz Fluorometer Micro Cell, Starna Cells, Inc.). Fluorescein is excited
at 490 nm (10 nm bandwidth) and fluorescein and rhodamine emissions are
measured at 520 nm and 580 nm (5 nm bandwidth), respectively. Likewise, Cy3
is excited at 555 nm (10 nm bandwidth) and Cy3 and Cy5 emissions are
measured at 565 nm and 665 nm (5 nm bandwidth), respectively. Emission
intensities from both donor and acceptor fluorophores are then used to calculate
FRET using Equation 2.5.
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2.5

Time-resolved FRET
Time-resolved FRET (trFRET) has been successfully used to characterize

the conformational dynamics of biological systems by measuring the distance
distributions. For example, Haas and co-workers first developed trFRET to study
the conformational dynamics of polypeptides in solution by measuring the
distance between the two ends of the polypeptide (106). Lilley, Millar and coworkers have used this technique to characterize the conformational isomers of
Holiday junction (107-109). Walter, Rueda and co-workers have also successfully
used this technique to characterize different RNA enzymes (110-112). In this
technique, FRET is determined by measuring the intensity decay or anisotropy
decay of the donor fluorophore in the presence and absence of the acceptor
fluorophore (100, 104). This technique is important because it allows detection of
two or more conformations simultaneously. Two types of measurements, a time
domain and frequency domain have been successfully used to measure donor
decay. In this study, time domain trFRET experiments were performed using the
Time-Correlated Single-Photon Counting (TCSPC) technique.
2.5.1 Time-correlated single-photon counting (TCSPC)
A home built trFRET setup is used in combination of ISS TCSPC module
as shown in (Figure 2.2). As previously described (110), time-correlated single
photon counting is performed before the collection of a time-resolved emission
profile for the donor fluorophore (Fluorescein and Cy3). A class-4 high power
Yb-doped fibre laser (Fianium inc.,UK) is used to excite the donor with 5 ps
pulses at 40 MHz. Fluorescein was excited at 470 nm (30-nm band-pass dichroic
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Figure 2.2 Schematic representation of TCSPC setup for time-resolved FRET
data acquisition. A class-4 high power Yb-doped fibre laser was used to excite a
sample after passing through an excitation filter and polarizers. The intensity of
the excitation beam is controlled by a neutral density filter (NDF). Emission is
passed through a selected filter and detected using a photo multiplier tube
(PMT). The arrival time (“START”) relative to the excitation pulse (“STOP”) is
determined by constant fraction discriminators (CFD) and a time-to-amplitude
converter (TAC). The START signal is provided by photons emitted and STOP
signals are detected by the photodiode (PD) from a fraction of excitation light
diverted by a quartz cover glass. Those signals are electronically delayed and
then feed to time to amplitude convertor (TAC) via CFD (104). Signals from TAC
are then passed through the analogue to a digital convertor (ADC) to the
computer.
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filter) and Cy3 is excited at 520 nm (20-nm band-pass dichroic filter). Donor
isotropic emission is collected at 520 nm (20-nm band-pass dichroic filter) for
fluorescein and 540 nm (20-nm band-pass dichroic filter) for Cy3. The magic
angle (54.7°) is used to detect the isotropic emission to more than 40000 counts.
Collection of fluorescence decay was done in 4816 channels with a time
increment of 12.2 ps/channel by using a micro-channel photomultiplier tube
(Hamamatsu R3890U-52) feeding with a time correlated single-photon counting
device (SPC-630, Becker & Hickl). A dilute solution of non-dairy coffee creamer
is used to measure the instrument response function.

Time-resolved

fluorescence decays are collected for donor only and donor-acceptor fluorophore
pair solutions.
2.5.2 TCSPC data analysis
The fluorescence intensity of the donor fluorophore decays exponentially
as shown in Equation 2.6.
$ t '
ID ( t ) = I0 exp& " ) ,
% #D (

(2.6)

Where, !D is a fluorescence lifetime of the donor and I0 is the initial
!
intensity, which depends on the concentration of the fluorophore. As previously

described (104, 110, 112), this donor-only emission decay is fit to a sum of three
exponential decays characterized by their lifetimes with fractional contributions "I
in the presence of acceptor. The data from the doubly-labeled complex are then
fit with the Förster model to determine distance distributions (Equation 2.7).
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Finally, these decay data is used to measure the donor acceptor distance
distributions.

' t - ' R * 6 0*
IDA ( t ) = " P ( R)$ # i exp)) %
/1+ ) 0 , 2,, dR ,
&
i
( D,i . ( R + 1+

(2.7)

Here, P(R) is the distance distribution, !i and "D,i are lifetime parameters

!
for singly-labeled
and R0 is Förster distance for 50% energy transfer which is 55
Å for fluorescein and TAMRA pair. The distance distribution P(R) is modeled as a
three-dimensional weighted Gaussian, (Equation 2.8), where N is a normalization
constant, and ! and µ describes the shape of Gaussian (Equation 2.8 and
Figure 2.3A).
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Figure 2.3 Time-resolved FRET data analysis of fluorescence decay for
fluorophore-labeled RNA. (A) The donor fluorescence decay profile shows the
fast decay of donor only (absence of acceptor, black line) and in the presence of
the acceptor fluorophore (blue line). The curves are then normalized to a peak
count of 40,000 with a fitting constant (!2) value of <1.3. (B) The probability
density profile for single distributions with the mean distance (60 Å) and the full
width half maximum (fwhm).
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Home written software was used to fit the data and the quality of fit was
judged by the reduced !2 value. Failure to obtain a good fit for a single
distribution alluded to the presence of more than a single donor-acceptor
species. In this situation, the decay was fitted to a second distribution to obtain a
better !2 value.
2.5.3 Information from trFRET experiments
trFRET experiments help to resolve the following information as shown in
Figure 2.3B:
I.

Fractional distribution: Defined as an equilibrium constant and free
energy difference between conformers.

II. Mean distance: The distance separation between conformers.
III. Full length with half maximum (FWHM): The contribution from global
flexibility.
2.6

Single-molecule spectroscopy
[Some portion of this section was taken from a methods paper published in

2010 (113).]
Over the last two decades, single-molecule spectroscopy has provided
valuable structural and kinetic information about complex biological systems
(114-120). Some of the advantages that single-molecule approaches offer over
ensemble-averaged experiments are that they directly reveal the presence of
heterogeneous populations and allow access to kinetic information without
synchronization. Furthermore, single-molecule experiments monitor kinetic
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pathways in real time, thus revealing the existence of relevant kinetic
intermediates. Single-molecule spectroscopy has been applied to elucidate the
mechanisms of numerous systems such as RNA and DNA polymerases (121128) and molecular motors (129, 130) among many others. More recently, singlemolecule assays have been developed to study gene expression in vivo (131,
132) as well as DNA and RNA sequencing (133-135).
2.6.1 Single-molecule fluorescence microscopy
Several types of single-molecule methodologies have been developed
(136). These include force-pulling and fluorescence techniques. Force-pulling
experiments employ one or two traps that can be either magnetic or optical traps
and the change in distance is monitored as the force is varied (120, 137-139).
These experiments have been successfully used to monitor RNA and DNA
unwinding and RNA transcription. Fluorescence techniques can be divided into
several categories. The molecules can either freely diffuse or be immobilized to
the slide and recorded on a single-molecule microscope. Freely diffusing set-ups
are generally coupled to confocal microscopes, and total internal reflection
(TIRF) is used for immobilized samples. These techniques have been used to
study small ribozymes, RNA-protein interactions, and DNA polymerase.
Multiple approaches have been developed to study immobilized singlemolecules with fluorescence detection (136, 140-142). Fluorescence studies
often rely on FRET, an increasingly popular approach to follow conformational
changes of macromolecules and measure intermolecular interactions in real time.
The combination of single-molecule spectroscopy and FRET enables real time
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monitoring of the global structure and dynamics of isolated molecules. Thus,
smFRET is complementary to other structural techniques, such as X-ray
crystallography, NMR or cryo-electron microscopy, which can provide structural
information at the atomic level but not in real time.
2.6.2 Total internal reflection fluorescence microscopy
Total Internal Reflection (TIRF) microscopy is particularly valuable as it
significantly reduces the background signal so that there is a better signal to
noise ratio for the molecules of interest. A prism-based TIRF set up was used
with an inverted microscope (IX-71, Olympus, Center Valley, PA) as shown in
Figure 2.4. Here, the molecules are immobilized on a quartz slide (Finkenbeiner,
Waltham, MA) that directly contacts the prism. A quartz Pellin-Broca prism (CVI
Melles-Griot, Albuquerque, NM) is used with immersion oil (Cargille, cedar
Grove, NJ) in between prism and quartz slide surface. A laser beam of 532 nM (3
mW, CrystalLaser GCL-532-L, Reno, NV) is used to excite the immobilized
molecules. The laser hits the solution with an incidence angle greater than the
critical angle such that the beam is totally reflected rather than entering the
solution, but produces an evanescent wave that can excite molecules about 100150 nm into the solution. The donor and acceptor intensities collected by the
objective are separated in a light tight box as shown in Figure 2.4 by using
dichroic mirrors and passed to the CCD (charge-coupled device) camera (Ixon+,
DV-897E, Andor, South Windsor, CT) (141, 142).
hundreds of molecules are detected in parallel.

Using this technique,
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Figure 2.4 Schematic diagram of excitation and single FRET pair emission for
prism-based TIRF (141, 142). The excitation beam reaches the slide-solution
interface and creates an evanescent wave that excites immobilized molecules in
aqueous solution. The emission from donor and acceptors are collected through
an inverted microscope objective and passed through a slit into a light-tight box,
where the donor (green) and acceptor (red) emissions are physically separated
by dichroic mirror. Finally, the two emission signals are detected side-by-side by
an electron multiplied back illuminated CCD camera. The focal length of the lens
L1 is represented by f1, d and h are distances and height of mirror from objective.
The refractive indices for air, prism, and quartz slide and aqueous solutions are
nair, nq and nsol respectively. L1-L3, lenses; M1-M6, mirrors; DM1-2, dichroic
mirrors. This figure is reproduced from (113).
2.6.3 Surface immobilization
Frequently, molecules are surface-immobilized to extend observation
times into the minute time scale (143). Molecules of interest can be immobilized
through a biotin-BSA, poly(ethylene glycol) (PEG) conjugated to biotin, PEG with
Ni2+ or Cu2+ ions, or using click chemistry (143). Immobilization is relatively
straightforward for nucleic acids alone (DNA or RNA) because their overall
negative charge makes them less likely to interact non-specifically with the
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microscope slide surface, which is also electronegative at neutral pH (144, 145).
The most common immobilization strategy for such straightforward experiments
is biotin-BSA. However, the study of RNA or DNA interacting with proteins is
more challenging because the latter can readily interact non-specifically with the
slide surface (Figure 2.5A) (146). One way to circumvent this issue is to
passivate the slide surface with a polymer-coating using, for example, PEG
(Figure 2.5B) (141, 147). Alternatively, Ni-NTA coated surfaces and PEG with
Ni2+ or Cu2+ ions can be used to immobilize His-tagged proteins; however, this
method is not generally applicable to all systems (148-150). The click chemistry
method of immobilization was recently introduced and may be useful in
preventing interactions with the slide, but it has not yet been applied to systems
that include protein (143). In addition, non-specific surface interactions can be
suppressed by trapping the molecules inside of lipid vesicles immobilized on a
PEGylated surface (151, 152). Several reviews have described both the theory
and basic protocols for smFRET as shown in Figure 2.4 (136, 140-142); the
basic protocols essential for studying protein-RNA interactions are explained
here (141, 147) (adapted from (113) with modifications, Figure 2.5).
2.6.3.1

Surface preparation

Two holes were drilled into a quartz slide (G. Finkenbeiner Inc. 33
Rumford Ave Waltham, MA) using a hand drill (Dremel 300-N, Racine, WI) and a
1 mm diameter diamond drill bit (Kingsley North, Norway, MI) (142) to prepare
the microfluidic channel for smFRET study as shown in Figure 2.6. The following
processing steps were performed to passivate the slide and coverslip surface.
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Figure 2.5 Stepwise representation of surface passivation and sample
immobilization. (A) The slide surface is cleaned. (B) The slide is aminosilanized
and ready for PEGylation. (C) PEG and biotin-PEG molecules are conjugated to
the amine-modified surface (D) Streptavidin is bound to the immobilized biotinPEG molecules. (E) The sample can be surface-tethered with an attached biotin
molecule. After washing to remove unbound sample, the slide is ready for use.
This figure is reproduced from (113).

33
2.6.3.1.1 Cleaning of slides and coverslips
Cleaning the slides and coverslips is one of the most vital steps in slide
preparation because the presence of impurities on the surface increases
background fluorescence. First the reaction container was cleaned with distilled
water and was dried completely by using nitrogen gas. Both the microscope
slides and the coverslips were thoroughly cleaned (Figure 2.5A) by using slightly
different cleaning protocol from elsewhere (140, 153, 154).
Slides were cleaned by scrubbing with Alconox (VWR International Inc.)
paste and then rinsed with distilled water. The slides were then thoroughly rinsed
with ethanol (200 proof) and followed by distilled water to remove debris from
previous experiments. After that slides were boiled for >20 min in 100 mL water,
20 mL NH4OH (ACS grade, Mallinckrodt Chemicals, USA) and 20 mL 30 % H2O2
(EMD Chemicals, USA) to remove organic materials and restore the silanol
groups on the surface. Slides were then rinsed with distilled water and dried with
a Bunsen burner flame, while avoiding formation of any dry deposits on the
surface. Coverslips and slides were placed in separate Coplin staining jars
(made from clear soda lime glass by Wheaton Industries Inc., USA) and rinsed
with distilled water. The slides and coverslips were sonicated in the presence of 1
M KOH (ACS certified, Fisher Scientific, USA) for 30 minutes, rinsed with distilled
water followed by methanol (ACS grade, Fisher Scientific, USA), and sonicated
for 30 minutes in presence of methanol.
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2.6.3.1.2 Aminosilanization of slides and coverslips
Clean slides and coverslips must be functionalized with an amino group,
which will later react with an N-hydroxysuccinimide (NHS) ester on the PEG
molecule (Figure 2.5B and C). This is achieved by aminosilanization with 3aminopropyltriethoxysilane. VECTABONDTM reagent (3-aminopropyltriethoxysilane Vector Laboratories, Inc., Burlingame, CA) is sensitive to oxidation and
should be stored under inert gas. VECTABONDTM should be a colorless solution;
yellowing is a sign that oxidation is occurring.
100 mL methanol, 5 mL acetic acid (ACS grade, Mallinckrodt Chemicals,
USA) and 1 mL VECTABONDTM reagent were mixed in a clean, dry beaker, and
then poured into the Coplin jar containing the slides and coverslips. The slides
and coverslips were then incubated for 10 minutes with the VECTABOND
solution, sonicated for 1 minute and further incubated for 10 minutes. The slides
and coverslips were further rinsed with methanol, distilled water and again with
methanol then dried with nitrogen gas.
2.6.3.1.3 Surface PEGylation
Poly(ethylene glycol) is typically used to passivate microscope slides and
coverslips to prevent non-specific interactions with proteins. Adsorption of
proteins to PEGylated surfaces depends on the size and the surface density of
polymer used (155). For standard applications, linear PEG is often sufficient;
however, for particularly highly adsorbent proteins, branched PEG can be used
(155). When branched PEG is used to coat the surface, intermolecular
crosslinking can increase the surface density and further prevent interaction
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between the protein and the glass surface (155, 156). Regardless of the type of
PEG used, a fraction of the PEG is biotinylated to provide an anchor for
immobilization of biotin-labeled samples through streptavidin (Figure 2.5C). The
biotin-avidin bridge is a convenient approach to surface immobilize nucleic acids
(157, 158) because they are both commercially available, they remain tightly
bound to each other (KD ~ pM) (159), and biotin can be easily incorporated at
either the 3! or 5! end of nucleic acids during synthesis or by a labeling reaction
(160, 161).
Biotin Polyethylene Glycol Succinimidyl Carboxymethyl (BIO-PEG-SCM,
MW 3400/5000, Laysan Bio. Inc, Arab, AL) and Methoxy Polyethylene Glycol
Succinimidyl Carboxymethyl (m-PEG-SCM, MW 5000, Laysan Bio. Inc) were
removed from storage at –20°C, 30-60 minutes before use to equilibrate to room
temperature. A PEGylation buffer (100 mM sodium bicarbonate, pH 8.4, Fisher
Scientific, USA) was prepared in distilled water and sterilized using a 0.2 !m
Supor" Membrane syringe filter. For five pairs of slides and coverslips, ~80 mg of
m-PEG-SCM and 5-8 mg BIO-PEG-SCM (which will introduce 5-10% biotinylated
PEG) were dissolved in 320 !L PEGylation buffer. The solution was gently
vortexed and centrifuged for one minute at ~10,000 rcf to remove bubbles. An old
pipette tip box was about 10% filled with distilled water to maintain a humid
environment and was used as a reaction chamber for further PEGylation. The
slides and coverslips were then dried with nitrogen gas. 70 !L of the PEGylation
reaction mixture was applied to the surface of each slide and one dry coverslip
was placed on the top of each slide and solution, avoiding formation of bubbles.
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The reaction was incubated in the humid chamber in the dark overnight. The
coverslips were carefully removed from the slides, rinsed with distilled water and
dried completely with nitrogen gas.
2.6.3.1.4 Preparation of sample channel with flow tubing
Sandwich-like ~4 mm wide and 200 !m deep flow channels (Figure 2.6)
were prepared to immobilize molecules or exchange buffers during experiments.
Slides were held on a micro slide staining rack (VWR International Inc.)
with a the PEG surface side down and ~10 cm of 0.51 mm I.D. SILASTIC!
laboratory tubing (Dow Corning, Midland, MI) was inserted through each hole,
such that a small portion protrudes from the PEGylated side. Tubes were fixed
with epoxy glue (5 min epoxy, ITW Devcon, Danvers, MA) on the non-PEGylated
surface of the slide. The protruding segment of the tube was removed from the
PEGylated slide surface using a razor blade. Double-sided sticky tape (Scotch,
3M) was used to prepare a microfluidic channel on the PEG surface. A piece of
tape was applied to each side of the drilled holes approximately 4 mm away and
parallel to the hole-centers (Figure 2.6). A second layer was added to increase
the channel depth to ~200 !m. A coverslip was placed on the sticky tape
centered on the slide with the PEGylated surface facing towards the slide. Epoxy
was used to seal the coverslip’s periphery (Figure 2.6C). The assembled slides
were stored in a 50 mL falcon tube under inert gas and protected from light in
order to protect from possible photo degradation.
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Figure 2.6 Diagram detailing slide specifications for single-molecule
experiments. (A) Top view of an assembled microscope slide. (B) Slide with 22
mm long, 8 mm wide and 200 !m deep microfluidic channel prepared using two
layers of double-sided tape between the quartz slide and coverslip. The
assembly is sealed with epoxy at the edges to prevent leaking from the channel.
(C) Slide in B with attached flow tubing for injection of sample. This figure is
reproduced from (113).
2.6.3.2

Sample immobilization and preparation

A biotinylated sample (DNA, RNA or protein) was prepared in a buffer of
interest (sample buffer) and immobilized on the single-molecule slide. During the
PEGylation process, 5-10% of biotinylated PEG was introduced to immobilize the
sample. A streptavidin solution (Molecular Probes S888, 0.2 mg/mL in 50 mM
Tris-HCl, pH 7.5, 50 mM NaCl) was injected and incubated for 5-10 minutes to
allow it to interact with biotin (Figure 2.5D). The excess unbound streptavidin
was washed out with the sample buffer, and 10-25 pM biotinylated sample was
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injected and allowed to interact with the streptavidin for 5-10 minutes (Figure
2.5E). The unbound sample was washed with the sample buffer and an OSS
solution prepared in 2 mM Trolox was injected. After 5-10 minutes, the prepared
slide was placed on the microscope stage and used to acquire data. Detailed
protocols about sample preparation, immobilization and detection have been
extensively reviewed (140-142, 144). After use, the slides were recycled and
reused by boiling the slides in water for ~1 hour to soften any epoxy or tape
residue from previous experiments which was then scraped off with a razor
blade.
2.6.4 Oxygen scavenging system for smFRET
Oxygen can be removed from a solution by using a system of glucose
oxidase and catalase in the presence of glucose (162). This two-step reaction
mechanism is very useful in single-molecule experiments to remove the solution
of excess oxygen. This oxygen-scavenging system (OSS) (10% wt/vol glucose,
50 !g/ml glucose oxidase (Sigma, C2133 ! 100 kU/g) and 10 !g/ml catalase
(Sigma, C3155 ! 35 kU/mg)) is used to deplete the solution of oxygen molecules
in effort to decrease photobleaching of the fluorophores, which can be stimulated
in the presence of oxygen (Figure 2.7A). In order to increase photostability and
decrease blinking of the fluorophores, it is important to include Trolox (Figure
2.7B) or "-mercaptoethanol ("-ME) (Figure 2.7C) in the solution (163). Trolox (6hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic

acid,

ACROS

Organics,

Belgium) is a vitamin E analog that can be used as an antiblinking and
antibleaching reagent in single-molecule experiments (164, 165) (Figure 2.7B).
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A saturated Trolox solution (~2 mM) in water is a better candidate to quench
triplet state-related blinking than !-ME (163). !-ME increases the photodarkening
of the fluorophore in a concentration dependent manner and may not be
compatible with many biological systems at high concentration (163-166). A
stock saturated solution of Trolox was prepared by dissolving 5 mg of solid
Trolox in 10 mL distilled water. The solution was shaken at room temperature for
20-30 minutes and filtered through a 0.2 "m syringe filter. This Trolox solution
was used in the preparation of buffers and OSS solution used in single-molecule
experiments in lieu of distilled water.

Figure 2.7 Oxygen scavenging system for single-molecule study. (A) Schematic
chemical reaction showing how glucose oxidase converts dissolved O2 in to H2O2
in the presence of glucose and decomposition of H2O2 back to the molecular O2
in the presence of catalase. (B and C) Chemical structures of Trolox (B) and !Mercaptoethanol (C) commonly used as antiblinking and antibleaching agents in
single-molecule studies.
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2.6.5 Single-molecule data analysis
Single-molecule data were processed and analyzed as previously
described (142, 158, 167, 168). Each single-molecule spot on the donor channel
of the CCD chip corresponds to the same molecule with same frame on the
acceptor channel as shown in Figure 2.8A. A second order, non-linear
polynomial equation was used to match these two spots. An image from
immobilized fluorescence beads with 0.2 !m red microspheres (Invitrogen,
Carlsbad, CA) was used for calibration. After integrating each spot, a
fluorescence trajectory of each fluorophore was obtained, which is characterized
by a certain donor intensity (ID) and acceptor intensity (IA). Each trajectory was
analyzed using MATLAB to select real single-molecules from other unwanted
data. Molecules with stable fluorescence emission, anti-correlated donoracceptor emission intensities and single step photobleaching are indicators of
real single-molecules (Figure 2.8B). FRET is calculated by using Equation 2.5
and each FRET trajectory is binned to a FRET histogram. FRET histograms of
many molecules are combined and can used to calculate thermodynamic
information, which depends on temperature, ionic strength, pH, protein nature
and RNA sequences. The number of peaks in the histogram characterizes the
number of conformations present and the ratio of those peaks is consistent
(Figure 2.8C) with the dynamic equilibrium between a number of conformations
(169). The peak width is a contribution from conformational fluctuations in a
single species. Along with peak width, a peak area and peak position
characterizes the equilibrium population and distance between donor and
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acceptor fluorophores respectively. The position of the peak is related to the
structure (169).
Kinetic information is calculated from the single-molecule measurements
by dwell time analysis of individual states. Each transition is selected and a
dwell-time histogram is calculated as shown in Figure 2.8D. Each bar in the
histogram represents the number of dwell times that correspond to a particular
time. Each cumulative histogram is fitted to get lifetimes (!) and transition rates.

Figure 2.8 Single-molecule data analysis. (A) Overlaid images of two-color
emission for donor (green) and acceptor (red) (113, 170). (B) A fluorescence
emission trajectory (top) for donor (blue) and acceptor (red) fluorophores
attached to the sample showing the anti-correlated behavior. A calculated FRET
time trajectory (bottom) shows the on and off states. (C) FRET histogram
obtained from more than 100 molecules reveals the probability of two states in B.
(D) Dwell time distributions in the on state (!on) and off state (!off) used to
calculate the on and off rate constants. Data points are processed with five points
average after collecting them every 33 ms.
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2.7

Fluorophores
Fluorophores are molecules that have the ability to fluoresce. The

delocalized electrons present in certain molecules have a tendency to absorb
photons of a specific wavelength and emit light of a different wavelength. The
wavelength of emission depends on the nature and chemical environment of the
fluorophore. For a dye to be useful, it should be photostable, so that it can emit
many photons before photobleaching, and exhibit a high quantum yield. The
quantum yield (defined as the ratio of number of emitted photons to the number
of absorbed photons) is a measure of the brightness of a fluorophore. The small
size, commercial availability, and ease of conjugation to biomolecules are other
important factors to consider when choosing a good fluorophore for fluorescence
experiments.
A good FRET dye pair requires a good spectral overlap between donor
emission and acceptor absorption, as well as, a large spectral separation
between donor and acceptor emission to reduce donor emission leakage into the
acceptor emission range. As mentioned before, both donor and acceptor
fluorophores should be photostable and have a good quantum yield (168, 169).
Fluorescein and Tetra-methyl rhodamine (TAMRA) have been used successfully
for steady-state FRET experiments and cyanine dyes (Cy3 and Cy5 pair) are
recognized as a good dye pair for smFRET experiments. The photophysical
properties of some common dyes used in this study are summarized in Table 2.1
with their chemical structures in Figure 2.9.
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Table 2.1 Photophysical properties of some common fluorophores.
Fluorophore

Excitation Emission Extinction coefficient Quantum yield
!max (nm) !max (nm)
(") (cm-1M-1)

Fluorescein (169)

490

520

83,000

0.7

TAMRA (169)

554

580

95,000

0.2-0.5

Cy3 (105)

550

570

150,000

> 0.15

Cy5 (105)

649

670

250,000

> 0.28

Figure 2.9 Common fluorophores used for FRET measurement. Fluorescein and
TAMRA were used as donor and acceptor in the steady-state and trFRET
measurement. Cy3 and Cy5 is a common donor-acceptor pair for singlemolecule study. The detailed photophysical properties are described in Table
2.1.
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2.8

Sample preparation

2.8.1 RNA purification
RNA samples were purified and labeled as previously described (110,
171). Briefly, an RNA with 2’-protection groups was purchased from the Keck
Foundation Biotechnology Resource Laboratory at Yale University School of
Medicine (New Haven, CT). The deprotection reaction was carried out according
the manufacturer’s protocol (172). In detail, solid RNA sample was dissolved in
200 !l N,N-dimethylformamide (DMF, EMD Chemicals, Belgium) and 850 !l
triethylamine trihydrofluoride (New Jersey, USA) and shaken overnight at room
temperature. The deprotected RNA was butanol precipitated and dried under
vacuum. The RNA was dissolved in water and purified by denaturing gel
electrophoresis (20% polyacrylamide and 8M urea). The RNA band was crushed
and soaked in elution buffer (0.4 M NH4OAc, 0.1% SDS, and 0.1 mM EDTA) at 4
°C overnight. The purification continued with chloroform extraction, ethanol
precipitation, and C8 reverse-phase HPLC with a linear acetonitrile gradient with
0.1 M triethylammonium acetate (TEAA, pH 7.4).

RNA concentration was

measured by UV-Vis from the absorbance at 260 nm after background
substraction.
2.8.2 Fluorophore labeling
To perform FRET experiments, the samples must have fluorophore labels
at appropriate positions. Fluorophores can be attached to DNA, RNA or proteins
and can thus be used to monitor conformational changes including changes in
nucleic acid structure, nucleic acid binding, and protein binding. After optimal
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positions based on the Förster radius have been determined, fluorophores can
be attached to oligonucleotides using a labeling reaction.
Oligonucleotides were synthesized with desired fluorophores at different
positions using phosphoramidite chemistry or with an amino linker at the 5’ end,
the 3’ end, or internally on a dT residue. Fluorophores conjugated with a
succinimidyl ester was reacted with the amino group during the labeling reaction.
The deprotected RNA sample was chloroform extracted, ethanol precipitated and
dried under vacuum. The RNA was resuspended in 66 µL water and 20 µL
labeling buffer (100 mM sodium carbonate, pH8.5 for Cy3 and Cy5; 100 mM
sodium tetraborate, pH 8.3 for TAMRA). The fluorophore solution (200 µg in
14µL DMSO) was added and the mixture was shaken at 650 rpm overnight at
room temperature.
After the labeling reaction was complete, the excess fluorophore was
removed and the labeled and unlabeled nucleic acids were separated. As a first
step, the reaction was ethanol precipitated with 100 nmol GTP (as carrier ion),
and resuspended in 100µL HPLC Buffer (0.1 M TEAA, pH 7.4 & 5% acetonitrile).
The labeled and unlabeled fractions were separated via HPLC and the labeled
fractions were dried under vacuum and resuspended in 100 µL distilled water.
The RNA concentration was measured by UV-Vis and stored at -20°C.
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CHAPTER 3
Alternative splicing regulation through RNA looping
3.1

Gene splicing
RNA transcription in eukaryotes produces precursor mRNA (pre-mRNA)

that contains coding sequences (exons) and non-coding sequences (introns) in
the nucleus. This pre-mRNA undergoes three processing steps: 5’ end capping,
3’ polyadenylation and splicing. Splicing is a eukaryotic phenomenon that
generates a mature mRNA from pre-mRNA by removing introns and ligating
exons together. The mRNA is then exported into the cytoplasm to be translated
into protein by the ribosome. The splicing machinery recognizes cis-acting
elements within the pre-mRNA to facilitate the splicing reaction. These elements
are more highly conserved in yeast than in mammals (173, 174). The 5’ end of
the intron contains the 5’ splice site (SS), a conserved GU dinucleotide; the 3’ SS
(3’ end) is a conserved AG dinucleotide; and the branch point sequence (BPS) A,
which lies before a pyrimidine tract ahead of the 3’ splice site (Figure 3.1A). All
these elements are recognized by the spliceosomes during assembly and
catalysis.
3.2

Spliceosome assembly
The spliceosome is a megaDalton (~ 3 MDa) (175) molecular assembly

composed of five small nuclear ribonucleoproteins (snRNPs) and more than 200
different accessory proteins (176, 177). The assembly of these trans-acting
factors is important for the folding of pre-mRNA and for the active splicing
reaction.
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Figure 3.1 Spliceosome assembly. (A) Pre-mRNA sequence elements of
metazoa and yeast conserved splice sites and sequences. Exons are in light blue
and intron is in grey. (B) The spliceosome assembly cycle showing different
complexes formed after assembly. Different snRNPs and other protein factors
are assembled to activate splicing reaction. Reprinted from (174), copyright
(2009), with permission from Elsevier.

48
There are five major uridine rich RNA sequences (UsnRNAs), U1, U2, U4,
U5 and U6. These UsnRNAs combine with serine/arginine (SR) and other
specific RNA binding proteins for splicing. During spliceosome assembly, first U1
snRNP recognizes the 5’ SS of the pre-mRNA intron through RNA-RNA
interactions. At the same time, splicing factor 1 (SF1) recognizes the BPS and
U2 auxiliary factor binds the polypyrimidine tracts at the 3’ splice site to form an
early spliceosome complex (E complex). Then U2 snRNP base pairs at the 3’
splice site and change the E complex to the A complex. The binding of
preassembled U4/U6.U5 tri-snRNP to the A complex leads to the formation of B
complex. Conformational rearrangement of the B complex releases U1 and U4
snRNPs to form a catalytically activated spliceosome complex, the B* complex.
This activated complex performs the first splicing reaction to form the C complex.
The C complex undergoes the second splicing reaction and generates the mRNA
and

post-spliceosomal

complex.

This

post

spliceosomal

complex

later

dissociates to release and recycle the snRNPS for next round of splicing (Figure
3.1 B).
3.3

Splicing reaction
The intron excision and exon ligation is a two-step transesterification

reaction performed by the B* and C complexes respectively. In the first step,
nucleophilic attack of the 2’-OH of A at the BPS to the phosphate at the 5’ splice
site to form a lariat structure linked by 2’-5’ phosphodiester bond. In the second
step, the free 3’-OH of 5’ exon attacks the phosphate at the 3’ splice site,
releasing intron lariate structure and ligating the two exons together (Figure 3.2).
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Figure 3.2 Two step trans esterification splicing reaction. In the first step, 2’-OH
of adenisine of the BPS attack the 5’ splice site generate a free 5’ exon and
intron lariate. In the second step, 3’-OH of the 5’ exon attacks the phosphodiester
bond at the 3’ splice site and generates a free mRNA and lariate structure.
3.4

Alternative splicing
First discovered by Walter Gilbert in 1978, alternative splicing changed the

one gene one protein hypothesis of the central dogma of molecular biology (178)
to the new paradigm of “one gene many protein” in higher eukaryotes. In which
two or more than two protein isoforms from a single gene (179). Alternative
splicing (AS) is a highly regulated biological process that plays a crucial role in
generating high proteomic diversity. Factors that regulate AS can impede the
early stages of spliceosome assembly (180).
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Figure 3.3 Different modes of alternative splicing responsible for generating
different spliced products. (A) The cassette exon. (B) Mutually exclusive
alternative exons. (C) Alternative 5’ SSs. (D) Alternative 3’ SSs. (E) Alternative
promoters. (F) Alternative poly (A) sites. (G) Intron retention.
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Alternative splicing occurs frequently in cells, and most RNA binding
proteins that influence alternative splicing were found to be non-spliceosomal
(181) It has been estimated that >90% of human genes are alternatively spliced
(182). Because of AS, the number of protein coding genes doesn’t correlate with
the number of protein and the overall cellular complexity of the organism (183).
For example, the number of protein coding genes in human is ~25,000, similar to
the ~20,000 genes present in the small flowering plant Arabidopsis thaliana
(183). A single gene can give rise to multiple protein isoforms as in the Down
syndrome cell adhesion molecule (Dscam) gene in Drosophila Melanogaster
(fruit flies) that can give rise to as many as 38,000 unique proteins by alternative
splicing of 95 different exons (184). A particular exon can be expressed or
repressed in a cell depending on different factors including the cell or tissue type,
sex, developmental stage and sometimes external stimuli (185).
The variation in spliced products is due to the selection of splice sites in
the pre-mRNA. Several modes of alternative splicing have been observed. In
some cases, most of the exons are constitutive and are always included,
however, the cassette exons can be either included or excluded from final mRNA
(Figure 3.3A). In contrast only one out of several alternative cassette exons is
included in the case of mutually exclusive exon types (Figure 3.3B). In addition,
selection of alternative 5’ or 3’ SS sites can increase or decrease the length of
particular exon (Figure 3.3C and D). Alternative selection of promoters and poly
(A) sites influences the pattern of exons due to 5’ and 3’ switch (Figure 3.3E and
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F). Finally, particular introns may be retained in mRNA when splicing does not
occur (Figure 3.3G) (180, 183, 186).
3.4.1 Alternative splicing regulation
Alternative splicing is a highly regulated biological process characterized
by the splicing control mechanism. Splicing regulation depends on different key
players such as cis-acting sequence elements (generally, 4 to 18 nucleotides
(186)) present in pre-mRNA and tras-acting factors (snRNPs and other protein
factors) that bind to the cis-acting elements. Cis-acting elements are critical in the
selection of splice sites. In animals, these sequence elements are classified as
intronic/exonic splicing enhancers or silencers. Furthermore, the binding context
of the regulatory elements can control the positive and negative regulation of
alternative splicing (180).
Exonic splicing enhancers (ESEs) are RNA sequences within exons that
promote splicing after binding with some regulator, commonly an SR family
proteins (43, 187). These SR proteins have N-terminal RNA recognition motifs
(RRMs) and a C-terminal RS domain. In general, RRMs confer sequence
specificity for particular exonic enhancers (Figure 3.4A). The RS domain
enriched with serine and arginine repeats can act as a protein- protein interaction
domain during spliceosome assembly (187, 188). It has been also proposed that
the RS domain also binds to the splicing signals in pre-mRNA (189). The RS
domain of SR proteins can be phosphorylated by several kinases. This
phosphorylation is important for protein-protein interactions between RS domains
and overall splicing activity of SR proteins (190, 191). The most studied SR
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protein, SF2/ASF, recognizes (GAR)n sequences in pre-mRNA, where R is either
G or A, and initiates spliceosome assembly (192, 193).

Figure 3.4 Alternative splicing regulatory elements. (A) Pre-mRNA showing
conserved splicing sites and other factors that can influence alternative splicing
regulation. Exon and intron splicing enhancers (ESE and ISE) can enhance the
splicing where as silencers (ESS and ISS) repress splice sites. Fate of
alternative splicing regulation depends on binding of trans-acting elements like
SR proteins, hnRNP, U1 and U2 to the cis-acting elements on pre-mRNA. (B)
Intron definition. After binding U1 and U2AF to the 5’ and 3’ splice site, SR
proteins starts to communicate with both splice sites to define intron. (C) Exon
definition. Binding to U1 snRNP to 5’ splice site enhances the recruiting of U2AF
at the 3’ end. This process needs SR protein to interact with both U1 and U2AF
to define exon.

Exonic splicing silencers are the RNA sequences present in exons of premRNA recognized by several heterogeneous nuclear ribonucleoprotein (hnRNP)
families of proteins that inhibit recognition of the adjacent splice site during
spliceosome assembly (180, 194). Members of this family are recognized by their
interaction with unspliced pre-mRNA and hence they are not a part of only one
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family protein (195, 196). One example of such protein is hnRNP A1, which
contains two RRM domains and one glycine rich auxiliary domain (180, 197). The
RRM recognizes the UUAGGG consensus sequence and controls splicing by
interacting with SR proteins (198). Other examples of hnRNP family proteins are
hnRNP H and F, with three RRMs recognizes G-tracts and binds to exonic
splicing silencer elements (199).
Intronic splicing enhancers are splicing regulatory elements in introns that
can enhance exon expression. Proteins that recognize these enhancers and
activate splicing include GUGBP and ETR-like factors (CELF). Some of this
family protein can compete with other splicing factors like polypyrimidine tract
binding protein (PTB) to enhance the exon inclusion. Most of neuron specific
splicing factors like NOVA-1 (neuro-oncological ventral antigen 1), a K homology
(KH) type RNA binding domains binds to the intronic enhancer sequences and
stimulate the inclusion of glycine receptor GlyR!2 exon 3. Likewise, a sequence
element present in intronic splicing element UGCAUG is recognized by RNA
binding protein Fox (Feminizing locus on X) and enhances splicing (44, 200).
These sequence elements are often expressed on downstream of the tissue- and
muscle-specific exons (201). The classical example of Fox dependent alternative
splicing is observed in neuron-specific N1 cassette exon in the c-src pre-mRNA.
Fox stimulates the inclusion of this exon after binding to the downstream
UGCAUG element (200, 202, 203). This mechanism will be examined in greater
detail in Chapter 4.
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Sequence elements of introns in pre-mRNA that repress the splicing of
associated exons are called intronic splicing silencers. Both SR and hnRNP
family proteins bind intronic splicing silencers (204). HnRNP A1, which
multimerizes both upstream and downstream of the exon can form a loop to
block the access of splicing factors. The most studied protein; PTB (hnRNP I)
binds to intronic splicing silencers and represses many tissue-specific exons.
This protein recognizes the CU rich elements and binds to block the access of
splicing factors as observed in c-src pre-mRNA (205, 206). This protein
repressed the N1 exon after binding CUCUCU elements in the pre-mRNA. The
mechanism of PTB mediated splicing regulation will be discussed in section 3.6.
3.4.2 Alternative splicing regulation and diseases
Splicing regulation is tightly controlled by trans-acting factors that bind to
cis-acting elements. Misregulation is linked to many diseases and disorders. Any
mutation of the cis- or trans-acting factors can disrupt the splicing code,
unbalancing the splicing regulatory mechanisms. Addition or removal of a single
nucleotide from cis-acting site may disrupt the open reading frame can express
aberrant mRNAs that can cause disease, if the mRNA bypasses the quality
control mechanism (nonsence-mediated mRNA decay; NMD) and is translated
into an abnormal protein (207). Several studies have shown that mutation of a
cis-acting element that affects a single gene can cause disease through
deleterious effects of a single gene product (8, 185, 208). On the other hand,
mutation of the trans-acting factors can effect the splicing of multiple genes that
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can disrupt the components of splicing machinery or regulatory mechanism
(209).
Previous studies have characterized several cancers (185, 210-213) and
neurological disorders (207, 214, 215) linked to misregulation of alternative
splicing mechanism. Diseases caused from mutation in cis-acting elements are
Fraiser syndrome (FS) (207, 216), cystics fibrosis (217), frontotemporal dementia
and parkinsonism (218) and many more. Diseases including spinal muscular
attropy (SMA) (219), retinitis pigmentosa (220), Prader-Willi syndrome (PWS)
(221), Huntington disease, (222) Myotonic dystropy (208, 214) arise from
mutations in trans-acting factors.
3.5

Splicing regulation of the c-src N1 exon
The mouse c-src transcript is a model system to study alternative splicing

regulation. This pre-mRNA encodes a receptor tyrosine kinase with an 18nucleotide long cassette exon (N1) between two consecutive exons 3 and 4
(Figure 3.5A). This exon is expressed in neuronal cells and skipped in other cells
(223, 224). There are two intronic regulatory elements present in this pre-mRNA
that are important for the regulation of N1 splicing (200, 202, 225). A CU reach
sequences (CUCUCU) present at the upstream of 3’ splice site of N1 is
recognized by PTB and is essential for N1 repression (226). Paradoxically, there
are additional CU rich elements present downstream of the N1 exon (nucleotides
17 to 142) that is required for both splicing repression and splicing enhancement
(227). The region from nucleotides 37 to 70 are highly conserved enhancer
region that contain a core sequence elements called downstream control
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sequences (DCS). This DCS has two regulatory sequence elements that are
important for splicing enhancement; a G-tract followed by CUG (GGGGGCUG)
and a UGCAUG element. Several RNA binding proteins have been characterized
to bind around DCS (228). PTB and its neuronal homolog (nPTB) bind to the CU

Figure 3.5 Splicing regulation of c-src N1 exon through multiple regulators. (A)
The c-src pre-mRNA with alternative exon N1 and two consecutive exons 3, and
4. Important regulatory elements are represented as PPT and DCS (sequence at
the top of pre-mRNA). PPT is an important for repression and located on both
upstream and downstream of N1 exon. DCS is present at the downstream of N1
exon and is important for splicing activation. DCS contains G-tract, PPT and Fox
binding site (UGCAUG). (B) Repression of the splicing of the N1 exon in nonneuronal cell. PTB binding block the assembly of spliceosomal complex at 5’
splice site and the downstream exon’s 3’ splice. (C) Activation of the N1 splicing
in neuronal cells due to splicing activators. PTB is replaced by nPTB while Fox
protein is also expressed in high level. Other RNA binding proteins like hnRNP
and KSRP are also expressed and binds at the downstream intron. Figure A is
adapted from reference (16) and Figures B and C are adapted from (229).

58
rich elements (227, 230), hnRNP F and hnRNP H, recognize the G-tract (230232), while KH-type splicing regulatory protein (KSRP) and Fox bind to UCGAUG
element (230, 232, 233).
Although there are many splicing factors associated with DCS, the
detailed mechanism of assembly and their roles in splicing regulation is poorly
understood. The most important splicing repressor of N1 exon is PTB, which
binds to the upstream and downstream polypyrimidine tracts (PPTs). Another
factor Fox binds the UGCAUG enhancer element to activate N1 expression but it
is not clear how Fox binding antagonizes action of PTB for splicing of N1 exon in
neurons. It seems that there is a communication between Fox and PTB to
regulate N1 exon, but the detailed mechanism is not well understood. Other
factor for high-level expression of c-src N1 exon in neurons is PTB paralog
nPTB. Even though, nPTB have similar sequence with PTB, this protein functions
as weaker splicing repressor in neurons than PTB (230). This study focuses on
both PTB and Fox proteins and their role in splicing regulation of c-src N1 exon
to elucidate this highly complex mechanism.
3.6

The polypyrimidine-tract-binding protein
The Polypyrimidine-Tract-Binding protein (PTB) is an important trans-

acting factor involved in splicing regulation. PTB is ubiquitously expressed and
most often associated with its role as a splicing repressor (180, 234, 235), but it
is also involved in other aspects of mRNA processing including 3' end
processing, (236, 237) mRNA localization and stability (238) and internal
ribosome entry site- mediated translation initiation of both cellular and viral
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mRNAs (239). PTB plays an important role in the splicing regulation of different
genes, including c-src, ! tropomycinin, ! actinin, Calcitonin/CGRP, GABA "2 and
its own mRNA (PTB mRNA) (13, 240, 241).
3.6.1 Structure of PTB
PTB is a 58 kDa member of the hnRNP family consisting of four RNA
recognition motifs (RRMs 1, 2, 3 and 4) connected by three inter-domain linkers
(30, 242). Humans have 3 variants of PTB (PTB1, PTB2 and PTB4) with similar
structures (Figure 3.6A). These variants differ only in the sequence of the
interdomain linker between RRM2 and RRM3 (240, 243). NMR studies of
individual domains showed that all domains have nearly 90 amino acid residues
that fold into a typical #!##!# topology where a four-stranded #-sheet packs
against two-! helices (38, 244) (Figure 3.6 B-E). An additional fifth # strand was
also observed in case of RRM2 and RRM3. PTB recognizes polypyrimidinetracts in the RNA target containing CU rich elements with a preference for
sequences within a longer PPT (92, 205, 206). Recently, the structures of all four
RRMs complexed with short CUCUCU RNA have been characterized in solution
(15). These results showed that all domains bind to RNA through the #-sheet
surface. Domains 1, 2 and 4 interact with 3 nucleotides but domain 3 interacts
with 5 nucleotides of RNA sequence. Furthermore, all RRMs have similar binding
affinity in the micromolar range that depends on sequence and the length of the
PPT. The binding affinity is higher for a longer PPT and sequence of PPT with
cytosine (15).
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Figure 3.6 The structure of PTB. (A) The domain organization of PTB1 (13).
NLS; N-terminal nuclear localization signal. RRM; RNA recognition motiffs. (B-E)
The structure of RNA (CUCUCU) bound to RRM1, RRM2, RRM3 and RRM4. (F)
Intermolecular interactions in RNA bound PTB34. RRM3-blue, RRM4-green,
interdomain linker-red and interacting residues-black. (G) PTB34 interdomain
interaction between helix 2 of RRM4 (green) and helix 1 of RRM3 (blue). (H)
Interactions between helix 2 of RRM3 with the interdomain linker (red). Sticks
represent side chains of amino acids in different color according to their domain.
Figures B-F are from reference (15). Reprinted with permission from AAAS.
Figures G and H are adapted with permission from Macmillan Publishers Ltd:
[EMBO] (242), copyright (2006).

3.6.2 Interdomain interaction between PTB domain 3 and 4 (PTB34)
All four PTB domains 1, 2, 3 and 4 bind RNA independently but the two Cterminal domains, 3 and 4, have extensive interactions (15) (Figure 3.6F-H).
Segmental isotope labeling experiments further characterized the interactions
between domain 3 and 4 that positioned the bound RNA in an antiparallel
orientation (242). Nearly 27 amino acids side chains from both helices of domain
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3, helix 2 of domain 4 and the inderdomain linker form a hydrophobic core that
place the RNA binding surface of the two domains in opposite orientation (242).
These inderdomain interactions are highly conserved in PTB paralogs (13, 230,
245). This interaction is also stabilized by a salt bridge between K398 and E502
(242). The most important interactions that observed in PTB34 are direct interRRM contacts that is mediated by interdomain linker. In order to further
characterize these PTB34 interactions, a mutational study have been done. Two
sets of mutants have been made to disrupt the interface by replacing
hydrophobic residues by charged residues and disrupting the salt bridge. One
mutant, PTB 3Mut was prepared with three mutations in RRM 4 !-helix 2
(E502K, V505E and I509K). A second mutant, PTB34-m was expressed with six
mutations; three mutations as in PTB 3Mut, one in RRM3 (I356K) and two in
linker (I446E and I449K). The interdomain interaction between domain 3 and 4 is
disrupted after mutation and they bind RNA independently (242). None of these
mutations affect the protein surfaces interacting with RNA.
3.6.3 PTB as a splicing regulator
PTB is involved in splicing repression of several alternative exons but the
mechanism by which PTB promotes exon exclusion is poorly understood (240).
The RNA map from the study of genome-wide analysis of PTB-RNA interactions
has revealed a positional effect of PTB binding on splicing regulation (246, 247).
In other word, splicing activity of PTB depends upon the location of the binding
site on the pre-mRNA with respect to the target exons (248). PTB binding near
alternative exon promotes exon skipping whereas it’s binding near consecutive
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distal sites facilitates exon inclusion (246, 247). The NMR structure of RNAbound PTB has suggested a potential mechanism of PTB action in splicing
whereby RRMs 3 and 4 bind the polypyrimidine-tracts flanking an alternative
exon and loop out the intervening RNA, thus repressing the exon (Figure 3.7)
(15).

Figure 3.7 Structural models for the RNA looping mechanism of PTB. (A) Full
length PTB1 bound to a long pre-mRNA-orange. (B) Models represent the
formation of RNA loop after binding full length PTB. This model is based on the
GABA-!2 exon 9 repression. (C) Repression of a short exon by one PTB
molecule. (D-F) Models showing how multiple PTB binding loop out a short exon.
(G) A hypothecal model showing how PTB loops out branch point A when it binds
to the 3’ SS. Figures A-G are from reference (15). Reprinted with permission
from AAAS.
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The two RRM-bound polypyrimidine-tracts appear in opposite directions
as if forming a loop to exclude the intervening exon or the branched adenosine
from the spliceosomal machinery. Other mechanistic models for PTB repression
have proposed a direct (235) and an indirect (235, 249) competition between
PTB and other splicing factors like U2AF65, co-repression with Raver-1 (250)
and PTB preventing exon (249) or intron definition (251). However, all proposed
mechanisms are consistent with RNA looping between RRMs 3 and 4. The NMR
structure also revealed that the RNA sequences with a 15-nucleotide spacer
between two CUCUCU elements have the highest binding affinity for PTB34 (15).
PTB binds cytosine-rich PPT more tightly than poly (U). On the other hand,
splicing factor U2AF is happier with poly (U) sites for binding. These findings
leads to the controlled mechanism of splicing frequency on the basis of cytosine
contents at the 3’ SS. High cytosine contents favors PTB binding and, hence,
increases exon repression (92, 206, 252).
The aim of this work is to test and characterize the suggested looping
mechanism of PTB34 using different biophysical and in vivo experiments.
Fluorescence Resonance Energy Transfer (FRET), NMR spectroscopy and in
vivo splicing assays were carried out to characterize the overall looping
mechanism and splicing repression.
3.6.4 Results
[This portion is adapted from reference (170).]
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3.6.4.1

PTB34 binds polypyrimidine-tracts and brings their 5’ and 3’ ends
into close proximity.

First, we tested the binding of RRMs 3 and 4 of PTB (PTB34,Figure 3.8A)
to several model RNAs using a FRET-based gel shift assay (110). We prepared
a series of single-stranded polypyrimidine-tracts (PPTs) separated by a variable
size loop (5’-CUCUCU(A)NCUCUCU-3’, N = 5-30, named PPT-N), and labeled
their 5’ and 3’ ends with fluorescein and tetramethylrhodamine (TAMRA),
respectively. FRET measures the distance between the fluorophores (110, 112),
and it enables monitoring of RNA conformational changes during the binding
reaction: if PTB34 loops the RNA, it should bring the RNA 5’ and 3’ ends into
close proximity resulting in a FRET increase. With this assay, we could detect
both the gel shift of our labeled RNAs upon PTB34 binding and the RNA
conformation by measuring the fluorescence intensity of the FRET pair. Distant
fluorophores yield green bands, while close ones appear red (110). Figure 3.8B
shows the results for PPT-5, 10, 15, 20 and 30 in the absence and presence of
PTB34. The free RNAs migrate as single bands, demonstrating the labeled RNA
purity. As the RNA size increases, the corresponding bands migrate more slowly
and change color from red (PPT-5) to yellow (PPT-30), as expected. Bound to
PTB34, the bands become red and migrate slower indicating the formation of the
protein-RNA complex. For PPT-5 and 10, a second super-shifted band is also
visible (80% and 30% intensity, respectively), but for PPT-15, 20 and 30, it does
not exceed 10% intensity. Based on the gel mobilities, we assigned the first band
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to a monomeric complex and the second band to a dimeric complex with two
RNAs and two PTB34 (Figure 3.8B).

Figure 3.8 Structure of RNA bound PTB34 and native gel. (A) Schematic
representation of the RNA looping mechanism by PTB34. The Figure shows two
possible looped conformations: with the intervening RNA on the same side of the
PTB34 interdomain linker (left) or the opposite (right). (B) FRET based nondenaturing gel electrophoresis of the fluorophore labeled PPTs in presence and
absence of PTB34, as shown. Donor emission is represented as green and
acceptor emission as red. RNA and RNA-protein complexes are assigned as
shown.
3.6.4.2

Steady-state experiment

We further studied binding of RNA to protein in solution with steady-state
FRET (ssFRET). Figure 3.9A shows the fluorescence spectrum of PPT-15 in the
absence (in blue) and presence (in red) of PTB34. In the free RNA, the donor
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intensity (520 nm) is larger than the acceptor (580 nm), indicating that the
fluorophores, and therefore the 5’ and 3’ ends, are distant. Bound to PTB34, the
donor intensity decreases while the acceptor increases, indicating that the 5’ and
3’ ends are brought into close proximity in the complex. The calculated FRET
ratio for PPT-15 increases from 0.38 to 0.66 (Figure 3.9B), in agreement with the
gel shift assay. Similar results were obtained for all PPTs except PPT-5, which
did not show a significant FRET increase. The initial FRET ratio in absence of
PTB34 decreases with increasing RNA length from 0.61 to 0.27. Bound to
PTB34, all FRET ratios increase to ~0.65. Small differences in the final FRET
ratios are likely caused by differences in the binding affinities of each RNA.
We tested for the specificity of the PPT-PTB34 interaction using a
fluorophore-labeled RNA lacking a polypyrimidine-tract, which did not show any
FRET increase upon addition of PTB34. We also tested whether non-specific
RNA binding proteins could loop the PPTs using the small protein B (SmpB), a
basic protein that binds tmRNA in bacteria (253). Although SmpB can bind PPT15 non-specifically, we did not observe any appreciable FRET change upon
addition of 1µM SmpB, confirming that the observed FRET increase is specific to
PTB34 binding
3.6.5 PTB34 looping efficiency depends on RNA loop size
We have used the observed FRET increases to quantify the binding
affinity of PTB34 to polypyrimidine-tracts (Figure 3.9B). A fit of the PPT-15
titration to a modified Hill equation yields a dissociation constant KD = 11 ± 5 nM
and a cooperativity coefficient n = 0.7 ± 0.2 (Figure 3.9C). The KD is expected to
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decrease in vivo because of the presence of two additional RRMs (1and 2) in the
full length PTB (92, 243). The cooperativity coefficient near unity confirms that
PTB34 binds stoichiometrically.

Figure 3.9 Evidence of RNA looping by PTB34. (A) Fluorescence emission
spectra of labeled PPT-15 RNA in the absence (blue) and presence of 100 nM
PTB34 (red). (B) FRET ratios for PPT-5-30 in the absence (blue) and presence
of 100 nM PTB34 (red). (C) FRET ratio of PPT-15 as a function of [PTB34]. The
black line is a fit to a modified Hill equation (Methods). Error bars stem from three
independent assays. (D) Apparent KD as a function of the intervening loop size.
Error bars stem from the standard deviation to the fit as shown in (C).
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Similarly, we determined the KD for all six PPTs (Figure 3.9D and Figure
3.10). The resulting KD’s decrease with increasing loop size and plateau for
PPT15 and higher, indicating that PTB34 requires a !15 nt long intervening
sequence to loop the RNA effectively (15). The KD obtained for PPT-5 and 10 are
global average constants for the monomer and dimer. The cooperativity
coefficients of all PPTs !15 are near unity, confirming the stoichiometric nature of
these complexes.

Figure 3.10 PTB34 binding of RNA with varying linkers. A 25 nM double-labeled
RNA samples were titrated with different PTB34 concentration. Protein
concentration was plotted with FRET values and fitted for KD values with the
modified Hill equation (Equation 3.1). Error bars are the standard deviation of the
three independent experiments. KD values are reported in nM for all PPTs. The
dissociation constants obtained for PPT-5 and 10 are global average constants
for the monomer and dimer. The cooperativity coefficients of all PPTs larger than
10 are near unity, supporting a 1:1 stoichiometry, while the cooperativity
coefficients for PPT-5 and 10 are higher, suggesting the presence of higher order
complexes in solution.
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3.6.6 All RNA-protein complexes have similar conformations
To characterize the global structure of all the PTB-RNA complexes, we
used time-resolved FRET (trFRET) to accurately measure the distances between
the two fluorophores (104, 144). trFRET consists of measuring the fluorescence
lifetime of the donor fluorophore in the presence and absence of the acceptor.
Figure 3.11A shows the donor fluorescence decays for PPT-20. In the absence
of PTB34 (compare black and blue curves), the donor lifetime decreases more
rapidly in the presence of the acceptor, which is indicative of FRET. This
difference is used to fit a distribution of distances between the dye pair (254).
The resulting distribution reveals a bimodal distribution (Figure 3.11A inset,
blue). We assign the major distribution (85%, 71 Å) to unfolded molecules where
the 5’ and 3’ ends are distant. The minor distribution (15%, 31 Å) is attributed to
a minor population of molecules transiently folding into hairpins or duplexes
where the pyrimidines and adenosines from the linker form base-pairs resulting
in closer 5’ and 3’ ends of the RNA. In the presence of PTB34, the donor lifetime
decreases dramatically, indicating a large increase in FRET (Figure 3.11A,
compare red and blue curves). The calculated distribution collapses to a single
distribution centered at 35 Å (Figure 3.11A, inset, red), confirming the shorter
distance between the 5’ and 3’ ends in the protein-RNA complexes observed in
previous experiments.
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Figure 3.11 Time-resolved FRET analysis. (A) Donor fluorescence decay (PPT20) in the absence (black) and presence of the FRET acceptor (blue), and in the
presence of PTB34 (red). Inset: Donor-acceptor distance distribution in the
absence (blue) and presence (red) of PTB34. (B) Average donor-acceptor
distance as a function of the intervening RNA length.
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We measured the donor-acceptor distance for all PPTs in the presence
and absence of PTB34 and found similar results. Figure 3B shows the mean
distance of the major distribution in the absence of PTB34 as a function of loop
size (blue). The distance between the two dyes increases linearly between 51
and 85 Å for PPT-5 and 30, respectively, with a slope of 1.4 ± 0.1 Å/nt. Upon
PTB34 binding, all PPTs have a mean distance ranging 32 to 38 Å. For PPT-5
and 10, the observed mean distance corresponds to a weighted average
between the monomer and the dimer (Figure 3.8B).
3.6.7 RRMs 3 and 4 bind the 5’ and 3’ polypyrimidine tracts, respectively
[These data were collected in Dr. Allain’s lab at ETH Zürich.]
We next used NMR spectroscopy to investigate the complex between
PTB34 and two pyrimidine tracts separated by 15 adenosines. Although the
FRET data showed unambiguously that PTB34 forms RNA loops, the FRET data
did not provide information on the directionality of binding: two binding modes are
possible with either RRM3 and RRM4 binding the 5’- and 3’-tracts, respectively,
or the opposite (Figure 3.8A). Complex formation with CUCUCU(A)15CUCUCU,
GGUCUCU(A)15CUCU and GGCUCU(A)15UCUCU resulted in almost identical
spectra, indicating that all three RNAs bind PTB34 in the same orientation even if
the pyrimidine-tract is shorter at the 5’end or the 3’end (5’-GG was used for in
vitro transcription). By comparing the spectra of PTB34 in complex with
GGUCUCU(A)15CUCU (1:1 stochiometry) and in complex with CUCUCU (1:2
stochiometry), we could observe clear differences indicating contacts between
the 15 adenine linker and the protein.
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Figure 3.12 Chemical shift mapping and structure of RNA bound PTB34. (A) Plot
of the chemical shift differences (in parts per million, plotted against the residue
numbers) between PTB34 bound to two 5’CUCUCU3’ and PTB34 bound to
GGUCUCU(A)15CUCU. Chemical shift differences are calculated as !" = [!"HN2
+ (!"N/6.51)2]1/2. (B) Structure of PTB34 bound to short pyrimidine-tract (15)
(RNA-orange, protein-grey). The nitrogen shown in blue are the residues which
chemical shift different is greater than 0.1 ppm and the nitrogen shown in cyan
indicate resonances that are broadened or disappeared upon binding of
GGUCUCU(A)15CUCU.
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Major chemical shift changes and line broadening are observed within the
interdomain linker (Q421, Q424 and N432, Figure 3.12) and in the loop between
!-helix 2 and "-strand 4 in RRM4 (H514 and D515, Figure 3.12). This indicates
that the adenine linker interacts with this region of PTB34. Hence, the RNA takes
the shortest path of the two possibilities (Figure 3.8A), where RRM3 and RRM4
are binding the 5’ and 3’ tracts, respectively (Figure 3.12B). The distance
measured in the structure between the 5’ nucleotide (nt) bound to RRM3 and the
3’ nt bound to RRM4 is 41 Å, which is in good agreement with the estimated
FRET distance of 32 to 38 Å between the two dyes. The spectra of PTB34 bound
with PPT-10 to -30 are very similar, indicating that the RNA is bound with this
same orientation independently of the linker length up to 30 nt.
3.6.8 A mutant reveals a synergistic role between RRMs 3 and 4 for
efficient RNA looping
The NMR structure of PTB34 free (242) and bound (15) has revealed
interactions between RRMs 3 and 4 involving 27 amino acids. We sought to test
the function of these interactions in the looping of RNA by PTB34. To this aim,
we used the FRET-based gel shift assay with a six-fold mutant of PTB34 that
was shown to prevent the interaction between RRM 3 and 4 (I356K, F446E,
I449K, E502K, V505E and I509K) (242). It is noteworthy that none of these
mutations affect the protein surfaces interacting with RNA. Figure 3.13A shows
that PTB34 mutant does not form the RNA-protein complex with PPTs as readily
as the wild type PTB34 (Figure 3.8B). This result suggests an active role for the
inter-domain interactions between RRMs 3 and 4 in PTB for looping, and
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Figure 3.13 Mutant PTB34 exhibits a different conformation than the WT. (A)
Non-denaturing gel electrophoresis of PPTs in the presence and absence of
PTB34-m. (B) Time-resolved FRET analysis for PPT-30. Donor fluorescence
decay in the absence (black) or presence of the FRET acceptor (green), and in
the presence of PTB34-m (red). Inset: Donor-acceptor distance distribution in the
absence (green) and presence (red) of PTB34-m. (C) Distance distributions for
PPT-30 in presence and absence of PTB34-m and comparison to the wild type.
Top panel: PPT-30 alone (blue). The average donor-acceptor mean distance is
87 Å. Middle panel: In the presence of PTB34 (red) a single distribution is
observed with an average distance of 36 Å corresponding to the loop RNA
Bottom Panel: In the presence of PTB34-m two distributions are observed. We
assign the short one (86%, 29 Å mean distance) to the dimer and the long one
(14%, 63 Å mean distance) to the 1:1 complex. This result indicates that the
PTB34-m can bind polypyrimide tracts but cannot loop the RNA as the WT.
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Figure 3.14 PTB34-m titration with different looped size RNA (PPTs). 25 nM
double-labeled RNA samples (as indicated in Figure) were titrated with different
PTB34-m concentrations. Data were fit with the modified Hill equation (Equation
3.1). Error bars are the standard deviation of the three independent experiments.
KD values are reported in nM for all PPTs. The resulting KD for PPT-30 (38 ± 6
nM) and n (1.6 ± 0.4) are four- and two-fold higher than WT PTB34 (Figure 3.9
and Figure 3.10), respectively, indicating the presence of higher order
complexes in solution, contrary to the WT.
implicates a synergistic effect between the two domains for efficient looping in
vivo. The resulting dissociation constant for PPT-15 (KD = 105 ± 4 nM) is ~10fold higher than the WT, and the large cooperativity coefficient (n = 7 ± 1)
indicates the presence of higher order oligomers, which result in the observed
high FRET value, similarly to PPT-5 and 10 (Figure 3.9). The formation of
stoichiometric complex is expected to occur at much lower concentrations than
the dimer, but almost no FRET increase is observed below 100 nM (compare
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Figure 3.10 and Figure 3.14), indicating that the FRET ratio of the stoichiometric
mutant complex is similar to that of the free RNA, also supporting the idea that
the mutant does not loop the RNA. The observed KD is, therefore, an average
value of multiple species in solution, and likely to be an upper estimate for the
stoichiometric complex. When the linker length increases (PPT-30), the affinity
for the mutant protein increases (KD = 38 ± 6 nM, Figure 3.14) due to an
increase of negative charges, while it remains almost the same for the WT PTB
(KD = 10 ± 3 nM, Figure 3.10). The cooperativity coefficient decreases too (n =
1.6 ± 0.4) indicating the presence of fewer higher order complexes. However, a
FRET gel shift assay reveals no specific looped complex as the WT (Figure
3.13A). These results indicate that the inter-domain interactions between RRMs
3 and 4 provide RNA looping and only slightly higher affinity.
3.6.9 Single-molecule FRET
Single-molecule FRET is a powerful tool to study the conformational
dynamics of protein-RNA complexes (114). We used this technique to study the
differences in binding of PTB34 and the six-fold mutant with PPT-15 Figure 3.15.
A biotinylated RNA and fluorophore labeled PPT-15 was surface-immobilized on
a PEG-passivated quartz slide via a biotin-streptavidin bridge. FRET histograms
are built from the observed FRET ratio of hundreds of individual molecules. In
the absence of PTB34 (Figure 3.15C, top panel), the majority of molecules
exhibit low FRET (0.2 - 0.4) and only few molecules transiently reach the high
FRET range. Such a broad FRET distribution is expected for a single-stranded
RNA without a well-defined secondary structure, consistent with our trFRET data
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(Figure 3.11). Addition of 10 nM PTB34 results in the appearance of a major
peak at 0.55 FRET (Figure 3.15C, center panel). We assign this major peak to
the PTB34-RNA complex, consistent with the bulk FRET experiments. In the
presence of 10 nM six-fold PTB34 mutant, the observed FRET distribution
resembles the RNA only distribution. A minor broad distribution ranging from 0.4
- 0.8 FRET and centered at higher FRET than the WT is also present. We assign

Figure 3.15 Single-molecule study of PTB-RNA interaction. (A) Schematic
diagram of the single-molecule experiment. (B) Single-molecule time trace for
RNA only sample. Top panel: donor intensity is in blue and acceptor intensity is
red. Bottom panel: A FRET trajectory calculated from donor and acceptor
intensities in top panel. (C) Single-molecule FRET histograms for RNA only (top),
the WT protein (middle) and the six-fold mutant (bottom). Histograms are built
from the observed FRET ratios of hundreds of single-molecules. The 0-FRET
peak corresponds to molecules without an acceptor. The fits to a Gaussian
distribution (red lines) are only intended to guide the eye.
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this distribution to the formation of the mutant PTB34-RNA complex. This result is
consistent with both the weaker binding of the mutant PTB34 and the lack of
interactions between RRMs 3 and 4. The observed FRET differences between
the WT and the mutant distributions suggest that in the absence of interactions at
the interface between RRMs 3 and 4, the mutant binds in a different
conformation.
3.6.10 RNA looping by PTB34 is essential for efficient splicing regulation
in vivo.
[These data were collected in Dr. Allain’s lab at ETH Zürich.]
To test the functionally importance of the interface between RRMs 3 and
4, we used a splicing reporter assay (200) in HeLa cells with a reporter gene
containing 2 separate polypyrimidine-tracts separated by a long linker (DS9-175)
(255). In a control experiment without protein over expression, the alternative
exon is 80% included, while only 34% is included when PTB is transfected and
overexpressed. This assay illustrates the repressive role of PTB in the regulation
of this alternative exon (Figure 3.16).
We then transfected the cells with a PTB mutant (PTB 3Mut) with three
mutations in helix 2 of RRM4 (E502K, V505E and I509K) that we know are
sufficient to prevent the interaction between RRMs 3 and 4 (17). Here, 74% of
the exon is included, indicating that PTB 3Mut is much less repressive than PTB
WT (Figure 3.16). To confirm that the loss of repression is not due to a lower
expression of PTB 3Mut, we performed a Western-Blot for the same splicing
assay (Figure 3.16C). PTB 3Mut shows an even higher expression (10%) than
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Figure 3.16 In vivo splicing assay showing the importance of the interaction of
RRM3 and RRM4 of PTB on splicing repression. (A) The previously
characterized splicing reporter gene (255). (B) In vivo splicing of the reporter
gene containing two polypyrimidine-tracts separated by a long linker. nPTB, PTB
WT and PTB 3 mut were over expressed in HeLa-cells and after RT-PCR
developed on a Typhoon PhosphorImager. (C) Western Blot corresponds to the
same splicing-assay shown on the left and verifies similar expression-levels of
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proteins. Consistent with published data (256) the expression-level of nPTB in
HeLa-cells was very low and near detection-limit. (D) Histogram of the splicingassay. Each RT-PCR product was quantified with the ImageQuant software and
the exon-inclusion ratio calculated (exon included product/ (exon excluded
product + exon included product)). Standard deviation was computed from three
independent experiments. (E) Quantification of the relative protein-levels of PTB
WT and PTB 3Mut to GAPDH from Western-Blot using ImageQuant software.
PTB WT, confirming that the loss of repression is not due to a lower expression
level. As a control, overexpression of neuronal PTB (nPTB) under the same
condition confirms earlier reports (230) that nPTB is less repressive than PTB
(56% exon inclusion), but still more repressive than PTB 3Mut. However, in the
case of nPTB loss of repression is due to a much lower expression level, as
reported (256). Since the interaction between RRMs 3 and 4 is essential for RNA
looping, these in vivo data support the idea that splicing repression by PTB
depends on the interface between RRM3 and RRM4 and consequently on the
ability of PTB to mediate RNA looping.
3.7

Discussion
Despite the diverse and crucial roles PTB plays in many processes, its

molecular mechanism of action remains elusive. We have used FRET, NMR
spectroscopy and in vivo splicing assays to study the ability of PTB to remodel
RNA structure. The FRET data unambiguously show the ability of PTB34 to bring
together (<40 Å) the RNA 5’ and 3’ ends, forming RNA loops as suggested (15).
However, the spacer between the two polypyrimidine-tracts must be !15 nt. The
FRET data also provide the affinity of these RNAs for PTB34, which is <50 nM
when the linker is !15 adenosines. Compared to the affinity obtained for each
domain separately (KD " 1 µM) (92), this indicates that the two pyrimidine-tracts
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bind synergistically even with a 30 nt long linker. These results prompted us to
look further into how PTB34 could favor RNA looping. Our NMR investigation of
PTB34 bound to pyrimidine-tracts linked by 15 adenines showed that the RNA is
bound to PTB34 with a specific directionality, with the 5’ and the 3’ pyrimidinetracts bound to RRM3 and 4, respectively. These data support earlier footprinting
experiments of the intron upstream of the alternative-exon 9 of GABA-!2 that
showed the binding of RRM4 to the 3’ pyrimidine-tracts and of the rest of the
protein to the 5’ pyrimidine-tract (257). This RNA binding directionality might be
due to the presence of several positively charged residues (R366, R418, R437,
K439, K440 and K444) in a region of the protein that interacts with the RNA linker
without sequence specificity.
Finally, we showed that the interaction between RRM3 and 4 is essential
for efficient RNA binding, looping and for splicing repression in vivo. However,
the question remains whether the differences in splicing repression between the
mutant and the WT arise from defective RNA looping or from its lower binding
affinity. The mutant binds PPT-15 with 10-fold lower affinity than the WT, while
the decrease for PPT-30 was only 3-4 fold (Figure 3.14). These KD are average
values of different species in solution, and likely to be an upper estimate for the
stoichiometric

complex.

Additionally,

the

tr-FRET

and

single-molecule

measurements (Figure 3.13 and Figure 3.15) confirm that the structure of the
mutant PTB34-RNA complex is different from the WT. Therefore, the observed
FRET increases in Figure 3.13 and Figure 3.15 are not due to the formation of
looped RNA, even if the apparent average FRET ratios are similar to the wild
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type. This is further supported by the much higher cooperativity coefficients
observed in the mutant titrations, which indicate the presence of higher order
complexes. The stoichiometric RNA-protein complexes, which should be formed
at lower concentrations than the higher order complexes, yield no apparent
FRET increase, indicating the lack of RNA looping. Based on these results, we
expect that the mutant will bind pyrimidine-tracts with longer spacers, such as
DS9-175 used in the splicing assay, with an affinity similar to the WT. Therefore,
the defective RNA looping, and not its weaker binding affinity, is the most likely
reason for the lower splicing repression of the mutant compared to the WT.
Altogether, this study confirms the unique ability of PTB34 to bring distant
pyrimidine-tracts into close proximity. These findings strongly support the model
that PTB could repress alternative exons by looping out the exon or the
associated branch point (13, 240). It also explains the RNA-remodeling role
proposed for PTB in IRES-mediated translation regulation, since PTB34 could
bring distant pyrimidine-tracts into close proximity, and therefore, influence the
IRES structure (13).
3.8

Conclusions
Preliminary work from a gel shift assay confirmed that PTB34 binds RNA.

This result is consistent with a previous electrophoretic mobility shift assay, which
already proved that RNAs with CUCUCU elements showed gel shift upon
addition of PTB34 (15). Steady-state FRET experiments showed an increased in
emission intensity for acceptor fluorophore (higher FRET efficiency) after the
addition of PTB34 in a solution containing labeled RNA. This increase in FRET
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value implies a decrease in the distance between the two fluorophores, which
supports the looping mechanism. PTB34 titration experiments with various size
RNAs revealed different binding affinities, leading to the conclusion that the
PTB34 binding depends on the length of the intervening sequence, which is
optimal for 15 nucleotides or longer. Time-resolved FRET was used to correlate
the distance and flexibility of labeled RNA. This experiment showed a decrease
in distance between the two fluorophores after adding PTB34 as compared with
RNA only. For all the set of RNA constructs, trFRET experiments showed nearly
the same distance between fluorophores after PTB34 binding, which is a key
point to propose looping of RNA by PTB34. These results clearly showed that the
binding of RRM3 and 4 of PTB34 brings the 5’ and 3’ ends of the ssRNA to a
close proximity, supporting a mechanism where PTB loops out the intervening
sequence and regulates the splicing of alternative exon. NMR investigation of
PTB34 bound to the several RNAs containing two polypyrimidine-tracts
separated by adenine linkers showed that the RNA is bound to PTB34 with
precise directionality, the 5’ and the 3’ pyrimidine-tracts being bound to RRM3
and RRM4, respectively. Single-molecule FRET experiment showed different
distributions for PTB34 and six-fold mutant.
3.9

Materials and methods

3.9.1 RNA purification and labeling
RNA samples with 5’ fluorescein and 2’-OH protection groups were
purchased from Keck Foundation Biotechnology Resource Laboratory at Yale
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University School of Medicine, deprotected, purified and labeled, as described in
Chapter 2 (110, 258).
3.9.2 Protein expression and purification
PTB34 and mutant proteins were over-expressed in E. coli and purified, as
described (15, 242). DNA encoding RNA binding domains 3 and 4 of PTB was
amplified from PTB1 (Acc. NO X62006) and cloned into pET28a (+) (Novagen)
with an N-terminal His-tag. The protein was expressed in BL21 (DE3) E. coli at
37 °C in LB containing 50 mg l-1 kanamycin. When the cells grew to OD600 !
0.7, they were induced with 1 mM IPTG (Isopropyl !-D-1 thiogalactopyranoside)
for 4 h, harvested by centrifugation (~ 4000 x g), and kept at -20°C overnight.
Cells were resuspended in 20 ml lysis buffer (300 mM NaCl, 50 mM Na2HPO4,
pH 8.0, 0.002% (v/v) SUPERase RNase inhibitor (Ambion Inc.) containing 10 mM
Imidazole and lysed using a French press. The cell lysate was centrifuged at
20000 x g and the supernatant was incubated with NiNTA beads (Bio-RAD
Laboratories Inc.) for > 1h. The beads were loaded in a column and after an
extensive washing with lysis buffer containing 10 mM Imidazole, the protein was
eluted with a step gradient of imidazole (20 – 500 mM) in a lysis buffer. The
purest fractions as judged by 15% SDS-PAGE (Figure 3.17) were dialyzed
against lysis buffer without imidazole and subjected to a second identical NiNTA
affinity column to reduce residual RNase activity. Pure fractions were dialyzed
against 5 liters NMR buffer (20 mM NaCl, 10 mM NaH2PO4, pH 6.5). The protein
was concentrated by centrifugation in an Amicon concentrator at 4 °C and ~3000
x g using a 5 kDa molecular mass cut-off membrane. RNase activity of the
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protein sample was tested for using a commercial RNase activity test (Ambion
Inc.).

Figure 3.17 SDS-PAGEs showing fractions of the NiNTA purification of PTB34.
M: molecular weight marker (Fisher’s EZ-Run Pre-Stained Rec Protein Ladder),
CL: soluble fraction of the cell lysate, FT: fraction of the cell lysate that did not
bind to the NiNTA resin, W: wash fraction (10 mM imidazole), E: eluted fractions
represented by fraction numbers. Gels were stained by comassie blue dye for
visualization.

3.9.3 FRET gel shift assays
15% non-denaturing polyacrylamide (29:1acrylamide: bisacrylamide ratio)
gel electrophoresis was performed in 20 mM NaOAc (sodium acetate) and 10
mM sodium phosphate (pH 6.5) using low-fluorescence glass plates, as
described (110). 10 pmol doubly labeled RNA samples were heated at 90°C for
45 s, annealed to room temperature and allowed to equilibrate with 40 pmol
PTB34 or PTB34-m for 5 minutes before loading. Acrylamide gel was
equilibrated for 15 minutes at room temperature before loading. Samples were
loaded on the gel, and constant electric field of 6 V/min was applied immediately.
After electrophoresis at 4°C, the gel was scanned with in glass plate in a
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Typhoon Imager by exciting the donor with a 532 nm laser. The fluorescence
emission of the donor (526 nm, fluorescein) and acceptor (580 nm, TAMRA)
were analyzed with Fluorsep program (Amershan Bioscience).
3.9.4 Steady-state FRET
Steady-state FRET measurements of doubly labeled RNA samples were
carried out in a spectrofluorometer as described in Chapter 2. A 25 nM RNA
sample was annealed in standard buffer, and fluorescence was measured in the
absence and presence of protein. Relative FRET efficiencies were calculated
Equation 2.5. The global dissociation constant (KD) and cooperativity coefficients
were obtained by plotting FRET as a function of protein concentration, and fitting
to the modified binding Equation 3.1.
n

FRET = FRET0 + ( FRETmax " FRET0 )

[PROTEIN ]
n ,
K Dn + [ PROTEIN ]

(3.1)

3.9.5 Time-resolved FRET for distance measurements
!
The distance between the two fluorophores was measured using timeresolved FRET (trFRET), as described in Chapter 2 (110). A 250 nM RNA
sample (donor only or doubly labeled) was heated for 2 minutes at 90°C and
annealed in standard buffer (20 mM NaCl, 10 mM sodium phosphate, pH 6.5).
After collection of photons from RNA only sample, 1 !M protein was added and
allowed to equilibrate for five minutes in room temperature. Photons were
collected from protein-RNA complex for both donor only and doubly labeled
sample. Data analysis was done as described in Chapter 2. Experiments were
repeated until to get a best fit characterized by a better !2 value.
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3.9.6 Single-molecule FRET experiments
PPT-15 [5’-CUC UCU (A)15 CUC UCU dTAA-3’] was labeled with 5’ Cy3
and 3’ biotin and purified as discussed in Chapter 2. Cy5 was attached to an
amino linker on dT following labeling protocol. The biotinylated single-stranded
RNA was annealed in standard buffer and surface-immobilized on a PEGpassivated quartz slide, as described (142, 147). The donor and acceptor
intensities (ID, IA) from single-molecules were used to calculate apparent FRET
efficiencies in the presence and absence of 10 nM PTB34 or PTB34-m.
3.9.7 NMR spectroscopy
[These experiments were performed in Dr. Allain’s lab at ETH Zürich.]
Complex formation for NMR spectroscopic measurement was carried out
as described (15). Resonance assignments for the

15

N-13C labelled PTB34 in

complex with GGU CUC U(A)15C UCU where obtained with the TROSY-HNCA
experiment at 313K.
3.9.8 In vivo splicing assay
[These experiments were performed in Dr. Allain’s lab at ETH Zürich.]
3.9.8.1

DNA constructs

PTB1, nPTB and reporter plasmid DS9-175 were prepared as described
(255). The 3 mutations in PTB1 (PTB 3Mut) were made with 2 consecutive PCRreactions using the primers 2Mut-F, 2Mut-R, 1Mut-F and 1Mut-R (Table 3.1).
The PCR-protocol included 20 cycles: 95°C for 30 s, 55°C for 1 min and 72°C for
7.5 min. The PCR followed a digestion with Dpn1 for 1 h at 37°C.
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3.9.8.2

Transfections

HeLa cells were cultured in EMEM (Eagle’s Minimum Growth Medium)growth-medium supplemented with 10% FBS (Fetal Bovine Serum) on six-wellplates and grown to a 90% confluence approx. DNA-Lipofectamine 2000
complexes were assembled according to the manufacturer’s protocol. The
complexes were added to the cells and incubated for 5 h. After, medium was
changed and cells grown for 19 h.
3.9.8.3

RNA-isolation and RT-PCR

Both were carried out following the instructions of the Cells-to-cDNA™ II
Kit. After RT-PCR, 5 µl of the resulting cDNA were used in a 50 µl PCR-reaction
with 10 µM of the: !-32P-labeled forward primer Dup1a and reverse-primer Dup8
(Table 3.1). The PCR-protocol included 35 cycles: 94°C for 30 s, 50°C for 30 s
and 72°C for 30 s. Samples of the PCR-reaction were then loaded on a 6%
denaturing acrylamide-gel. The gel was exposed to a PhosphorImager and the
bands quantified using ImageQuant software.
3.9.8.4

Western blot

Cells were lysed in RIPA-buffer containing a protease inhibitor cocktail.
Protein-lysate (30!g) was used for Western Blot, and chemiluminescent
detection of the Flag-Tag protein was carried out by using the Immun-Star
Western C Kit. PTB 3Mut and PTB34 concentrations were normalized to GAPDH
concentration and quantified from the Western Blot using ImageQuant software.
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Table 3.1 List of primers used to study in vivo splicing assay.
Name

DNA sequence (5’-3’)
CAG ATG GGC TCC GTG AAG GAG GCG GAG CAG GCC CTC

2Mut-F
ATT GAC GTC
2Mut-R AAT GAG GGC CTG CTC CGC CTC CTT CAC GGA GCC CAT CTG
1Mut-F

GCG GAG CAG GCC CCA AGG ACC TGC ACA ACC ACG AC
GTC GTG GTT GTG CAG GTC CTT GAG GGC CTG CTC CGC

1Mut-R
CTC
Dup1a

CTC AAA GAA CCT CTG GGT CCA AGG

Dup8

GAC ACC ATG CAT GGT GCA CCT G
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CHAPTER 4
Fox-1 antagonizes PTB to activate N1 splicing
4.1

Introduction
The Feminizing locus on X (Fox) protein is an important tissue specific

splicing enhancer that binds to intronic enhancers and regulates alternative
splicing. In mammals there are three Fox-1 paralogs: Fox-1, Fox-2 and Fox-3.
Among these, Fox-1 and Fox-2 are well characterized and expressed in neurons
and muscle cells, where as Fox-3 has only been observed in neurons and has
not been characterized in detailed (203, 259). Fox-1 is a small protein (~100
amino-acid) with only one RRM, which is highly conserved among its paralogs. It
has a typical RBD fold with a four stranded antiparallel !-sheet packed against
two "-helices that can form a !"!!"! topology (41) (Figure 1.3B). The !-sheet is
a primary RNA binding site that can bind three to four nucleotides present is a
single-stranded RNA (30) The NMR structure of UGCAUGU bound Fox-1
showed that Fox-1 interacts with all seven nucleotides of the RNA (Figure 1.3B)
(41). Fox-1 specifically recognizes UGCAUG RNA sequences in pre-mRNAs with
a high preference for U (200). Fox-1 has an unusual binding mode to singlestranded RNA with intra-RNA interactions that form a curvature in the RNA and
change the conformation of RNA as observed in the NMR structure of the
protein-UGCAUGU complex (Figure 1.3B) (41). The binding affinity of Fox-1 to
UGCAUGU is 0.49 nM at 150 mM NaCl and decreases with increasing ionic
strength (41). The binding affinity for this protein is very high compared to other
single-stranded RNA binding proteins.
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Previous studies have shown that UGCAUG sequence elements are
enriched in the downstream introns of many neuronal and muscle cassette exons
(44, 201, 202, 260). Fox-1 can act as either a splicing activator or repressor
depending on the location of UGCAUG elements in pre-mRNA. It has been
proposed that Fox-1 binds a UGCAUG element in the c-src gene downstream of
the N1 exon and activates exon inclusion (Figure 3.5 A and C) (203, 261). C-src
pre-mRNA has two regions that are important to regulate N1 splicing (200, 202,
225). The CUCUCU element at the 3’ splice site is important for the repression of
the N1 exon. Downstream of the N1 exon is a second regulatory element mainly
responsible for splicing enhancement. This highly conserved region of the gene
sequence, consisting of 37 to 70 nucleotides in this enhancer region, is called the
Downstream Control Sequence (DCS) (200). The DCS contains multi-protein
binding sites specific to the neural extracts, which are important for splicing
regulation. The UGCAUG element recognized by Fox protein also lies in the DCS
region. Two PTB binding sites are located on either side of the Fox binding
sequence and are important for splicing repression. There is an activator and a
repressor element in the DCS region that most likely regulate N1 splicing (227).
PTB represses splicing of the N1 exon in all cells; however, in neuronal
cells, Fox has been hypothesized to antagonize the effect of PTB by competing
with overlapping binding sites as observed in DCS sequence and helps to
activate N1 splicing. The high binding affinity of Fox-1 (0.49 nM at 150 mM NaCl)
and its sequence specificity might help to find the correct binding sites and could
be an efficient competitor for binding sites in the pre-mRNA (16, 41). Fox-1
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binding to the UGCAUGU element could break the RNA loop that was induced
by PTB34 (170) upon binding to the CU rich elements presents on either side of
Fox binding sequence. However, the mechanism of this process and its
implications for alternative splicing regulation is still poorly understood.
4.2

Results

4.2.1 Designing RNA samples
To understand how Fox-1 competes with PTB34 for binding and ultimately
aids in the regulation of N1 splicing, binding and competition experiments were
performed using a single-stranded RNA with a 15 nucleotide loop containing both
PTB and Fox-1 binding sites (Figure 4.1). As a control, adenine nucleotides were
added in between PTB and Fox binding sites (Table 4.1). Here, the 5’ end of the
RNA was labeled with fluorescein and TAMRA was positioned at either the 3’
end (PPT-15F) or an internal dT modification (PPT-15F-dT). The change in
FRET was used to monitor the conformation of the RNA in the presence and
absence of PTB34 and Fox-1.

Figure 4.1 RNA constructs and position of labeled fluorophores.
To measure the true binding affinity of Fox-1 to the ssRNA with
UGCAUGU element, a small RNA oligonucleotide, CUCWT, was prepared
without a poly-A tract as an optimal Fox substrate. This RNA, along with PPT15P (contains both PTB and Fox binding sites without fluorophores), was labeled
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at 5’ end with

32

P to allow accurate measurement of the binding affinity of Fox-1

and PTB34 (Table 4.1).
Table 4.1 List of RNA oligonucleotides used
Name

RNA sequence (5’-3’)

CUCWT

CUC UGCAUGU

PPT-15P

32

PPT-15F

CUCUCU (A)15 CUCUCUGCAUGU

PPT-15F-A

CUCUCU (A)15 CUCUCU (A)N UGCAUGU, (N = 1, 3 and 5)

PPT-15F-dT

CUCUCU (A)15 CUCUCdTGCAUGU

PPT-15F-dTA

P CUCUCU (A)15 CUCUCUGCAUGU

CUCUCU (A)15 CUCUCdT (A)N UGCAUGU (N = 3, 5, 10, 20
and 30)

4.2.2 Gel shift assay
A FRET based gel shift assay was performed in the presence of Fox-1
and PTB34 separately for doubly labeled PPT-15F RNA sample as described in
Chapter 3. The band shift in native gel suggested that both proteins bind
individually to their respective binding sites on RNA. For Fox-1 (Figure 4.2A),
these band shifts were observed only in the presence of higher protein
concentrations. Quantification of each gel bands was performed to calculate the
fraction of RNA bound to Fox-1. The fraction bound was plotted as a function of
Fox-1 concentrations that gave a binding affinity of 2 !M after fitting with the Hill
equation (Figure 4.2A, right). This KD is not able to reflect a true binding affinity
of protein-RNA complex because the RNA concentration used in FRET gel was
relatively high (0.5 !M).
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Figure 4.2 Gel shift assay shows Fox-1 bind to RNA. (A) FRET gel shift for
doubly labeled PPT-15F RNA (0.5 !M) in the presence of increasing Fox-1
concentrations (0.1 !M to 7 !M). 5’ 32P-labeled PPT-15P (B) and CUCWT (C)
(~1 nM) in the presence of different Fox-1 concentrations as indicated. Graphs
on right are quantitative analysis of the gel shift data of each gel. Quantification
of each gel bands and analysis were performed as described in the Materials and
Methods section.
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To further quantify the binding affinity of Fox-1 to the UGCAUGU
sequence elements present on RNA, CUCWT and PPT-15P RNAs (Table 4.1)
were

32

P-labeled at the 5’ end. Gel shift experiments were performed for both

RNAs (~1 nM) in the presence of Fox-1 and a clear band shift was appeared only
in the presence of higher Fox-1 concentrations (Figure 4.2B and C). At low
concentrations, bands were diffuse and less prominent. Quantification of PPT15P was performed and the calculated binding affinity was 94 nM with higher
cooperativity value (Figure 4.2B, right) after fitting with the Hill equation. Similar
trends were observed for CUCWT RNA in the presence of Fox-1 (Figure 4.2C).
These experiments clearly showed the formation of RNA-protein complexes but
the quantification did not provide a true binding affinity of Fox-1 to the RNA.
4.2.3 Fox-1 binds with high affinity to Fox binding site
A steady-state FRET experiment was performed in the presence of 25 nM
doubly labeled RNA at different Fox-1 concentrations. The calculated FRET for
PPT15-F RNA in the absence of protein was 0.21 and increased to 0.3 in the
presence of 100 nM Fox-1 (Figure 4.3A). This increase in FRET is due to the
formation of a curvature in the RNA upon binding of Fox-1, bringing its 5’ and 3’
ends closer. This result is consistent with a previous study of protein-RNA
complex from NMR spectroscopy (41). A titration was performed using different
Fox-1 concentrations and the observed FRET increase was used to quantify the
binding affinity of Fox-1 to PPT-15F. A fit to a modified binding equation
(Equation 3.1) indicates stoichiometric binding with high binding affinity of Fox-1
to PPT-15F (n=1, KD = 8 ± 1 nM) (Figure 4.3A). Fox-1 titration was repeated for
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other RNA constructs as well (Table 4.2). The calculated KD (10 ± 1 nM) for PPT15F-dT is not significantly different from PPT-15F, indicating that the labeling
position in the RNA does not alter protein binding.

Figure 4.3 Steady-state FRET to measure the change in FRET for PPT-15F
RNA. (A) FRET as a function of Fox-1 concentration. (B) FRET as a function of
PTB34 concentration. (C) A Fox-1 competition experiment in the presence of 50
nM PTB34. Normalized fluorescence was plotted as a function of wavelength;
RNA only (blue), RNA-PTB34 complex (green) and RNA-PTB34-Fox-1 complex
(red). (D) FRET as a function of Fox-1 concentration to measure the K1/2 in the
presence of 50 nM PTB34. Data were fitted with the binding Equation 3.1.
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Similarly, a PTB34 titration was performed for PPT-15F (Figure 4.3B) and
other RNA constructs and the calculated dissociation constant were slightly
higher than previously characterized for PPT-15-PTB34 complex (170). The
cooperativity and increased KD of PTB34 for PPT-15F RNA suggest the
formation of different secondary structure in the presence of extra UGACUGU
sequence elements at the 3’ end of the RNA. This change in secondary structure
eventually prevented PTB34 binding to the binding site that leads to increase in
KD. Similar binding affinities and cooperativity constants were observed for all the
tested RNA samples and are summarized in Table 4.2.
Table 4.2 Binding affinities and inhibition constants for different RNA samples
KD (Fox) nM

KD (PTB34) nM

K1/2 (nM)a

PPT-15F

8±1

38 ± 1 (n = 2)

2±1

PPT-15F-1A

8±1

70 ± 2 (n = 3)

2±1

PPT-15F-3A

4±1

58 ± 3 (n = 3)

5±1

PPT-15F-5A

3±1

57 ± 3 (n = 3)

7±1

PPT-15F-dT

10 ± 1

58 ± 3 (n = 3)

2±1

PPT-15F-dT3A

n/a

42 ± 1 (n = 3)

15 ± 2

PPT-15F-dT5A

n/a

n/a

7±1

PPT-15F-dT10A

n/a

n/a

6±1

PPT-15F-dT20A

n/a

42 ± 1 (n = 3)

11 ± 1

PPT-15F-dT30A

n/a

n/a

36 ± 5

Name

a

measured in the presence of 50 nM PTB34; n/a = experiments have not

performed at those conditions.; n = 1, otherwise it was mentioned

4.2.4 Fox-1 competes with PTB34 for binding
Competition experiments were performed by titrating Fox-1 in the
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presence of PTB34 bound PPT-15F. A Fluorometer was used to monitor change
in fluorescence intensities of the donor and acceptor fluorophores. As shown in
Figure 4.3C, donor intensity in the absence of protein is higher than acceptor
intensity (blue) resulting in a 0.21 FRET value. In the presence of 50 nM PTB34,
donor

intensity

decreased

and

acceptor

intensity

increased

(green)

simultaneously, yielding a 0.49 FRET value (Figure 4.3C). This increase in
FRET implies a decrease in the distance between the donor and acceptor
fluorophores. This is possibly due to looping of PPT-15F RNA when PTB34 binds
to form a RNA-PTB34 complex. This result is consistent with our previous results
where binding PTB34 loops out RNA (170). In the presence of 100 nM Fox-1,
donor intensity then increased and acceptor intensity decreased (red), thus
decreasing the FRET value to 0.34 (Figure 4.3C). This decrease in FRET is only
possible when the distance between donor (5’) and acceptor (3’) fluorophores of
PPT-15F is increased. For this to happen, domain 4 of PTB34 may dissociate
from the RNA-PTB34 complex. Fox-1 protein then binds to this free RNA binding
site to form a RNA-PTB34-Fox-1 complex or vice versa. The final FRET state of
0.34 is equivalent to the final FRET value in the presence of 100 nM Fox-1 alone
as shown in Figure 4.3D. Here, the inhibition constant (K1/2 = 2 ± 1 nM) (Figure
4.3D) is slightly lower than Fox-1 dissociation constant after fitting with binding
equation (Equation 3.1). Further experiment with PPT-15F-dT yielded a similar
value for K1/2 (2 ± 1 nM). These dada suggest that Fox-1 competes with PTB34
for overlapping binding site and release domain 4 of PTB34 from the RNAPTB34 complex.
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4.2.5 Competition depends on PTB34 concentration
We

attempted

to

perform

the

competition

at

different

PTB34

concentrations. However, 25 nM PTB34 did not cause a large enough initial
FRET change to allow us to monitor competition by Fox-1. On the other hand,
100 nM PTB34 causes a large increase in overall FRET, but the addition of Fox1 did not cause a change in FRET. This indicates that at the saturating
concentrations of PTB34, Fox-1 cannot compete with PTB34 for RNA binding.
These experiments clearly show that Fox-1 causes a release of PTB domain 4
from the PTB34-RNA complex and competes for the RNA binding site in a
concentration dependent manner. A reverse competition experiment was also
performed and showed that PTB34 still binds in the presence of 25 nM as well as
50 nM Fox-1 with a high dissociation constant and higher stoichiometry.
4.2.6 Effect of intervening sequences between PTB and Fox binding sites
Competition experiments were performed in the presence of different
lengths of intervening sequences (adenines; As) between PTB and Fox-1 binding
sites. RNA samples; PPT-15F-A(N) and PPT-15F-dTA(N) were prepared with
incorporation of adenine nucleotide in between two binding sites as shown in
Table 4.1. The PTB34-RNA complex was prepared in the beginning by
equilibrating 50 nM PTB34 with 25 nM RNA in a standard buffer (10 mM
NaH2PO4 and 20 mM NaCl, pH 6.5).
After scanning this complex in a Fluorometer, Fox-1 titration was
performed with different Fox-1 concentrations and the FRET ratio was calculated.
The observed FRET was plotted as a function of Fox-1 concentration and fitted
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Figure 4.4 Competition experiment performed for different PPT-15F-dT RNA
samples in the presence of 50 nM PTB34.
using Equation 3.1 to calculate K1/2 (Table 4.2 and Figure 4.4). For PPT-15F
samples (3A and 5A), K1/2 increases slightly with linker length. This indicates that
when the separation between binding sites are increased, both PTB34 and Fox-1
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can bind to their respective binding sites so that Fox-1 cannot replace PTB34
efficiently from RNA-PTB34 complex.
In the same way, competition experiments were performed for PPT-15FdT RNAs with variable intervening sequences (Table 4.2 and Figure 4.4) and
the K1/2 was measured. The resulting K1/2’s were plotted as a function of a linker
length as shown in Figure 4.5. The observed K1/2’s for 3 to 20 nucleotide linkers
are slightly higher as compared to RNA with overlapping sequence. The smaller
K1/2 for 5 and 10 than 3 might be due to the greater flexibility or secondary
structure of RNA, but still small size of the five and ten nucleotide linkers that
could allow the two binding sites to be closer in space. These surprising results
suggest that Fox-1 can compete with PTB34 for binding even when the binding
sites are separated by 20 nucleotides, but efficiency is smaller than for an
overlapping binding site. A very long linker results in a K1/2 of 36 ± 5 nM for 30A
RNA; this construct significantly abrogates the inhibitory effect of adding Fox-1.
Presumably the protein binding sites are too distant for the proteins to compete.
Taken together, Fox-1 replaces domain 4 from the PTB34-RNA complex with
smaller affinity for distant binding sites, but when the separation is 30 nucleotides
or more, Fox-1 is a less efficient competitor. Direct competition at binding sites
that are separated by significant lengths could be a result of secondary structure
of the RNA that brings binding sites in close proximity, or there may be an
interaction between the two proteins that allow Fox-1 to replace PTB even when
two binding sites are separated in space.
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Figure 4.5 Inhibition constant as a function of linker length. Error bars are from
the standard deviation to the fit as shown in Figure 4.4.
4.2.7 Time-resolved FRET for distance distributions
To characterize the global structure of the PTB34-RNA and PTB34-RNAFox-1 complexes, we used time-resolved FRET to measure the distances
between the two fluorophores for PPT-15F RNA sample (104, 144). Experiments
and data analysis were performed as described in Chapter 2 and summarized in
Table 4.3 and Figure 4.6. For RNA only (PPT15-F), the distance between two
ends was 72 Å, which is comparable to the distance for PPT-20 from our
previous experiment (170). The measured distance for 1!M Fox-1 and 250 nM
RNA complex is calculated as 68 Å. This suggests that Fox-1 binding to the RNA
slightly decreases the distance between the two ends of the RNA that was
consistent with the previous study where a curvature was observed on Fox-RNA
complex (Figure 4.6C) (41).
In the presence of 0.5 !M PTB34, the calculated distance distribution was
44 Å, confirming the shorter distance between the 5’ and 3’ ends for PTB34-RNA
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Figure 4.6 Distance distributions for PPT-15F in the presence of Fox-1 and
PTB34. (A) Donor fluorescence decay in the presence of acceptor (black), in the
presence of 1!M Fox-1 (blue), and in the presence of 0.5 !M PTB34 (green). (B)
Distance distributions for RNA alone with a mean distance of 72 Å (middle). The
average donor-acceptor mean distance is 68 Å in the presence of 1 !M Fox-1
(left). In the presence of 0.5 !M PTB34 an average distance of 44 Å was
observed, which corresponds to the loop RNA. (C) Schematic representation of
distance distributions from B with respect to protein binding and change in the
RNA conformation.
complex that is consistent with an RNA-looping mechanism (Figure 4.6C) (170).
Upon addition of 1 !M Fox-1, the calculated distance was 45 Å for PTB34-RNAFox-1 complex (Table 4.3). This distance was not changed even in the presence
of 2 !M Fox-1. These distance distributions are according to our expectations at
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higher PTB34 concentrations. At this moment we believe that in the presence of
higher RNA (250 nM) and PTB34 (0.5 !M) concentrations, Fox-1 is not able to
replace PTB34. This is consistent with what was observed in steady-state
experiment, where in the presence of 100 nM PTB34, increase in FRET after
titrating Fox-1 didn’t occur. As a control, we calculated the distance for PTB34RNA complex in the presence of 1!M PTB34 which was 36 Å and is similar to a
previously measured distance of PTB34-PPT-20 complex (170).
Table 4.3 Distance distributions measured from trFRET
SN

4.3

Sample

Distance (Å)

1

RNA Only (PPT-15F)

72 ± 1

2

RNA + 1.0 !M Fox-1

68 ± 1

3

RNA + 0.5 !M PTB34

44 ± 2

4

RNA + 0.5 !M PTB34 + 1!M Fox-1

45 ± 1

5

RNA + 0.5 !M PTB34 + 2!M Fox-1

45 ± 1

6

RNA + 1.0 !M PTB34

36 ± 2

Discussion
It has been known form a long that UGCAUG sequence elements are

shown to control many alternative exons including c-src N1 exon (203, 262, 263).
These sequence elements are recognized by an RRM in Fox-1 and they regulate
splicing of many tissue-specific alternative exons (260, 264, 265). The c-src N1
exon is one of the most studied alternative exons that can be regulated through
both positive and negative control mechanisms (203, 266). PTB binding to the
intronic splicing silencer of c-src pre-mRNA elements can repress N1 expression
in non-neuronal cells. The downstream of this exon is a complex and flanked by
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binding sites for several proteins including hnRNPs and KH-types (230, 232,
233). Specifically, highly conserved hexanucleotide sequence is located
downstream of neuron-specific-exons (201). Recent studies been proposed and
characterized the RNA looping mechanism for splicing regulation of the N1 exon
in non-neuronal cells (15, 170). It has been proposed that Fox-1 and PTB
compete for overlapping binding sequences and Fox-1 replaces domain of PTB
from the PTB-RNA complex to regulate the N1 expression (16). However, the
exact mechanism by which Fox-1 up-regulates the N1 expression on neuronal
cells is yet to be explored. We have used a FRET assay to study the binding and
competition of Fox-1 to the ssRNA with UGCAUGU sequence and 15 nucleotide
spacer in between two poly-pyrimidine tracts. It has been previously shown that
PTB efficiently loop out RNA with !15 nucleotide spacer (170). Our results show

Figure 4.7 The proposed model for splicing regulation of c-src N1 exon. PTB34
loops out the N1 exon that blocks N1 inclusion (left). Fox-1 competes with
overlapping binding sites and displaces domain 4 of PTB34 from complex and
disrupt the RNA loop induced by PTB34 (right) (16).
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that both PTB34 and Fox-1 bind to their respective binding sites where Fox-1 has
high affinity (~8 nM) for the Fox binding sequence. Competition experiments
revealed that Fox-1 replaces domain 4 of PTB34 from protein-RNA complex.
Here, Fox-1 competes with PTB34 for overlapping binding sequence U present
as in downstream control sequence (DCS) (Figure 4.7). This is consistent with
the previous NMR study of the PTB34-RNA complex (16). The calculated K1/2 is
slightly lower than the Fox-1 dissociation constant. This is possibly due to the
formation of secondary structure that allowed Fox-1 binding more efficiently in
PTB-RNA complex. Another explanation for this is the possible protein-protein
interaction between PTB34 and Fox-1 that helps to find UGCAUGU elements
more efficiently in a PTB34-complex rather than RNA alone. These experiments
also revealed that Fox-1 replaces PTB34 in a concentration dependent manner
such that it is only an efficient competitor at PTB concentrations !50 nM.
The same experiment with ssRNA was also performed in which the
downstream pyrimidine tracts were separated by additional adenine nucleotides
from Fox-1 binding sequence. All these RNAs bound with PTB34 with similar
binding affinities (Table 3.2). The competition experiments were performed for
these RNAs and the K1/2 was measured to be largest for 30 nucleotides
separation. This data suggests that the secondary structure formed under these
conditions keeps the two binding sites close in proximity so that Fox-1 is able to
replace PTB4 from the complex. Another explanation for this might be that from
the protein-protein interactions, rather than direct competition for an RNA binding
site or steric clashes, actually allow Fox-1 to displace PTB34. These findings are
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related to the splicing regulation by Fox-1 that helps to express N1 exon of c-src
pre-mRNA in neuronal cells.
4.4

Conclusions
The designed RNA substrate can bind PTB34; upon binding, it decreases

the distance between two fluorophores, which supports the looping mechanism
of splicing repression. However, when Fox-1 is added as a competitor, the
fluorophores become further apart, suggesting that Fox-1 inhibits RNA looping.
The tight binding affinity of Fox-1 observed here indicates that it could be an
efficient competitor for binding pre-mRNA in the DCS of the c-src N1 exon. The
competition experiments showed that Fox-1 competes with PTB34 for same
binding site in a concentration dependent manner at concentrations that are likely
to be physiologically relevant. Since the binding affinity of Fox-1 is higher than
PTB domain 4, we propose that Fox-1 replaces domain 4 from PTB-RNA
complex. Together, these data support the hypothesis that Fox-1 counteracts the
splicing repression by displacing PTB34 and thereby disrupting the RNA loop to
enhance the splicing of the N1 exon.
4.5

Materials and methods

4.5.1 RNA purification and fluorophore labeling
RNA samples with or without 5’ fluorescein and 2’-OH protection groups
were purchased from Keck Foundation Biotechnology Resource Laboratory at
Yale University School of Medicine and were deprotected, purified and labeled as
described in Chapter 2 (110, 258).

108
4.5.2 Radioactive 5’ labeling of RNA
Both CUCWT and PPT-15P RNA (20 pmole) were labeled at the 5' end in
T4 PNK buffer (50 mM Tris·HCl, pH 7.6, 5 mM DTT, 10 mM MgCl2, 0.1 mM
EDTA and 0.1 mM spermidine) with 10 !Ci [!

-

32

P]-ATP and 10 units of T4

polynucleotide kinase (PNK) enzyme in a volume of 50 !l at 37 °C. The reaction
mixture was centrifuged through a spin column at 3000 rpm for one minute. The
labeled RNA samples were used in gel shift assays for protein binding.
4.5.3 Protein expression and purification
Fox-1 was over-expressed in E. coli and purified as described previously
(41). In brief, DNA encoding the RNA binding domain of Fox-1 (residues 109208, Swissport Q9NWB1) was PCR amplified from a full length Fox-1 cDNA and
cloned into pET28a (+) (Novagen) with an N-terminal His-tag. The protein was
expressed in BL21 (DE3) E. coli at 37 °C in LB containing 50 mg l-1 kanamycin.

Figure 4.8 SDS-PAGEs showing fractions of the NiNTA purification of Fox-1. M:
molecular weight marker (Fisher’s EZ-Run Pre-Stained Rec Protein Ladder), CL:
soluble fraction of the cell lysate, FT: fraction of the cell lysate that did not bind to
the NiNTA resin, W: wash fraction (10 mM imidazole), E: eluted fractions
represented by fraction numbers. Gels were stained by comassie blue dye for
visualization.
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After this, induction and purification was performed as described in Chapter 3 for
PTB34. Figure 4.8 shows the SDS-PAGEs of the purification of Fox-1 protein.
4.5.4 Gel shift assays
Non-denaturing polyacrylamide gel electrophoresis was performed as
described in Chapter 3 to observe the protein binding to the purified RNA. For the
competition experiment, RNA was allowed to bind first protein (PTB34 or Fox-1)
and equilibrated for five minutes in room temperature. Next, the second protein
was allowed to bind and loaded on a pre-equilibrated native gel. Similarly,

32

P-

labeled RNA samples were heat denatured in standard buffer and allowed to cool
down to room temperature. Protein was allowed to bind with RNA and loaded on
a pre-equilibrated native gel. After running (0.5x TBE) for 6 hours at 4 °C, the gel
was exposed on a phosphoimager and was scanned using typhoon.
Quantification of each gel bands was performed using ImageQuant software
(Molecular dynamics). The fraction bound were plotted as a function of Fox-1
concentration and fitted using Hill equation.
4.5.5 Steady-state FRET
Steady-state FRET measurements of doubly labeled RNA samples were
carried out in a spectrofluorometer as described in Chapter 2. A 25 nM RNA
sample was annealed in standard buffer, and fluorescence was measured in the
absence and presence of protein (PTB34 and Fox-1). Relative FRET efficiencies
were calculated by using Equation 2.5. The global dissociation constant (KD) and
cooperativity coefficients were obtained by plotting FRET as a function of protein
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concentration, and fitting to the modified binding Equation 3.1. For the
competition experiment, after scanning RNA only sample, different PTB34
proteins (25, 50 and 100 nM) were added to the solution and scanned to
measured FRET. After that, protein titration was performed as described before
and K1/2 was calculated by plotting FRET as a function of protein concentration
after fitting with Equation 3.1.
4.5.6 Time-resolved FRET for distance measurements
The distance between the two fluorophores was measured using timeresolved FRET (tr-FRET), as described in Chapter 2 (110). A 250 nM PPT-15F
RNA sample (donor only or doubly labeled) was heated for 2 minutes at 90 °C
and annealed in standard buffer. After collection of photons from the RNA only
sample, 0.5 !M PTB34 protein was added and allowed to equilibrate for five
minutes at room temperature. Photons were collected from PTB34-RNA complex
for both donor only and doubly labeled sample. 1 !M Fox-1 was added to the
solution and photons were collected after equilibrating for five minutes. Data
analysis was done as described in Chapter 2.
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CHAPTER 5
Protein-RNA dynamics in the 30S ribosome assembly
5.1

Introduction to the ribosome
The ribosome is a macromolecular machine, responsible for synthesizing

proteins during a process called translation. Ribosomes utilize messenger RNA
(mRNA) as a template and aminoacyl-transfer RNAs (tRNA) as substrate during
translation. Ribosomes is a ribonucleoprotein complex, composed of ribosomal
RNAs (rRNAs) and ribosomal proteins (rproteins). The 70S bacterial ribosome
has a mass of 2.6-0.28 MDa and a diameter of about 20 nm (267-269). Each 70S
ribosome is composed of a small (30S) and a large (50S) subunits (86). The
small subunit is composed of one rRNA, 16S (1642 nucleotides) and 21 rproteins
(S1-S21), whereas the large subunit is composed of two rRNAs, 23S (2900
nucleotides) and 5S (120 nucleotides), and 34 rproteins (L1-L34) (86, 94)
(Figure 5.1). The intermolecular bridges between 30S and 50S help to associate
the two subunits during the formation of a complete 70S (270).
Both subunits have different roles in protein synthesis (271). The 30S
subunit is the location of the decoding center and is responsible for the selection
of the correct tRNA on the basis of mRNA codons. This subunit also helps in the
formation of the initiation complex. On the other hand, the 50S subunit is
responsible for the formation of the peptide bond since the peptidyltransferase
center (PTC) is located in this subunit. The 50S subunit also helps to release
nascent polypeptide and tRNA (267). Both subunits have three tRNA binding
sites during translation: the A, P and E sites.
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Figure 5.1 Composition of bacterial ribosome. 70S is composed of 30S and 50S
subunits. 30S subunit consists of 16S rRNA and 21 rproteins where as 50S
subunit consists of 23S rRNA, 5S rRNA and 34 rproteins. Figures are generated
from PDB IDs: 2aw4 (50S) and 2avy (30S) (272).

Figure 5.2 Crystal structure of ribosomal subunits. (A) Structure of 30S subunit: 16S rRNA (grey) and rproteins (cyan).
(B) Structure of 50S subunit: 23S rRNA (blue), 5S rRNA (purple) and rproteins (green). Figures are generated from
PDB IDs: 2avy (30S) and 2aw4 (50S).
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5.2

Ribosomal RNA
Ribosomal RNA of both subunits are transcribed from the same

transcriptional unit called the rrn operon. The native transcript undergoes
enzymatic processing with the help of different enzymes in order to form a
functional rRNA (273, 274). This mature RNA is the catalytic part of the
ribosome. The overall folding of the nucleotide sequences have been
characterized by different biophysical studies such as chemical modification
assays, evaluation of nucleotide susceptibility to nucleases, co-variation analysis
and so on. These studies have ultimately generated the secondary structure of
rRNA and determined the conserved nucleotides for ribosome function in all
forms of life (275, 276). The secondary structure of 16S rRNA is divided into the
5’ domain (1-556), the central domain (557-918), and the 3’ domain (919-1542).
The 3’ domain is further divided into 3’ major and 3’ minor (decoding region)
domains (82, 276) (Figure 5.3). The 23S rRNA is divided into six domains
(domains I-VI) with the peptidyltransferase center located in domain V.
The folding of the secondary structure of rRNA is stabilized by the
formation of different secondary structure motifs. The important secondary
structure motifs involved in rRNA are hairpin loop, bulge loop, internal loop and a
junction loop (Figure 5.4). Hairpin loops consists of a double-stranded stem
formed by complementary sequences with a single-stranded loop. Hairpin loops
are prevalent building blocks of RNA secondary structures. About 70% of the16S
rRNA nucleotides are associated with hairpin structures (277). On the other hand
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Figure 5.3 Secondary structure of E. coli rRNA with major domains. 5’ is a 5’
domain, C is a central domain, M is 3’ major and m is 3’ minor domains. This
Figure is adapted from reference (278).
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for bulge loops and internal loops, an unpaired region is present either on one
side or on both sides, respectively of a helical region (279).
The stability of these loops depends on the loop closing base pairs, loop
complementarity with other loops in the structure, the sequence of the stems
adjacent to the loops, and the number of nucleotides in the loop(s) region (277,
280, 281). Junction loops are formed when three or more than three helices
intersect. All these secondary structural motifs are the sites for folding nucleation,
protein interactions, and drugs or other small molecules (metal) binding (279).

Figure 5.4 Secondary structural motifs of rRNA. (A) Hairpin loops (B) Bulge loop
(C) Internal loop (D) Junction loop.
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5.3

Ribosomal proteins
The original hypothesis for protein synthesis stated that it was carried out

by rproteins while rRNA only acted as the structural scaffold for the rproteins.
Later on different studies suggested that the ribosome is not a multi-enzyme
complex, but instead it is a ribozyme, where rRNA carries out the catalytic activity
(282, 283). Ribosomal proteins bind to rRNA to assist in its folding in order to
maintain the correct structure for catalytic activity. E. coli has fifty-five rproteins
that are globular with extended N- and C-terminal domains. The globular
domains are mainly located on the surface (81). The remaining portion of the
rproteins extends into the core of the ribosome to help reduce the steric
hindrance between phosphate backbone (80, 82, 284). Although rproteins are
distributed through out the surface of the ribosome, none are present near the
decoding region and PTC (80, 82). The peptidyltransferase activity of 50S is still
possible even after depletion of many rproteins (285), which demonstrate that the
catalytic activity of ribosome is carried out by rRNA. Besides providing the folding
platform for rRNA and its catalytic activity, many rproteins have several other
roles in the cell. For example, S15 and S4 have autoregulatory activity for the
translation of the rprotein operon genes (286).
5.4

Ribosomal assembly
The biogenesis of ribosomes takes place in a well-defined manner. The

several steps of biogenesis are rRNA transcription, rprotein synthesis, RNA
processing and folding, protein binding and modification. All these steps are not
sequential; some of them might be parallel or cotranscriptional (287). After
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transcription, all rRNA undergoes processing events and at the same time
rproteins are synthesized and undergo assembly in a hierarchical manner. For
example 30S subunit assembly occurs simultaneously with transcription in a 5’ to
3’ direction (287). Several in vitro reconstitution experiments were performed in
order to determine the binding orders of rprotein to the rRNA (288, 289).

Figure 5.5 Assembly map of 30S ribosomal subunit. Primary binding proteins are
in red, secondary binding proteins are in blue, tertiary binding proteins are in
purple and quaternary binding proteins are in orange. Black arrows indicate the
binding order and dependencies (288-290).
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Very few modifications have been made to the first proposed model by
Nomura (290, 291) (Figure 5.5). Out of 21, six of the rproteins (S4, S7. S8, S15,
S17, and S20) of the 30S subunit are capable of binding directly to the naked
16S rRNA and are known as primary binding proteins. The binding of these
rproteins changes the conformation of rRNA and allows binding of the second set
of proteins, called secondary binding proteins (S6, S9, S12, S13, S16, S18 and
S19). The tertiary binding proteins (S5, S10, S11 and S14) bind only after the
binding of primary and secondary rproteins. Finally, the last set of rproteins;
quaternary binding proteins (S2, S3 and S21), bind resulting in a fully assembled
30S subunit. Assembly of 50S occurs in a similar manner to 30S subunit (292).
After complete assembly of 30S and 50S, the two subunits associate with the
help of interacting bridges to form a complete 70S subunit. There are twelve
intersubunit bridges characterized in the 70S crystal structure (293).
5.5

Protein synthesis
Ribosome with the help of several factors can translate mRNA into protein.

There are three steps in protein synthesis: initiation, elongation and termination.
Initiation is the first step of protein synthesis that starts with binding of 30S
subunit to the mRNA (294). In bacteria, the Shine-Dalgarno sequence (SD) of
mRNA recognizes the anti-Shine-Dalgarno (ASD) sequence of 16S rRNA, which
positions the AUG start codon in the P-site of 30S subunit (295-297). The
positioning of the start codon allows the binding of tRNAfMet to the P-site (298).
This initiation complex then associates with 50S subunit through several
intersubunit bridges. Initiation factors (IF1, IF2 and IF3) help to prevent
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premature binding of the initiation complex with 50S and non-initiator tRNA from
entering the P-site (299).
The elongation of protein synthesis takes place after binding of an
incoming aminoacyl-tRNA incomplex with elongation factor (EF)-Tu and GTP to
the A site (299). After this, GTP hydrolysis takes place that releases the
aminoacyl end of the tRNA from EF-Tu (294). The conformational changes in
rRNA orient the peptydyl-tRNA and aminoacyl-tRNA to allow peptide bond
formation that forms the polypeptide at A-site and leaves the deacylated-tRNA at
P-site creating the pre-translocation complex (300). The rotation of the ribosome
after the pre-translocation stage moves the deacylated-tRNA to a P/E hybrid
state and the aminoacylated-tRNA to the A/P state (301). This is recognized by a
complex of EF-G and GTP and another translocation takes place upon GTP
hydrolysis where the tRNAs moves from the hybrid state to their final position in
the P-site and E-site, which moves the mRNA ahead by one codon (294, 300,
302). After this the next round of elongation starts.
The final stage of protein synthesis occurs when the A-site encounters a
termination codon (UAA, UAG or UGA) in the mRNA. At this stage, release
factors interact with both the decoding site as well as the PTC and then protein
release is catalyzed by the PTC (303). After hydrolysis of the peptide bond,
ribosome-recycling factors (RRF) break the intersubunit bridges between the two
subunits and dissociate 30S and 50S for another round of protein synthesis.
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5.6

Ribosome and antibiotic resistance
Ribosomes of the three domains of life (bacteria, archaea and eukaryotes)

have significantly different structures and nucleotide sequences on their RNA.
These structural differences permit some compounds (antibiotics) to bind and
inhibit ribosome function without affecting human protein synthesis. Antibiotics
are chemical compounds produced by some organisms or chemically
synthesized, which are used to kill other organisms. Almost half of the clinically
used antibiotics target ribosomes and protein synthesis. Figure 5.6 shows the
possible antibiotic targets of the elongation cycle. Antibiotics have different
binding sites in the ribosome, for example, the aminoglycoside family of
antibiotics bind to the decoding region of 16S rRNA (A-site) and cause
mistranslation

(269,

304,

305).

On

the

other

hand,

the

macrolides,

chloramphenicol, lincosamides, oxazolidines and so on target the PTC and block
the peptide bond formation (306, 307).
The emergence of resistance to antibiotics has been a major challenge of
the medical field since its discovery in 1940’s (308, 309). Bacteria utilize several
different mechanisms like target modification, inductive expression of latent
chromosomal genes, plasmids or transposons, degradation of the antibiotic,
inactivation by modification of functional groups, efflux of the antibiotic and so on
(309). Among these, target modification is the greatest concern because most
synthetic antibiotics become resistant due to mutation of the target-binding site in
rRNA (310-312).
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Figure 5.6 Schematic representation of translation elongation cycle and sites for
antibiotic action. Reprinted from (307), 2010 with permission from Elsevier.
Due to the slowing down in development of antibiotics and an increase in
resistance rate by bacteria, it is necessary to explore new possible drug leads
and targets. Several approaches are being employed to develop new antibiotics.
Ribosomes could be a good drug target to study from both a structural and a
genetic point of view. Recent high-resolution crystal structure with and without
bound antibiotic (313-315) increases our understanding of the interactions of
rRNA with small molecules. These structural constraints are being used by
different computational scientists in their structural based drug discovery to
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predict small molecule binding to the ribosome. The predicted compounds are
synthesized, assayed for its function and binding to its particular target as a drug
lead (316). Other approaches to study drug development are genetic-based
study. These allow studying target modifications in the ribosome caused by
mutations. According to this approach, mutational studies are performed to
determine the critical structural nucleotides in the target. Since there are multiple
rRNA operons, the phenotype of a mutation in one operon will be overshadowed
by the wild-type (WT) operons. This along with the lethal phenotype of other
mutations has made it difficult to do mutational studies. To study the rRNA
structure and function, the Cunningham lab has developed a pRNA123 plasmid
system (317, 318). The plasmid allows mutational studies in vivo without
affecting normal cellular function (317, 318). This system has two-reporter genes,
the green fluorescence protein (GFP) and chloramphenicol acetyltransferase
(CAT) along with ampicillin (bla) gene and a complete rRNA operon, rrnB (Figure
5.7). This rRNA operon is under the control of the IPTG inducible lac (lacUV5)
promotor. The Shine-Dalgarno (SD) sequence of the reporter genes has been
modified in a way that recognizes the complementary anti-Shine-Dalgarno
sequence (ASD) of the plasmid 16S rRNA. This allows only plasmid-derived
ribosomes to translate GFP and CAT mRNA and is suitable to study the function
of any mutation in the plasmid rRNA by determining the level of GFP production
(317). After finding the functional target sequences, potential drug leads (small
molecules or peptides) can be identified and a phase display can be used to
select the possible peptides that bind to the target.
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Figure 5.7 Genetic system for studying the functional analysis of the 16S rRNA.
CAT and GFP are two reporter genes can only translated by plasmid ribosome
but not translate by chromosomal transcripts (317).
5.7

Protein-RNA dynamics in the central junction control 30S ribosomal
subunit assembly
The interactions between ribosomal proteins and ribosomal RNA (rRNA)

facilitate and stabilize the folding of rRNA into its active conformation. The central
domain of 16S rRNA contains several protein-binding sites. S15 is a central
domain primary binding protein that has been shown to trigger a conformational
change in the rRNA (83). This conformational change allows other central
domain binding proteins to bind to the central domain causing a cascade of
changes resulting in the functional structure of the central domain. Previous
biochemical and structural studies have revealed two regions that are minimally
required for binding S15 in vitro. One of these regions is the junction of helices
20, 21, and 22 in 16S rRNA (Figure 5.8).
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Figure 5.8 Location of the junction loop in the central domain and S15
interaction. (A) The central domain secondary structure showing the important
helices and junction loop (square box) (276). (B) 30S subunit with position of
central domain and junction loop. A magnification of the junction loop and S15;
rproteins are colored light orange and 16S rRNA is in light grey; S15 is red
(Lys64, Tyr68, and Lys72 are within 2-3 Å of side B and interact with the
backbone of side B); S8 is in light blue, 652:753 in green; 654:752:754 in blue;
653 in orange. In both 16S and 30S, helix 20 is in pink, helix 21 is in purple, and
helix 22 is in cyan. Part of this Figure is taken from reference (286).
This junction includes nucleotides 652-654 and 752-754 plus two or three
base pairs in each helix to maintain the junction structure. All junction nucleotides
except 653 are highly conserved in bacteria, implying that these nucleotides are
functionally important. Saturated mutagenesis and S15 over-expression studies
identified the functionally important sequence and structural elements within the
junction loops complemented by S15. Nonfunctional mutants were not
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complemented by over-expression of S15. Here, we present the results of
comprehensive in vivo genetic and in vitro single-molecule fluorescence studies
that identify the key sequence, structural motifs and structural dynamics of the
central junction are responsible for its role in proper ribosome assembly and
function.
5.8

The central domain
The 16S rRNA is divided into 4 domains as indicated above. Each domain

plays an important role in rRNA folding and protein synthesis. The central domain
consists of nucleotides 557-918 (Figure 5.8A) that make helices 19 through 27.
Some of the universally conserved sequences like the 690 loop and the 790
loops are within the central domain (94, 267). Both of these loops are important
for 30S and 50S subunit association during protein synthesis (293, 319). Another
important part of this central domain is the junction region of helices 20, 21 and
22, which plays a role in assembly of the central domain (83, 320, 321). Besides
these rRNA, there are multiple proteins associated with the central domain.
These proteins are S6, S8, S11, S15, S18 and S21 (Figure 5.8B) (83).
5.9

S15 and junction loop interaction
The interactions between ribosomal proteins and ribosomal RNA facilitate

and stabilize the folding of rRNA into its active conformation. The central domain
of the 16S rRNA contains several protein-binding sites. S15 is a central domain
primary binding protein (288, 289) that has been shown to trigger a
conformational change in the rRNA (321). This conformational change allows
other central domain binding proteins to bind to the central domain causing a
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cascade of changes resulting in the functional structure of the central domain.
Previous biochemical and structural studies have revealed two regions that are
minimally required for S15 binding in vitro. One of these regions is the junction of
helices 20, 21, and 22 in 16S rRNA (Figure 5.8). This junction includes
nucleotides 652-654 and 752-754 with two to three base pairs in each helix to
maintain the junction structure. All junction nucleotides except 653 are highly
conserved in bacteria, implying that these nucleotides are functionally important
(276).
S15 is a small protein with 89 amino acids that has only one domain and
folds into four ! helices. This protein doesn’t recognize any specific base in 16S
rRNA but interacts with the backbone of junction nucleotides 752-754 (81, 83).
The nucleotide interactions in the junction region 652-654 and 752-754 create
the backbone conformation to bind S15 and proper folding of the junction. S15
binding promotes the cooperative binding of S6 and S18 and then S11 and S21
(83). So, the formation of correct junction structure is very important for S15
binding and assembly of other central domain proteins.
5.10 Results
This project is divided into two parts. In the first part, regions of importance
in S15 binding to the central domain were genetically analyzed. This study
characterizes the different sequence elements that are important for S15 binding
and proper folding of central domain. In the second part, those mutants were
used to characterize the dynamics of junction-S15 interaction by using a
biophysical method. Here we chose to use single-molecule fluorescence
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resonance energy transfer (smFRET), which allows protein-RNA interactions to
be studied at a molecular level. In this section, I have summarized some of the
most exciting results that were obtained from the genetic study and have
described the single-molecule data.
5.10.1 Genetic analysis of important regions for S15 binding to the central
junction
[Kris Ann Baker performed this work in Prof. Cunningham’s lab. All results
in this section are adapted from her dissertation submitted to the graduate school
in 2008 (286).]
5.10.1.1 Mutational study
To identify functionally important sequence and structural elements within
the central junction, three nucleotides 652-654 (side A), and 752-754 (side B) of
the E. coli 16S rRNA junction loop were subjected to saturation mutagenesis
using PCR (318, 322). The mutations were cloned in the ribosome expression
vector pRNA228 (317, 318, 323), expressed in E. coli DH5 cells (324) and
functionally active mutants were isolated by selecting with 100 !g/ml of ampicillin,
50 !g/ml of chloramphenicol, and 1 mM IPTG (LBCm50).
Side A mutations: A total of 48 side A mutants were analyzed (318).
Among these, only 15 unique sequences that produce ribosomes with in vivo
activities >10% of WT ribosomes were identified indicating that transformants
expressing other mutant sequences produced inactive ribosomes (318).
Analysis of the 15 survivors revealed a random distribution at positions 652 (!2,
"=0.98) and 653 (!2, " = 0.87), however; only the WT G654 was isolated in 14 of
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the 15 mutants (!2, " = 3.6x10-8). The other mutation, U654, produced ribosomes
with only 12 % activity.
Side B mutations: We analyzed 45 side B mutants but only six unique
sequences with >10% activity in vivo were identified. Though the sample size is
insufficient for statistical analysis, it is interesting to note that each of the six
mutants contained only a single mutation and that mutations were isolated at
each of the randomized positions. The lowest activities observed among the
mutants were C754U (16%) and C754A (11%).
Side A and B mutations: Out of 735 chloramphenicol-resistant
transformants, only 64 unique mutants with >10% functions were analyzed. Nonrandom distributions were observed at all positions in the junction loop (!2, " !
5.1 x 10-5). The WT nucleotide was preferred at every position except 653, at
which 32 of the 64 mutations were U653A. All of the mutations isolated in the
side A only and side B only selections were present in the combined mutant pool.
If interactions between the two sides of the junction are important for ribosome
function, functional sequences excluded during the side A only and side B only
selection should be presented among the sequences isolated when all six
nucleotides were mutated. Fifteen mutations that were absent among the side A
survivors and 17 mutations that were absent among the side B survivors, were
isolated when all six nucleotides were mutated. In each clone, the excluded
single-side sequence was accompanied by additional mutations on the opposite
side.
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Figure 5.9 Covariation analysis of selected junction mutants. Helix 20 is in red,
helix 21 is in pink and helix 22 is in cyan. Colored nucleotide indicates the
interaction observed in the crystal structure. Font size corresponds to the
frequency of the nucleotide identity in the selected mutants. Boxes lines with pvalues indicate the position of significant correlation between nucleotide identity
and function. Lines with p-values are covariation positions.
To determine if the occurrence of these mutations was due to
complementation between the sides of the junction, each of the 32 mutants was
subcloned in the absence of mutated nucleotides on the opposite side of the
junction and assayed. All but four of the 32 subclones produced inactive
ribosomes (<10% of WT) indicating that interactions between the nucleotides on
each side of the junction are important for ribosome function. The four singleside mutants with >10% activities were added to the pool of selected mutants for
further analyses.
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5.10.1.2 Identification of functionally important sequence and structural
motifs
Position 654 and 754: A covariation analysis was performed to understand
the requirement for interaction between the nucleotides on either side of the
junction (318) (Figure 5.9). A weak covariation was observed between positions
652 and 753 (!2, " = 1.9 x 10-2), 654 and 752 (!2, " = 7.8 x 10-4), and 752 and
754 (!2, " = 4.4 x 10-3). However, a highly significant covariation was observed
between positions 654 and 754 (!2, "=6.4 X 10-26). Of the 64 junction mutants, 23
were able to form Watson-Crick (WC) base-pairs at this position. The mean
activity of mutants, which can form WC base-pairs, is 32%. This activity assay
confirmed that a WC base-pair between positions 654 and 754 is an important
component for functionally active ribosomes (Table 5.1). A base-triple between
G654, G752, and C754 in the crystal structure also correlates the importance of
this interaction for ribosome function (Figure 5.10A and C) (83, 272). The
observed weaker covariations between positions 654 and 752, and 752 and 754
may be due to the selection of nucleotide combinations that could facilitate the
formation of strong interaction between 654 and 754. Thus, 34 out 64 functional
mutants had mutations at 654 and/or 752 and only 3 of the 34 contained
nucleotide combinations that can form WC base pairs between 654 and 752.
These findings support the importance of nucleotides in positions 654 and 754 in
ribosome function.
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Table 5.1 Nucleotide distribution of selected junction mutants (286)
Nucleotide

652

653

654

752

753

754

A. Nucleotide distribution among functional mutantsa
A

11 (6)b

32 (18)

5 (2)

11 (5)

48 (27)

11 (3)

C

6 (4)

10 (6)

9 (3)

4 (1)

2 (0)

36 (23)

G

9 (4)

8 (4)

39 (24)

41 (24)

7 (3)

9 (3)

U

38 (18)a

14 (4)

11 (3)

8 (2)

7 (2)

8 (3)

pc

6.2 x 10

-9

5.1 x 10

-4

(7.1 x 10 )

-5

8.2 x 10

-4

(2.8 x 10 )

(7.1 x 10 )

-10

1.3 x 10

-11

-9

(1.7 x 10 )

(4.1 x 10 )

(3.6 x 10 )

-9

1.3 x 10

-18

-13

2.4 x 10

-7

-8

B. Nucleotide distribution among bacteriad
A

6

6345

13

17

12915

10

C

11

476

10

4

5

12910

G

3

803

12900

12904

9

7

U

12913

5309

10

8

4

6

a

Nucleotide distribution in 64 selected mutants with the WT sequence in bold.

b

Numbers indicate the distribution of selected mutants with >40% function.

c

Probability of random distribution based on Chi-square analysis.

d

Nucleotide distribution in all bacterial sequences obtained from the Ribosomal

Database Project from Michigan State University (Cole et al. 2003).
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Figure 5.10 Junction loop structure with important interactions. (A) A position of
RNA backbone after the formation of a base triple between G654:C754:G752.
(B) Base stack observed in crystal structure; G588, A753, G654 and A 655.
These two Figures are adapted from (286). Helix 20 is in pink, helix 21 is in
purple and helix 22 is in cyan. (C) A schematic representation of triple base pair
between G654:C754:G752. (D) A reverse-Hoogsteen interaction observed
between U652:A753.
Position 652 and 753: A small but significant covariation (Figure 5.9)
between 753 and 652, support the importance of this interaction for ribosome
function. This interaction is observed in the crystal structure where, A753 stacks
with A655, G654, and G588 (Figure 5.10B). The stacking interaction of A753 is
stabilized by the formation of a reverse-Hoogsteen pair with U652 (272, 325)
(Figure 5.10D). Out of 30 mutants isolated, 22 (73%) had the ability to form a
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reverse-Hoogsteen pair (326), which is not much higher than the number of
potential reverse-Hoogsteen pairs that would be expected by random chance
(62%). So, the nucleotide interaction at 652 and 753 is important for ribosome
function but there is no requirement for a reverse-Hoogsteen pair to be formed.
Fifty-five mutants out of 64 contained purines at position 753 suggesting that the
ability of the residue at position 753 to participate in the 655/654/753/588 stack is
more important for ribosome function than its ability to form a reverse-Hoogsteen
pair with the nucleotide at position 652 (Figure 5.10B and D). From the crystal
structure, a hydrogen bond between the O4 of U652 and the 2’-OH of G752 was
observed (272). Out of selected nucleotides at position 652, only U652 was
capable of forming both the H-bond with G752 and the reverse-Hoogsteen
interaction with A753. Disturbance of this interaction could have a small impact
on 655/654/753/588 stack, which is important for S15 binding.
Position 653: This position is the least conserved in the junction region
with nucleotide U653 acting as a spacer nucleotide, which was determined from
the crystal structure and in vitro studies (321, 325, 327, 328). The single deletion
mutant, U653! was only 3% as active as WT, but all the single substitution
mutations had near-WT function. These findings are consistent with the role of
U653 as a spacer nucleotide. The amount of GFP produced and the growth rate
was observed to be the same for all single mutations at 653 except U653!
mutant. Out of several mutants, U653A significantly produced ribosomes with
higher function. This suggests that the presence of U653A in combination with
other mutations increases ribosome function in the junction.
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5.10.1.3 Mutation on junction affects S15 binding
S15 over-expression assays were performed to test whether the loss in
function for some mutants was due to decreased S15 binding. For overexpression, the S15 gene was cloned into the pKan5 expression vector and all
mutants were assayed in the presence of over-expressed S15. Out of 94
selected mutants, 78 junction mutants were complemented by over-expression of
S15 with an increase in ribosome function from 4% to 91% (Figure 5.11). The
remaining 16 mutants that were not complemented by over-expression of S15
did not contain WC pairs at positions 654 and 754.
5.10.1.4 S15 binding affects 30S subunit assembly
Two mutants J12 and U653! were selected for further analysis in order to
understand the effect of mutation on ribosome function. Since S15 is a primary
binding protein, the loss in function might correlate with failure of the mutant
ribosomes to assemble into active 30S subunits. Ribosomes from each mutant
and the WT were prepared and ribosomal RNA was extracted from the 30S and
and 70S peaks. A primer extension was performed to determine the percentage
of plasmid-derived 16S rRNA in each peak (Figure 5.12) (318). Out of the total
ribosome pool, approximately, 37% of the plasmid-derived ribosome is present in
the WT cells. In each mutant, the percentages of mutant ribosomes in the 30S
peaks and in the 70S peaks are approximately equal (Figure 5.12) but loss of
activity in the mutants is accompanied by a decrease in the percentage of mutant
ribosomes in each peak relative to the WT. Interestingly, in each mutant the
decrease in the number of mutant ribosomes was less than the decrease in
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protein synthesis activity, indicating that not all of the mutant ribosomes were
equally active.

Figure 5.11 S15 over-expression and its effect on ribosome function. The
production of GFP correlates the function of ribosome. Blue bars are GFP
production levels in the absence of over-expression and green bars are with
over-expression. Letter J is for complemented mutant and letter C is for noncomplemented mutants.

Figure 5.12 Primer extension gels for WT and selected junction mutants. (A) WT (B) J12 mutant and (C)
653! mutant. Number of percentage near each band corresponds to the amount of 16S rRNA formation
from chromosomal ribosomes (top) and plasmid ribosomes (bottom). 70S indicated the 16S rRNA
isolated from 70S and 30S peaks respectively. Percentage values are from the average of three
individual experiments
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Over-expression of S15 in the mutants (Figure 5.12 B and C) significantly
increased the activity of the mutant ribosomes and also increased the proportion
of mutant ribosomes in the 30S and 70S peaks. The increase in activity,
however, was disproportionately greater than the increase in the ribosome in
each peak, indicating that S15 over-expression increases the total number of
mutant ribosomes in each peak while also increasing the proportion of mutant
ribosomes that are active. These data together support the hypothesis that loss
in function of mutants is due to the decrease in assembly of the functional 30S
subunit.
5.10.2 Junction dynamics
Previous studies have shown that the helices comprising the central
junction undergo a significant conformational change during ribosome assembly
involving the ribosomal protein S15 (321, 329, 330). Three helices - h20, h21 and
h22, are in an open conformation with equivalent interhelical angles. In the
presence of S15 and Mg2+, h21 and h22 stack coaxially and h20 adopts acute
angle with h22 (329, 331). Ha et al. have previously utilized smFRET to examine
the dynamics of these three helices with WT sequence in the presence of S15
and Mg2+ (332).
Potentially the loss of function observed with the junction mutants may be
partially due to a change in the dynamics of the three helices. To investigate this
possibility, a series of smFRET experiments with the WT junction loop and
several selected mutants, J58, J12, and C12 (Tables 5.2) were performed in the
presence of S15 and divalent metal ions, such as, Mg2+ (83, 332, 333). The
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mutants were chosen for further study because they have a range of function and
ability to be complemented by S15 over-expression. J58 with 3 mutations and
J12 with 6 mutations have high (74%) and low (18%) levels of function,
respectively, yet both were complemented by over-expressed S15 (Table 5.2).
C12, however, despite only having a single G654C mutation, has only 1%
function and was unable to be complemented by over-expressed S15 (Table
5.2). Comparison of the structural dynamics of these mutants to that of the WT
sequence in the presence and absence of S15 revealed specific sequence and
structural motifs in the junction loop that are important in ribosome function.
Table 5.2 Summary of junction mutants from saturation mutagenesis
Junction nucleotides
Type

Sample
WT

1

J58

2

J12

3

C12

% Function

652

653

654

752

753

754

U

U

G

G

A

C

100

100

U

A

U

G

A

A

74

102

G

A

C

A

U

G

18

83

U

U

C

G

A

C

1

1

5.10.2.1 Native gel to observe the formation of the junction and S15
binding
The construct utilized for the FRET experiments consisted of the E. coli
junction loop region from the central domain of the 16S rRNA that was truncated
as shown in Figure 5.13A. Minor modifications at the bulge near helix 20 were
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Figure 5.13 Single-molecule study of the central domain junction loop of E. coli
16S rRNA. (A) The truncated junction region showing three helixes h20, h21 and
h22 labeled according to the E. coli 16S secondary structure. Donor Cy3 and
acceptor Cy5 fluorophores are attached at 5’ and 3’ ends respectively to the
RNA1 strand where as biotin is attached to second strand. The nucleotides in
bold on helix 20 were modified from WT (ACG) sequence (RNA3) to increase the
efficiency of annealing during the formation of the junction. (B) Schematic
representation of a slide preparation for single-molecule experiment. Quartz slide
is covered with PEG-biotin and RNA sample is immobilized through biotinstreptavidin interaction. In the slide, the junction loop shows the conformation
change in the presence of S15. (C) Typical single-molecule time trajectory in the
presence of 10 nm S15 and 1 mM Mg2+ for the WT junction loop; upper is the
donor intensity in blue and acceptor intensity in red, which are anti-correlated.
Lower panel is the FRET trajectory calculated from the fluorescence intensities of
the donor (ID) and acceptor (IA) from upper panel by using Equation 2.5.
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made in order to increase the efficiency of annealing during sample preparation.
The modifications here are feasible since the bulge was previously shown not to
be critical for S15 binding (332, 333).
The three RNA strands of the FRET construct (Figure 5.13A) were
annealed as described in the Materials and Methods. The complete formation of
the junction construct and binding of S15 was then verified on a native gel as
shown in Figure 5.14. The gel shift was observed and positions of bands were
found significantly different for RNA1, RNA1+RNA2 and for a complete junction
loop with three strands. The formation of the junction loop was observed for WT
and all mutant samples with or without modification. The modified RNA sample
increased the efficiency of the formation of junction loop as compared to the
unmodified sample.
Gel shift assays were also performed in the presence of S15. Here, 20
pmoles of S15 was allowed to equilibrate with 10 pmoles of RNA sample for five
minutes at room temperature. Mobility of the RNA with and without S15 bound
was compared by gel electrophoresis. In the presence of S15, the color of bands
became red and the RNA migrated slower than in the sample without protein,
which indicated the formation of protein-RNA complex (Figure 5.14B). S15
binding was observed for both modified and unmodified junction loop, which
showed that the modification near the helix did not affect S15 binding to the
junction. The formation of a protein-RNA complex was clearly observed for WT,
J12 and J58 mutant loops but not for mutant C12.
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Figure 5.14 FRET based non-denaturing gel electrophoresis of the fluorophore
labeled junction RNAs in presence and absence of S15. RNA and RNA-protein
complexes are assigned as shown. R1 is RNA1, R2 is RNA2 and junction has all
three RNA strands. (A) Gel showing no effect of modification on S15 binding.
This also showed that modification helped to anneal three RNA strands and form
a complete junction. (B) Comparison of S15 binding with WT and three other
modified mutant loops. WT and J59 mutant bind S15 on similar manner than J12
and C12 mutants.

143
5.10.2.2 The WT junction loop is highly dynamic
In the absence of S15 and under near-physiological conditions (1 mM
Mg2+), smFRET trajectories reveal that the WT junction adopts an open
conformation with FRET values ranging 0.4-0.6. A time-binned FRET histogram
built from >100 trajectories reveals the presence of two major conformations
centered at ~0.4 and ~0.6 FRET (Figure 5.15). Based on the time trajectories,
however, these two conformers interchanged more rapidly than our time
resolution (33 ms). Increasing [Mg2+] to 10 mM results in a FRET increase to
~0.8 (Figure 5.15), indicating that h20 and 22 are brought in close proximity
forming a closed conformation. The corresponding smFRET trajectories reveal
that the junction can still transiently explore the open conformation, which results
in a second minor and broad distribution below 0.8 FRET (Figure 5.15). Dwell
time analysis of >100 time trajectories (Figure 5.16A) show that the closing rate
constant (kclose = 9 ± 1 s-1) is ~5-fold larger than the opening rate constant (kopen =
1.8 ± 0.1 s-1), in agreement with the FRET histogram (Figure 5.15B). In the
presence of S15 and under near-physiological conditions (1 mM Mg2+), a similar
effect was observed. The junction resides primarily in the closed conformation
with brief transitions to the open conformation. The opening and closing rate
constants (Figure 5.16B) were similar to those measured in 10 mM Mg2+,
suggesting that S15 and Mg2+ ions may play similar roles in stabilizing the closed
conformation, as proposed previously (332).
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Figure 5.15 FRET time trajectories and histograms calculated for WT junction
loop at different conditions. Data points are processed with three point average
after collecting them every 33 ms. (A) FRET trajectories at 0.5 mM [Mg2+] (top),
most of the time WT loop is in low (0.4) FRET state. Second panel, WT loop is in
the presence of 1 mM [Mg2+], here WT loop is in medium (0.6) FRET. When the
magnesium concentration is increased to 10 mM (third from top), WT loop is in
high FRET (closed) state i.e. 0.8 FRET state and frequently goes to a lower
FRET (open) states. In presence of 10 nM S15 with 1 mM [Mg2+] (Bottom), WT
loop is stabilized to high FRET (0.8). (B) FRET histograms obtained from number
of events at different magnesium concentrations in presence and absence of
S15. Gaussian fit of histograms provides the distributions of molecules at each
FRET state. Histograms are built with 100 molecules at each case unless
otherwise mentioned. At 0.5 mM [Mg2+] (top) WT loop has predominantly (~93%)
0.4 FRET state and ~ 7 % in higher FRET state. When [Mg2+] is 1 mM (second)
WT loop has higher events (~66%) at 0.6 and (~34%) at 0.4 states. When the
magnesium concentration is increased to 10 mM (third from top), the distribution
in the FRET histogram for WT junction loop is high (~92%) at 0.8 FRET state and
8% at lower FRET state. The distribution in the histogram in the presence of 10
nM S15 and 1 mM magnesium (bottom), WT junction (50 molecules) shows
similar results as 10 mM magnesium (~94% at 0.8 and 6% at lower FRET
states).
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Figure 5.16 Histograms of the number of events observed from dwell time
analysis in docked (closed,right) and undocked (open, left) states. Histograms
are fitted with a single exponential equation to calculate the dwell time of the
open and closed states. (A) Dwell time for the WT junction loop at 10 mM [Mg2+],
the opening rate is 1.8 ± 0.1 s-1 and the closing rate is faster than 9 ± 1 s-1. (B) In
the presence of 10 nM S15 and 1 mM [Mg2+], the opening rate is (1.4 ± 0.1 s-1)
and the closing rate is (14 ± 1 s-1), which is similar to rate at 10 mM magnesium.
These results show that the junction loop is stabilized to a closed conformation in
the presence of high magnesium concentration or S15. (C) Dwell time of the type
3 mutant junction loop in the presence of 10 nM S15 and 1 mM [Mg2+]. The
opening rate is 8 ± 1 s-1 where as the closing rate is 2.8 ± 0.2 s-1. Type 3 mutant
loop is not stabilized to a closed state in the presence of S15 as compare to the
WT.
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5.10.2.3 Type 1 mutant (J58) junction requires S15 for proper dynamics
The clone J58 has near-WT function (74%) and is complemented to WT
levels in the presence of over-expressed S15. This suggests that J58 would have
similar junction dynamics to the WT. However, single-molecule trajectories of
clone J58 reveal that this mutant cannot fold like the WT. In the absence of S15
and under 1 mM Mg2+, this mutant exhibits a single conformation at FRET ~0.4
and the fast dynamics that were observed for the WT under these conditions
disappeared (Figure 5.17). Increasing the [Mg2+] to 10 mM recovered the
partially open ~0.6 FRET state observed for the WT, but not the closed
conformation (0.8 FRET). This indicates that the junction mutations in J58 may
have disrupted an important Mg2+ binding site thus preventing folding of the
junction into the closed conformation. Interestingly, in the presence of S15 and
only 1 mM Mg2+, folding in the closed conformation was restored. This result
shows that S15 alone can stabilize the closed conformation even when Mg2+
cannot, suggesting that S15 and Mg2+ stabilize the closed conformation by
different mechanisms. It appears that direct contacts between S15 and the
central junction rather than electrostatic interactions are mostly responsible for
the stabilization of the closed conformation in near-physiological conditions.
5.10.2.4 Type 2 mutant (J12) juncyion dynamics can be restored with
higher S15 concentrations
The clone J12 is a low functional mutant (18%) that can be rescued by
over-expression of S15 in vivo (Table 5.2). In the absence of S15 and 1 mM
Mg2+, J12 smFRET time trajectories exhibit only a low FRET state (0.4) indicating
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Figure 5.17 FRET time trajectories and histograms calculated for type 1 mutant
(J58) junction loop at different conditions. (A) FRET trajectories at 1 mM [Mg2+]
(top), most of the time this mutant loop is in low (0.4) FRET state. Second panel,
is in the presence of 10 mM [Mg2+], here this mutant loop is in medium (~0.6)
FRET. When the magnesium concentration is increased to 20 mM (third from
top), still ~0.6 FRET state. In presence of 10 nM S15 with 1 mM [Mg2+] (bottom),
type 1 mutant is stabilized to high FRET (0.8) as WT. (B) FRET histograms
obtained from number of events at different magnesium concentrations, and in
presence and absence of S15. Gaussian fit of histograms provides the
distributions of molecules at each FRET state. Histograms are built with 100
molecules at each case unless otherwise mentioned. When [Mg2+] is 1 mM (top)
type 1 mutant loop has only one distribution at ~0.4 FRET state. When the
magnesium concentration is increased to 10 mM (second) peak is shifted to ~0.6
state (58%) from 0.4 state (38%) and remaining 4% are in lower FRET state
which is observed from the 3 distributions in the histogram. Similarly, three FRET
distributions are observed in the presence of 20 mM (third from top) [Mg2+]. In the
presence of 10 nM S15 and 1 mM magnesium (bottom), this mutant has only one
distribution at 0.8 FRET state.
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that this mutant adopts primarily the open conformation, as observed with J58.
Increasing the [Mg2+] to 10 or 20 mM does not result in the appearance of higher
FRET species (Figure 5.18). Therefore, Mg2+ alone cannot stabilize the 0.6
FRET or the closed conformations. However unlike J58, time traces of J12 in the
presence of 10 nM S15 and 1 mM Mg2+ showed a few rapid transitions to the 0.6
FRET state or the closed state. The corresponding time-binned histogram of 35
trajectories shows that the 0.6 and 0.8 FRET states are only reached 21% and
4% of the time, respectively. Because these excursions were never observed in
the absence of S15, this result shows that S15 is still capable of transiently
binding the junction with lower binding affinity, but fails to stabilize the higher
FRET conformations. To estimate the binding affinity of S15 for J12, we
increased the S15 concentration to 25 nM (1 mM Mg2+) (Figure 5.18).
Unfortunately, at this concentration S15 precipitated on the PEG coated quartz
surface and only few molecules behaved well. Among greater than 50 well
behaved molecules, 10 exhibited the closed conformation (0.8 FRET) indicating
that under higher concentrations S15 binds and closes the junction, in agreement
with the in vivo data.
5.10.2.5 S15 is not sufficient to restore type 3 mutant (C12) junction
dynamics
Clone C12 is a low functioning mutant in vivo, which cannot be rescued
even when S15 is over-expressed. Time trajectory traces of C12 in 1 mM Mg2+
and in the absence of S15 reveal the presence of a new static low FRET
conformation (0.2) (Figure 5.19A). Increasing [Mg2+] to 10 or 20 mM reveals no
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Figure 5.18 FRET time trajectories and histograms calculated for type 2 mutant
(J12) at different conditions. (A) FRET trajectories at 1 mM [Mg2+] (top), most of
the time this mutant loop is in low (~0.4) FRET state. There is no significant
change in FRET sate when the magnesium concentration is increased to 10
(second) or even 20 mM (third from top). In presence of 10 nM S15 with 1 mM
[Mg2+] (fourth from top), type 2 mutant have some events in 0.6 FRET with a
dominant 0.4 FRET state. In presence of 25 nM S15, most events are in higher
FRET (0.8) state. (B) FRET histograms obtained from number of events at
different magnesium concentrations, and in presence and absence of S15. When
[Mg2+] is 1 mM (top) this mutant loop has only one distribution at ~0.4 FRET
state. When the magnesium concentration is increased to 10 mM (second) or
even of 20 mM (third from top) [Mg2+], type 2 mutant have only one distribution at
~0.4 FRET state. In the presence of 10 nM S15 and 1 mM magnesium (fourth
from top), the type 2 mutant (35 molecules) shows three distributions 75% at 0.4,
21% at 0.6 and 4% at 0.8 FRET states. These distributions point out a
proceeding of traces from lower to higher FRET states for the mutants in this
condition. In the presence of higher S15 (25 nM), only one (0.8) FRET state is
observed (10 molecules). Due to the protein crashing and accumulation on the
slide surface, we were not able to collect many molecules at this protein
concentration.
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conformational changes showing that Mg2+ ions alone cannot fold the junction
even into the 0.4-FRET state.
Time-binned histograms of >100 time trajectories at 1, 10 and 20 mM
Mg2+ show no discernable folding of the C12 clone junction loop (Figure 5.19B).
A possible explanation for this observation is that the G654C mutation prevents
the formation of the 654-754 base pair, in favor of a 654-752 base pair. In turn
this allows A753 to base pair with either U653 or U652, and C754 with G587
from h20. These three base pairs are then capable of stacking between h22 and
h20, thus generating a long extended helix which would result in ~0.2 FRET, as
observed. This multi-stack structure would be expected to stabilize the 0.2-FRET
conformation.
Since over-expression of S15 does not rescue the C12 clone, the
expectation is that S15 cannot bind at all to this mutant. However, time
trajectories in 1 mM Mg2+ and in the presence of S15, revealed an unexpected
behavior. The junction adopted the extended 0.2-FRET conformation but briefly
transitioned to FRET states ranging between 0.4 and 0.6 (Figure 5.19).
Because these excursions are never observed in the absence of S15, these
dynamics indicate that S15 is still capable of binding the extended helix
conformation and attempts to fold it, however, 0.4-0.6 FRET conformations are
destabilized by the presence of the extended stack between h20 and h22. Time
traces were completely different than those in absence of S15. Dwell time
analysis of these transient excursions yield a kclose = 2.8 ± 0.1 s-1 and kopen = 8 ±
1 s-1 (Figure 5.16C). These rates are the opposite of what was observed for the
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Figure 5.19 FRET time trajectories and histograms calculated for type 3 mutant
(C12) at different conditions. (A) FRET trajectories at 1 mM [Mg2+] (top), most of
the time this mutant loop is in low (0.2) FRET state. There is no significant
change in FRET state when the magnesium concentration is increased to 10
(second) or even 20 mM (third from top). In presence of 10 nM S15 with 1 mM
[Mg2+] (bottom), this mutant show different behaviors, most of the time traces are
in low FRET (~0.2, open) state and frequently jumps to a higher FRET (closed)
state. (B) FRET histograms obtained from number of events at different
magnesium concentrations, and in presence and absence of S15. Histograms
are built with 100 molecules at each case unless otherwise mentioned. When
[Mg2+] is 1 mM (top) type3 mutant is in 0.2 FRET state. When the magnesium
concentration is increased to 10 mM (second) and 20 mM (third from top) the
distribution in the FRET histogram for type 3 mutants do not have significant
differences on these [Mg2+] as compared to 1 mM [Mg2+]. The distribution in the
histogram in the presence of 10 nM S15 and 1 mM magnesium (bottom), type 3
mutant (49 molecules) also has two distributions at ~0.2 (~94%) and ~6% at
higher FRET states.
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WT junction loop under the same conditions (Figure 5.16B). It is impossible to
distinguish whether each excursion to the high FRET conformation corresponds
to sequential protein binding events or to one S15 molecule bound for an
extended period of time. However, the large magnitude of kclose and the high
frequency of excursions suggest that each bound S15 makes multiple,
unsuccessful, attempts at closing the junction indicating that the protein remains
bound to the extended junction for long periods of time (>10 s) contrary to our
initial expectations. This result raises the interesting possibility that the structure
and dynamics of the S15-junction complex, and not protein binding alone, are
important for the assembly of functional 30S ribosomes.
5.10.3 Discussion
Previous studies have shown that the central junction is involved in
ribosomal protein S15 binding. S15 is a primary binding protein that is important
for proper assembly of the 30S ribosomal subunit. In the crystal structure of 30S,
the junction loop structure is stabilized by a base triple between nucleotides
G654-G752-C754 and a non-canonical base-pair (reverse-Hoogsteen) between
U652-A753 (83) (Figure 5.10). This structural arrangement allowed the
backbone to be positioned for recognition by S15.
A saturated mutagenesis study performed in the Cunningham lab has
demonstrated a significant covariation and correlation of base identity with
ribosome function between the G654:C754 WC pair. This indicates the
importance of this interaction for ribosome function. The WC base pairing

153
between G654 and C754 twists the backbone from its standard helical position,
becoming perpendicular to A753 and creating a localized parallel strand (272).
This backbone conformation is recognized by S15 and this interaction is critical
for ribosome function in vivo. On the other hand, nucleotide G752 forms a basetriple with G654:C754 through its sugar edge (Figure 5.10B) (272, 325, 326),
which also provides additional stabilization to the G654:C754 base-pair (325). All
these interactions correspond with the mutational study, where loss of a
hydrogen bond between the N2 of G752 and O6 of C754 in the single G752A
mutant reduces protein synthesis by 29% in vivo. This also decreased the KD for
S15 binding by 50 fold in vitro. (328).
The reverse-Hoogsteen interaction between 652 and 753 in the crystal is
not observed as critical as base pair for ribosome function. The reverseHoogsteen interaction allows A753 to stack with 588, 654, and 655 as observed
in crystal structure (Figure 5.10B and D) (272, 325). This positioning of 753
contributes to the formation of the right conformation of the side B backbone,
which is important for S15 binding. The importance of this identity and interaction
is also observed in vitro, where A753G mutation reduced the S15 binding by 60
fold. (328).
It has been thought that 653 might act as a spacer (327, 329). This is
consistent with the mutational study from the Cunningham lab that showed the
single-site mutations at 653, all those mutants had WT and near-WT function.
While the deletion mutant U653! was only 3% active and also had a defect on
ribosome assembly (Figure 5.12). Interestingly, the U653! mutant was
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previously demonstrated to have no effect on S15 binding in vitro, which is in
contrast to its effect on assembly. It is possible that the U653! is able to bind
S15 but is unable to fold into the structure required for full 30S assembly as was
observed in the smFRET results for junction mutant C12.
Previous studies have shown that the disruption of the above interactions
by site-directed mutagenesis or any chemical modifications have a defect on S15
binding (83, 272, 328, 334). Over-expression of S15 was revealed to restore the
function of all 64 junction mutants to near WT. This indicates that the junction
mutants have defects in S15 binding. This defect is also observed in a primer
extension experiment of a selected functional mutant (J12) that demonstrated the
decreased S15 binding affinity causing an assembly defect for 30S subunit.
The conformational change in the junction region after S15 binding is
important for proper folding of the central domain into its active conformation.
S15 binding allows h21 and h22 to coaxially stack and h20 forms an acute angle
with h22 (83, 329). Previous studies have also characterized that a similar role of
S15 can be played by divalent metal ion Mg2+ (329, 331).
Mutations in the junction region affect its ability to bind S15 and to
assemble into an active conformation. This allowed us to put forth a hypothesis
that mutations in the junction region affect its dynamics. Ha et al. previously used
smFRET and the labeled three-strand construct of helices h20, h21 and h22,
respectively, to study the conformational dynamics of the WT junction in the
presence of S15 and Mg2+ (332). In the current study, we have used a similar
method to study the dynamics of the WT and selected mutants (Table 5.2).
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Mutants were selected according to their function and ability to be complemented
by S15 over-expression.
For the WT loop, single-molecule trajectories showed that, as the
magnesium concentration is increased, the junction shifts from an open
conformation (~0.4 FRET state) to the closed conformation (FRET: ~0.8). The
dynamics of molecules observed at 10 mM [Mg2+] (kclose 9 ± 1 s-1 and kopen 1.8 ±
0.1 s-1) is similar to 10 nM S15 plus 1 mM [Mg2+] (kclose 14 ± 1 s-1 and kopen 1.4 ±
0.1 s-1) (Figure 5.16A and B). These results are comparable with previous data
that suggest the similar conformational change in junction with [Mg2+] and S15
(329, 331, 332).
Since S15 is a primary binding protein, the conformational change after
binding this protein is an important for binding S6 and S18, in vitro. For S6 and
S18 to bind the central domain, h23b and h22 must coaxially stacked where
h23a can interact with h22 and h20 (83). Since the binding affinities of S15 (3.5
nM) and Mg2+ (240 !M) (332) to the junction are different, only magnesium
binding is not sufficient to allow binding of S6 and S8 in the absence of S15.
The type 1 mutant (J58) has 74% of WT function in vivo that increases to
WT levels when S15 is over-expressed. This allowed comparison of the
dynamics for this mutant to WT. But in contrast, this mutant exhibits significantly
different behavior with Mg2+. Most of the time, molecules were in the low FRET
state (~0.6) even in the presence of higher [Mg2+]. This FRET value is
comparable with WT in the presence of 1 !M Mg2+. According to the crystal
structure of the S15-rRNA complex, Mg2+ has been shown to bind to positions
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653, 752, and 753 in the central junction (333). The U653A mutation, might
affects the binding affinity of Mg2+, which is a cause for the instability of junction
in the presence of Mg2+ for J58 mutant. Unlike the dynamics of J58 with Mg2+,
presence of 10 nM S15 with 1 mM Mg2+ shifted the junction to a more closed
state similar to WT. Most of the time, molecules are in a high (~0.8) FRET state
(Figure 5.17) with a very few transitions to the low FRET state. This suggests
that the binding affinity of S15 is higher for J58 than WT. The different dynamics
for Mg2+ and S15 indicate that S15 and Mg2+ stabilize the junction by two
separate mechanisms as suggested by previous studies (329). It is possible in
vivo that binding of Mg2+ and S15 are both critical for junction folding as indicated
by the loss of function in the J58 mutant.
The type 2 mutant has mutation in all positions in the junction region. This
position includes the three Mg2+ binding nucleotides (653, 752. and 753) (333). In
the smFRET experiments, most of the time J12 mutant loop is in low (~0.4)
FRET state for all three different (1, 10, and 20 mM) [Mg2+] concentrations
(Figure 5.18). This result indicates that the junction remained in the open
conformation at all times. A predominant FRET state of ~0.4 was also observed
in the presence of 10 nM S15 plus 1 mM Mg2+ with some excursions to the
higher FRET states (~0.6 and 0.8) (Figure 5.18). This indicates that, at low S15
concentrations, the J12 junction remains in the open conformation for most of the
time due to a decreased affinity for S15. These smFRET results are consistent
with the functional assays and the primer extension experiments that show
mutant J12 has 18% function in vivo with a decrease of 30S assembly (Figure
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5.12B). In vivo functional assays show the complementation of J12 to 83% of WT
levels by over-expressed S15. The single-molecule study in the presence of 25
nM S15 with 1 mM [Mg2+] showed that molecules for this mutant were in the high
(~0.8) FRET state for most of the time. This smFRET data correlates with the
functional study in vivo. The transition to lower FRET states suggests the lower
level of complementation (83%) indicates the junction is prevented from
completely closing.
For the type 3 mutant (C12), a FRET state of 0.2 was obtained for all
tested Mg2+ concentrations (1 mM, 10 mM, and 20 mM) (Figure 5.19). This
predicts that h20 and h22 for this construct are in a wide-open conformation.
Interestingly, C12 is a single G654C mutant that has the potential to base pair
with G752. The wide-open conformation observed in the smFRET experiments
and the ability of G654C to base pair with G752 suggests that h20 and h22
coaxially stack instead of h21 and h22, which would prevent 30S subunit
assembly and cause the low function in vivo (1%). In the presence of 10 nM S15
plus 1 mM Mg2+, the junction was still in the open conformation in most of the
times. However, unlike the experiments with Mg2+, multiple rapid transitions to
the higher FRET (~0.6 - ~0.8) were also detected in the presence of S15 (Figure
5.19). The calculated dynamics (kclose = 2.8 ± 0.1 s-1, and kopen = 8 ± 1 s-1 , Figure
5.16C) in this condition implies that the junction failed to reach the closed
conformation. These rates are opposite to the rates obtained for the WT under
the same conditions. Mechanistically, S15 attempted to stabilize the junction to
the closed conformation but was unable to do so.
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5.10.4 Conclusions
The saturation mutagenesis study from the Cunningham lab proposed the
importance of junction loop for S15 binding and proper assembly of the 30S
ribosomal subunit. Single-molecule FRET experiments performed in this study
characterized S15 and Mg2+ induced dynamics for WT and three other selected
mutants. Both S15 and Mg2+ stabilized a WT junction loop in a closed
conformation with equivalent closing and opening rates observed from dwell time
analysis. These results confirm previous data that suggested Mg2+ and S15 both
cause a similar conformational change in the junction loop. Mutant J58 exhibits
significantly different behavior as compared to WT in the presence of Mg2+ where
even high magnesium concentrations did not allow this mutant to fold like S15.
Similar effects of magnesium were observed for two other mutants J12 and C12.
The compensatory mutant J12 did not stably form the closed conformation in the
presence of a low concentration of S15 but an increase in S15 concentration
resulted in the junction loop folding to the closed conformation. The third mutant
C12 has a significant folding defect with unique dynamics. In the presence of
S15, dwell time analysis showed that the opening rate constant was ~ 3 fold
faster than the closing rate constant; in contrast to WT, here the closing rate
constant is ~10 times faster than opening. These observations clearly indicate
that junction dynamics are important for proper assembly of the 30S ribosomal
subunit.
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5.10.5 Materials and methods
[Kris Ann Baker performed the genetic and primer extension studies in Dr.
Cunningham’s lab. Kris has written and submitted this work as a dissertation
submitted in 2008 (286).]
5.10.5.1 Cloning, expression and purification of E. coli S15 (EcS15)
An expression vector pET15B-EcS15 was constructed by using PCR
product from E. coli rpsO (encodes for rprotein S15) from a DH5 genomic prep.
Primers 5p pET15-EcS15 (5’ – AGG AGA TAT ACC ATG GGC AGC AGC CAT
CAT CAT CAT CAT CAC AGC AGC GGC ATG TCT CTA AGT ACT GAA GC –
3’) and 3p pET15-EcS15 (5’ – TTA GCA GCC GGA TCC TCG AGT TAG CGA
CGC AGA CCC AGG CGC TCG ATG A – 3’) were used to do PCR. The product
was cloned into pET15b (335, 336) using NcoI and XhoI placing EcS15 with a Nterminus 6X-histidine tag behind a T7 promoter then transformed into
BL21(DE3)pLysS (F-,dcm, ompT, hsdS(rB-mB-), gal, !(DE3), [pLysS CamR] (337)
for protein over-expression. A colony of pET15B-EcS15 in BL21(DE3)pLysS was
used to inoculate a 3 mL LB-Amp100 + Cm50 (50 µg/mL of chloramphenicol for
pLysS) culture that was incubated overnight at 37ºC. The culture was diluted
1:500 into four flasks of 500 mL of LB-Amp100 + Cm50 and grown at 30ºC until
OD600 reaches 0.4 to 0.6. Protein expression was induced by adding IPTG to a
final concentration of 1 mM to the culture then allowing the culture to be grown
for an additional 16-18 hrs at 30ºC. The cells were pelleted at 6000 X g,
resuspended in 30 mL of 1X K-eq/wash buffer (50 mM potassium phosphate and
300 mM KCl, pH7) total, and lysed using a French Press. After lysis, ribosomes
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were precipitated out of the lysate using standard methods (338) to remove the
possibility of pulling down other rproteins along with the EcS15. After removal of
ribosomes, EcS15 was purified by immobilized metal affinity chromatography
using Profinity IMAC Resin (BioRad) charged with Ni2+ and potassium buffers
(elution buffer contained 1 M potassium chloride). After purification, EcS15
protein was concentrated and the imidazole removed by filtering protein column
fractions through an Amicon Ultra15 filter (MW: 5kD) and washing with K-1M
buffer (50 mM potassium phosphate and 1 M KCl, pH7).
5.10.5.2 FRET gel shift assays
15% non-denaturing polyacrylamide (29:1acrylamide: bisacrylamide ratio)
gel electrophoresis was performed in 20 mM NaOAc (sodium acetate) and 10
mM sodium phosphate (pH 7.2) using low-fluorescence glass plates, as
described (110). 10 pmol doubly labeled RNA samples were used to load on gel
in combination with other RNA as mentioned in Figure 5.14. For S15 binding
experiments, 10 pmole junction RNA (WT or mutants) was allowed to equilibrate
with 20 pmol S15 for 5 minutes prior to loading on gel. The acrylamide gel was
equilibrated for 15 minutes at room temperature before loading samples.
Samples were loaded on the gel, and constant electric field of 6 V/min was
applied immediately. After electrophoresis at 4 °C, the gel was scanned with in
glass plate in a Typhoon Imager by exciting the donor with a 532 nm laser. The
fluorescence emission of the donor (Cy3) and acceptor (Cy5) were analyzed with
Fluorsep program (Amershan Bioscience).
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5.10.5.3 RNA purification and labeling
All RNA oligonucleotides with 2’-OH protection groups were purchased
from Keck Foundation Biotechnology Resource Laboratory at Yale University
School of Medicine (New Haven, CT), purified and labeled as described in
Chapter 2. At the time of RNA synthesis, 3’-biotin was incorporated in RNA
strand 2 (RNA-2) (Figure 5.13A) in order to immobilize RNA on a glass surface
during single-molecule experiments. A 1 !M solution of the central junction was
produced by combining the three RNA strands, RNA1:RNA2:RNA3 (Figure
5.13), in the ratio of 1:2:10 (by concentration) in annealing buffer (10 mM
NaH2PO4 (pH 7.2) and 20 mM NaCl). The mixture was heated to 90°C for 45
seconds and allowed to cool down to room temperature. A 15% non-denaturing
acrylamide gel electrophoresis was used to monitor the formation of the junction
as previously described (170).
5.10.5.4 Steady-state FRET
Steady-state FRET measurements of doubly labeled Junction samples
were carried out in a spectrofluorometer as described in Chapter 2. A 25 nM
junction sample in standard buffer (10 mM NaH2PO4, pH 7.2 and 20 mM NaCl)
was excited and fluorescence was measured in the absence and presence of
protein S15. Relative FRET efficiencies were calculated by using Equation 2.5.
5.10.5.5 Single-molecule experiments
The biotinylated junction construct was immobilized on a PEG passivated
quartz slide via a biotin-streptavidin interaction and smFRET experiments were
done in buffer A (50 mM MOPS, pH 7.2, 100 mM potassium chloride, 2 mM
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Trolox) as described in Chapter 2. For S15 experiments, buffer A containing 1
mM MgCl2 was used. After detection by total internal reflection fluorescence
microscopy, data processing and analysis were done as described in Chapter 2.
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CHAPTER 6
Kinetic analysis of an RNA kissing interaction and effect of Hfq
on its resolution into an extended duplex
6.1

Introduction
Recently, many RNAs have been discovered that have a role in genetic

regulation (339, 340). In eukaryotic cells, small interfering and micro RNAs can
control gene expression where as small non-coding RNA (ncRNA) and
riboswitches control gene expression in prokaryotic cells (341-343). Genetic
regulation

may

occur

either

co-transcriptionally

or

post-transcriptionally

depending on the cell type. Bacterial ncRNA can control post-transcriptional gene
regulation by recognizing another RNA through RNA-RNA interactions. The looploop contacts between two RNA hairpins are dominant regulatory mechanisms in
bacterial and viral systems. Frequently, loop-loop interactions act as an initial
recognition signal between two RNA molecules. In some cases, RNA-RNA
interactions are sufficient to control the regulatory mechanism but in most cases
RNA binding proteins are required. For example during the bacterial cold shock
response, a loop-loop contact between a ncRNA (DsrA) and its mRNA partner
(rpoS) initially triggers the initial recognition between two RNA partners. With the
help of the protein cofactor Hfq, a strand displacement reaction takes place to
form an intermolecular base pairing between DsrA and rpoS sequences to form
an extended duplex (60, 344). In general, RNA hairpins loop-loop interaction can
generate more or less stable structure by base pairing with complementary
sequences, known as kissing interactions.
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6.2

RNA kissing interaction
Diverse biological functions are modulated by RNA intermolecular

interactions and kissing interactions can be the initiation signal for interaction.
RNA kissing interactions, which vary in stability, consist of Watson-Crick basepairing between nucleotides in the loop of two hairpins (345). The stability of
kissing interactions depends on several factors including, loop complementarity,
internal loop structure, the loop closing base pairs and the sequence of the stems
adjacent to the loops and the number of nucleotides in the loop(s) region (277,
280, 281, 346, 347). A classical example of kissing interactions is the RNA looploop interaction in the packaging of the HIV genome into capsids. In this process
the dimerization initiation sequence (DIS) forms a transient kissing intermediate
and resolves it into an extended duplex (348-351). The extended duplex is
thermodynamically stable that might form through several possible pathways as
shown in Figure 6.1. At low temperature, the initiation of strand displacement
reaction takes place either through the formation of 3’/5’ zipper intermediate
(path A) or through the formation of a kissing intermediate (path B). However, at
elevated temperatures or in the presence of enzymes (helicases), the hairpins
may unfold completely and then anneal to the complementary strand (path C)
(347, 352). Despite their importance in biology, the kinetic and thermodynamic
stabilities of kissing interactions have not been explored in detail.
6.3

DsrA and rpoS as a model system to study loop-loop interaction
Post-transcriptional regulation of rpoS is an example of genetic regulation

by ncRNA. The rpoS mRNA gene encodes the !S transcription factor that is
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involved in the bacterial stress response (353, 354). Previous studies have
suggested that the expression of rpoS is activated by the ncRNA DsrA (87 nt
ncRNA from E. coli). The 5’-UTR of rpoS mRNA forms a stem loop that inhibits
the Shine-Dalgarno ribosome binding site and prevents translation at the 3’ end
of rpoS. DsrA rescues translation by binding and disrupting stem-loop to free the
Shine-Dalgarno sequence (60, 355). This process requires the protein cofactor
Hfq that increases the rate of DsrA binding to the rpoS and facilitates the
formation of DsrA/rpoS extended duplex (Figure 6.2A) (356).

Figure 6.1 Possible pathways for a strand displacement reaction. Strand
displacement can be nucleated either by zipping 3’/5’ (A) or by formation of
kissing intermediate (B). At higher temperature and in the presence of helicases,
two complementary strands might be annealed directly (C) (347).
6.4

Hfq
In the cell, the RNA binding protein Hfq helps to convert kissing complexes

to extended duplexes. Hfq was originally discovered in E. coli as a host factor for
Q-! bacteriophage that has sequence and structural homology with archeal and
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eukaryotic Sm and Lsm proteins (59, 356, 357). Further experiments showed that
Hfq play a role in post-transcriptional gene regulation in which it helps small
ncRNAs to identify their target mRNA (60-62). During stress response, Hfq binds
both the ncRNA and its target mRNA simultaneously and forms a stable ternary
complex in which the complementary sequences of the two RNAs anneal and
expose the mRNA coding sequence for translation (62, 358, 359). Hfq acts as a
chaperone and promotes the intermolecular base pairing between DsrA and rpoS
(359). However, the exact mechanism by which Hfq promotes DsrA and rpoS
interaction and gene regulation is not yet understood. Besides translational
activation of DsrA and rpoS system, Hfq also functions as a transcriptional
repressor of the hns mRNA at low temperature (358). Previous studies have
shown that Hfq is also involved in mRNA and protein degradation (358, 360,
361).

Figure 6.2 Translational activation of rpoS gene by DsrA and Hfq. (A) Secondary
structures of DsrA and rpoS. Basepairing sequences are represented in green. In
the absence of DsrA, rpoS self inihibit the translation by the formation of stemloop that block the SD sequence for ribosome binding. In the presence of DsrA
and Hfq the SD is free to bind ribosome which signify the gene is turned on.
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Structural studies of Hfq have revealed a doughnut-shaped homohexameric ring with a ~70 Å diameter and a 12 Å central cavity in the absence of
RNA (21, 58, 59). The crystal structure of S. aureus Hfq with a short RNA (5’AU5G-3’) revealed that the RNA bind around the basic central pore as shown in
Figure 1.4B (21). Mutational studies showed that Hfq has two independent RNA
binding sites on the two flat surfaces of the hexamer (58, 358). The proximal and
distal ends, which specifically recognize the two different RNAs independently.
This is further characterized by a crystal structure of E. coli Hfq bound with
poly(A) tail (53). Now it is clear that the proximal surface of Hfq binds ncRNA
(AU5G sequence elements) whereas the distal end preferentially binds poly(A)
sequences (53, 358).
In this study, I have characterized the kinetics of the kissing interaction of
RNA hairpins as a model system from DsrA and its partner rpoS mRNA and the
effect of Hfq on the strand displacement reaction.
6.5

Results

6.5.1 RNA hairpin design
To characterize the energetic and dynamic behavior of the kissing
complex and its progression into the strand displacement reaction, RNA hairpins
were designed according to the DsrA and rpoS hairpin sequence with some
modifications Table 6.1. The modifications allowed this reaction to proceed from
hairpin to kissing complex and finally to strand displacement. We can also force
the reaction to stop at the point of kissing interaction. The thermodynamic
behavior of these hairpins has been characterized by Isothermal Titration
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Calorimetry (ITC) and UV-melting experiments in a protein free environment. In
the first part of my experiment, I have used these hairpins to study the kinetic
behavior of kissing interactions and its resolution into an extended duplex by
using smFRET. In the second part, I have characterized the effect of the RNA
binding protein Hfq on the kinetics and energetic of these reactions. These
hairpins are designed to exhibit a low FRET state in dissociated state,
intermediate FRET state in the kissing complex and high FRET state in the
extended duplex (ED) form.
Table 6.1 List of hairpin sequences
Name

Sequence (5’-3’)a

Labeling

HP1 (BP)

ACGAGGCAUUUCCCCUUGU

5’ Cy5

HP2

AUAACAAGGGGAAAUGCCUUGU

5’ Biotin, 3’ Cy3

HP3

ACGAUCAGCAUUUCCCUGAUGU

5’ Cy5

HP3:C1!,C7!

ACGAUCAGAUUUCCUGAUGU

5’ Cy5

HP1:Hfq

ACGAGGCAUUUCCCCUUGUAACGAAUUUUUUA

5’ Cy5

HP2-R

ACAAGGGGAAAUGCCUUGUAUA

5’ Cy3, 3’ Biotin

HP1-R

ACGAGGCAUUUCCCCUUGdT

5’ Cy5

HHP1-R

ACGAGGCAUUUCCCCUUGdTCGAAUUUUUUA

5’ Cy5

a

The loop nucleotides are underlined.

HP1 and HP2 are two parent hairpins, which have complementary
sequences in both loop and stem regions that can form a kissing complex and
can be resolved into an extended duplex. HP3 was derived from HP1 can only
form a KC but not able form ED with HP2 because of noncomplementary stem
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regions. The mutant HP3:C1!,C7! was generated by deleting 1, and 7
nucleotides from HP3 loop region (Figure 6.3A). The Hfq binding sequence
AACGAAUUUUUUA was added at the 3’ end of HP1 hairpin to make HP1:Hfq.
Thermal melting experiment suggest that these hairpins don’t form dimers in
solution (347).
6.5.2 Thermodynamic analysis of KI and ED formation
[This experiment was performed in Prof. Andrew Feig’s Lab (347).]
Isothermal titration calorimetry (ITC) was used to measure the
thermodynamic parameters of KI and ED formation. This is a very sensitive
technique than thermal melting because ITC relies on heat of binding rather than
hyperchromocity (362). The measured !G°37 for the formation of seven base pair
kissing interactions between HP2 and HP3 is -8.4 kcal/mol and is stabilized by 1
kcal/mol in the presence of 10 mM Mg2+. The substitution of a G•C base pair or
deletion of two bases that form a five base pair interaction (HP3:C1!,C7! ) at the
end of kissing complex abolish the formation of KC. This suggests that the
stability of the kissing interaction depends on the G•C base pairs at either ends
of the kissing complex. The thermodynamic parameters for HP1 and HP2
interactions are quite different than those for the kissing complex suggesting that
the formation of ED takes place rapidly under the experimental conditions. The
potential energy diagram presented in this study indicates an 8 kcal/mol energy
barrier for the formation of KC from a free hairpins and an 18 kcal/mol barrier for
dissociation. These experiments also suggest that the kissing interaction is not a
necessary intermediate state for the strand displacement reaction.
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Figure 6.3 Schematic representation of single-molecule study. (A) The RNA
hairpins and positions of fluorophore labeling used in this study. Loop sequences
are labeled for clarity. (B) Schematic representation of total internal reflection
setup used in this study. A kissing interaction and extended duplex formation are
shown in the presence of 35 nM RNA hairpin with acceptor fluorophore.
6.5.3 Single-molecule study of kissing hairpins
Single-molecule

FRET

experiments

were

used

to

observe

the

conformational dynamics of the kissing complex and its resolution into an
extended duplex. For this experiment HP2 was labeled with a FRET donor (Cy3)
and HP1 or its derivatives with a FRET acceptor (Cy5) (Table 6.1 and Figure
6.3A). The Cy3 labeled RNA hairpin was immobilized on a quartz slide surface
with biotin and streptavidin interaction and the fluorescence signals from
fluorophores were monitored from using a CCD camera, as described (Method
section) (Figure 6.3B). In the absence of acceptor, the histogram of more than
100 donor only hairpin (HP2) molecules has a peak near 0 FRET, which means
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there is no energy transfer from donor fluorophore (Figure 6.4A). Control
experiments on pre-annealing of HP2 with HP1 (1:2 ratio) yielded predominantly
an ED complex with a FRET state of 1.0 whereas similar annealing with a control
RNA (HP3:C1!,C7!) that was labeled but non-complementary yielded a FRET
ratio near zero (Figure 6.4B and C).

Figure 6.4 FRET histograms calculated for more than 100 single-molecule
trajectories from control experiments with schematic representation of RNA
hairpins and extended duplex formation. (A) A donor only RNA hairpin HP2
exhibits a single FRET state at 0.0. (B) Pre-annealed non-complementary
hairpins (HP3: C1!, C7!) and HP2 do not form the ED. (C) Two pre-annealed
complimentary RNA hairpins (HP1 + HP2) show two distributions (0.0 and 1.0
FRET states) after imaging.

In order to observe an intermediate states in the strand displacement
reaction, HP2 was immobilized on the slide and 35 nM HP1 was added so that
binding follows pseudo-first-order reaction kinetics. A typical single-molecule time
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trajectory (Figure 6.5B) in the given condition (50 mM tris, pH 7.5 and 10 mM
Mg2+) showed that the fluorescence intensity of the donor and acceptor
fluorophores jumps stochastically between two states in an anti-correlated
fashion. The resulting FRET trajectory shows that the jumps correspond to two
distinct ~0.0 and ~0.5 FRET states. These two states are assigned to donor only
(HP2) and HP1:HP2 kissing interaction, respectively.

Figure 6.5 Single-molecule study of HP1::HP2 Hairpins. (A) The representation
of hairpins, kissing interaction and extended duplex formation. (B) Typical singlemolecule time trajectory. The upper panel shows the anti-correlated intensities of
the donor (blue) and acceptor (red). The second panel shows the corresponding
FRET trajectory. The third (transition from hairpins) and fourth panels (transition
from KI) show the FRET trajectories in extended duplex. (C) Cumulative
histogram showing three distributions at 0.0, 0.5 and 1.0 FRET states. 0.0 FRET
state is free HP2, 0.5 FRET state represents the kissing complex and 1.0 FRET
state corresponds to the extended duplex.
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These kissing complexes can persist for a long time and they can
associate or dissociate many times before they proceed to extended duplex
Extended duplex formation is characterized by higher FRET (1.0) values where
the maximum energy is transferred from donor to acceptor due to the close
proximity of fluorophores. Under our experimental conditions, a very few (1-2%)
transitions from KI to ED were observed (Figure 6.5B and C). Once formed, the
ED state remains effectively trapped and dissociation back to hairpins was not
observed. The transitions of molecules directly from free hairpins to ED duplex
were also observed (Figure 6.5B).
6.5.4 Kinetic analysis of kissing interaction
Dwell time analysis was performed from more than 100 single-molecule
traces in order to calculate the rates of each state. From the dwell times in each
FRET state, the dwell time distributions were calculated to estimate the rates of
association and dissociation kon and koff (Figure 6.6). The distributions were fit to
single exponential decays to yield kon = 0.12 ± 0.01 s-1 and koff = 0.17 ± 0.02 s-1.
The kissing free energy calculated from these rates (!G˚22 = -9.9 ± 0.2 kcal/mol)
agrees well with the ensemble-averaged ITC data from Prof. Feig’s lab and that
calculated from the FRET distribution histograms (Figure 6.5C) (347). This result
also shows that the immobilization approach used through this experiment does
not affect the dynamic behavior of the kissing hairpins.
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Figure 6.6 Dwell time distributions for the dissociated (A) and kissing (B) states
from single-molecule trajectories for HP1 and HP2 hairpins. Each distribution
was fit to a single-exponential decay to yield the pseudo-first order rate constants
kon and koff.
6.5.5 RNA hairpin with Hfq binding site
In order to characterize the Hfq mediated extended duplex formation, the
RNA hairpin HP1:Hfq was designed with the

Hfq binding sequence

AACGAAUUUUUUA at the 3’ end of the hairpin HP1 (Table 6.1). This RNA
hairpin was fluorophore labeled with acceptor (Cy5) and was subjected to
smFRET experiments with Cy3 labeled RNA hairpin HP2. The first experiment
was performed in the absence of Hfq to characterize the effect of a long tail at
the 3’ end on kissing kinetics at different salt conditions. A protein free singlemolecule study at 50 mM tris, pH 7.5 and 10 mM Mg2+ revealed very similar
kinetic behavior (kon = 0.2 ± 0.01 s-1 and koff = 0.08 ± 0.01 s-1) to the hairpins
without the long tail (Figure 6.7A). Experiments with additional 50 mM NaCl
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Figure 6.7 Dwell time distributions and histograms for HP1:Hfq and HP2 hairpins
at different conditions. (A) At 50 mM Tris, pH 7.5 and 10 mM Mg2+. (B) At 50 mM
Tris (pH 7.5), 10 mM Mg2+ and 50 mM NaCl. (C) At 50 mM Tris (pH 7.5), 10 mM
Mg2+ and 100 mM NaCl. In each histogram, very few extended duplex molecules
are not included.
(kon = 0.25 ± 0.01 s-1 and koff = 0.15 ± 0.01 s-1) and 100 mM NaCl (kon = 0.16 ±
0.02 s-1 and koff = 0.10 ± 0.01 s-1) did not show significantly different kon (0.12 ±
0.01 s-1) and koff (0.17 ± 0.02 s-1). This result shows that the long Hfq binding tail
at the 3’ end of RNA hairpin and increased sodium concentration have no
significant effect on the dynamics of kissing interaction. The histograms of more
than 100 molecules in each condition have clear 2 distributions near 0.0 and 0.4
FRET states (Figure 6.7). The observed FRET state at 0.4 is assigned as a
kissing complex, which is 0.1 lower than that of HP1:HP2 (Figure 6.5C). These
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control experiments are important for further experiments with Hfq because this
protein is stable only at high NaCl (100 mM) concentrations.
6.5.6 Hfq promotes extended duplex formation
Single-molecule experiments were performed in the presence of Hfq at 50
mM Tris (pH 7.5), 10 mM Mg2+ and 100 mM NaCl. Binding of Hfq to RNA hairpins
was monitored by native gel electrophoresis. In the smFRET experiment, first
HP2 was immobilized on a PEG-passivated quartz slide and 35 nM HP1:Hfq
hairpin was flushed in a slide. After acquiring some data, pre-mixed HP1:Hfq (35
nM) with different Hfq concentrations were injected while recording. This
maintained pseudo-first-order reaction kinetics. The number of molecules was
counted in the KC and ED states in each Hfq concentrations.
In the presence of 1 nM Hfq (hexamer), the fraction of molecules in the
high FRET (~1.0) state increases to 18% as compared to ~3% in the absence of
Hfq. At this point we speculated that the increase in the number of high FRET
molecules are due to the formation of extended duplex that is promoted by Hfq.
When the protein concentrations were increased, the numbers of molecules in
high FRET state increased and the numbers of molecules in low FRET state
(0.0) decreased (Figure 6.8A). These experiments were repeated in the
presence of different protein concentrations and the numbers of molecules in 1.0
FRET state were counted. As shown in Figure 6.8B, increasing the protein
concentration increases the number of molecules in the 1.0 FRET state, which is
98% at 30 nM Hfq. The percentage of molecules in an ED were plotted as a
function of Hfq concentrations and fitted with a binding equation to obtain a
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binding constant (KD = 11 ± 4 nM, hexamer). The number of molecules in the
extended duplex state was stable through out the experimental time of ~ 1 hour.
These data show that Hfq helps to form intermolecular base pairing, but does not
help to dissociate the duplex in to free hairpins. In this experiment, none of the
transitions were observed from KI to ED. This might be because either the
transition is faster than our time resolution (33 ms) or the kissing intermediate
may not an obligatory intermediate state. To further study the effect of
fluorophore positions and immobilization on Hfq binding, RNA hairpins were
designed by flipping the positions of fluorophore and biotin as mentioned in
Table 6.1. Preliminary experiments in a protein free environment were similar to
the described experiments.

Figure 6.8 Hfq promoted strand displacement reaction. (a) Single-molecule
FRET histogram obtained in the presence of 25 nM Hfq hexamer. Three distinct
peaks are observed that belongs to dissociated hairpins (0 state), kissing
complex (0.4 state) and extended duplex (1.0 state). The peak height at 1.0
FRET state represents more molecules are in the extended duplex. (B) Hfq
binding curve calculated from a number of molecules in ED as a function of Hfq
concentration. Increase in protein concentration increased the number of duplex
molecules.
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6.6

Discussion
Despite their importance in biology, RNA kissing interactions have not been

well characterized (345, 363). HIV-DIS is one of the most-studied kissing
complex and thermal scanning of the transition temperature has shown that the
stability of the kissing complex depends on the closing base pair of the stem and
sequence identities (348, 351, 364, 365). The molecular dynamics of the
formation of kissing hairpins have not been resolved in detail. This study has
successfully used a single-molecule technique to characterize the dynamics of
the formation of kissing complex for designed RNA hairpins. The thermodynamic
and kinetic parameters obtained from the single-molecule study were validated
with the ITC and SPR data for the same hairpins (347).
Single-molecule study of RNA hairpins showed a single representative
intermediate FRET state near 0.5. This suggests that there might be only one
rearrangement step of strand displacement. This finding is surprising as the
study of HIV-DIS strand displacement proposed that the rearrangement of KC is
actually a two-step process. The first step involves the formation of loop-loop
helical structure and in the second step; three helical elements coaxially stack to
form a final stable structure (366, 367). The single one kissing species observed
in this study might be due to our inability to capture a fast second step or lack of
significant FRET change between two conformations with the current fluorophore
positions. From this study it has been resolved that the kinetics of kissing
interaction are quite stable for approximately ~ 6 s at room temperature. When
the loop size is decreased to 5 nucleotides, not even transient kissing
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interactions are observed. This information is supported by the thermodynamic
data from ITC experiment (347).
The nature of single-molecule FRET trajectories implies that the kissing
interaction can be made and broken several times before hairpins dissociate or
resolve into an extended duplex at room temperature. The rarity of extended
duplex formation throughout this experiment suggests that there is a huge energy
barrier between the KC and the ED. The two different types of ED FRET
trajectories in Figure 6.3B show that ED can form either directly from free
hairpins or they can resolve slowly form kissing intermediate. In the former case,
the kissing interaction might exist for a very short time, which is not possible to
capture into our time frame (33 ms). Since the progression of kissing interaction
to the extended duplex is very rare, they are not enough to measure the kinetic
parameters

at

room

temperature.

However,

previous

experiment

from

temperature jump (T-jump) study have calculated that nearly 25 % of molecules
refold into the extended duplex from KC at 67°C. Even though this number is
lower than KC dissociation (62 %) but have a clear picture of temperature effect
on ED formation (368). The refolding temperature (54°C) is higher than the
dissociation temperature (47°C), also suggesting that the activation barrier for ED
is higher than the dissociation of KC into the free hairpins. This might correlate to
the number of hydrogen bonds broken and formed during the formation of
extended duplex than dissociation (368).
In vivo, RNA binding proteins help to convert kissing complexes to an
extended duplex. A nucleopsid protein NCp7 is a well-characterized chaperone
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that facilitates the formation of intermolecular base pairing in DIS system (365,
367, 369, 370). However, Hfq is involved in many systems to facilitate the binding
of ncRNA and their targets (62, 371). It has been proposed that under normal
conditions in the cell, Hfq is not necessary when two RNAs can form a stable
complex by themselves (372). Hfq facilitates the forward progression of ED
formation by lowering the high-energy barrier between the KC and ED. Our
experimental data showed that Hfq binds with model RNA hairpins and helps to
resolve them into an extended duplex. Hfq accelerated the association of two
hairpins and its chaperone activity helps to anneal them to form an intermolecular
base pairing. These results are consistent with previous studies on DsrA and
rpoS systems (356, 359). When Hfq concentration is low (1 nM, hexamer) 18% of
molecules were in ED with few molecules in kissing complex. When Hfq
concentration was increased, the number of molecules in extended duplex
increased and reached up to 98% at 30 nM Hfq. These suggest that Hfq
promotes the kissing complex to refold into an extended duplex. After analyzing
many molecules, we never observed a transition of molecules from kissing
complex to the ED. This data indicate that the kissing complex may not an
obligatory intermediate for strand displacement reaction. This is also supported
by our thermodynamic data (347). The decreased in number of kissing
intermediate might due to the decrease in background RNA concentration after
the formation of many extended duplexes. Out of nearly 500 analyzed molecules,
no molecules in the ED state dissociated back to free hairpins within time frame
of more than one hour. This is in contrast with previous finding in which Hfq helps
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to break the intermolecular base pairing between DsrA and rpoS (359). After the
formation of base pairing between two RNA, Hfq might dissociate from a complex
leaving stable RNA-RNA interactions as proposed earlier (58, 356, 359, 372).
This cannot be addressed using fluorophores labeled on the RNA hairpins and
unlabeled protein. We can clearly observe the formation of extended duplex from
our construct but we cannot observe whether Hfq leaves or stay intact with the
RNA-complex. On-going experiments with fluorophore labeled Hfq might address
this issue where the decrease in fluorophore signal correlates the dissociation of
Hfq from a protein-RNA ternary complex.
6.7

Conclusions
Small ncRNAs regulate gene expression in response to biological stimuli

through a mechanism that relies on RNA-RNA interactions. When loop
sequences are complimentary, they form a kissing intermediate that rearranges
to a stable structure. Single-molecule study of RNA hairpins revealed that the
kissing interaction forms readily, but strand displacement and extended duplex
formation is rare. Formation of extended duplex may be inefficient due to a
higher energy barrier between the extended duplex and the kissing intermediate.
In the cell, RNA binding proteins often help to overcome high-energy barriers to
facilitate the formation of functional structures. Our data suggest that Hfq acts as
a chaperone to facilitate the progression of strand displacement and extended
duplex formation, thereby preventing the dissociation of free hairpins.
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6.8

Materials and methods

6.8.1 Preparation of RNA hairpins
RNA hairpins were designed as described before. The designed RNA
hairpins were purchased with 2’-OH protection groups from Dharmacon RNA
Technologies and Keck Foundation Biotechnology Resource Laboratory at Yale
University School of Medicine, purified according to the manufactures protocol
and labeled as described in Chapter 2.
6.8.2 Hfq expression and purification
Hfq protein was expressed and purified in Prof. Feig’s lab according to
previously described protocol (58). In brief, expression of a C-terminal His6-tag
wild-type Hfq was induced by 1 mM IPTG at A600 = 0.4 for 4 hours at 37 °C. The
cell pellets were resuspended in 25 ml lysis buffer (50 mM HEPES, pH 7.5, 500
mM NH4Cl, 20 mM imidazole, 5% (w/v) glycerol) with EDTA-free Complete
protease inhibitor cocktail (Stratagene) and lysed by ultrasonication. Cell lysate
was treated with DNase I (100 U) and RNAse A (100 g) and incubated on ice for
1 h. After centrifugation, Hfq was purified by Co2+-affinity chromatography. A Hitrap metal chelation column (Amersham-Pharmacia) was prepared and
preloaded with CoSO4. Cell lysate was passed through the column and was
washed with five volumes of lysis buffer followed by five volumes of wash buffer
1 (50 mM HEPES, pH 7.5,1 M NH4Cl, 5% (w/v) glycerol). Hfq was eluted with five
volumes of elution buffer 1 (50 mM HEPES, pH 7.5, 500 mM NH4Cl, 250 mM
imidazole, 5% (w/v) glycerol) followed by five volumes of elution buffer 2 (50 mM
HEPES, pH 7.5, 8 M urea, 1 M NH4Cl, 50 mM EDTA, 5% (w/v) glycerol). The
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pure fraction was monitored by SDS-PAGE, concentrated and dialyzed against
storage buffer (50 mM HEPES, pH 7.5, 250 mM NH4Cl, 1 mM EDTA, 10% (w/v)
glycerol). Warburg-Christian method was used to measure the concentration of
Hfq (373). The proper folding of Hfq was monitored by spectrometer and by
dynamic light scattering and stored in storage buffer.
6.8.3 FRET gel shift assays
15% non-denaturing polyacrylamide (29:1acrylamide: bisacrylamide ratio)
gel electrophoresis was performed in 50 mM sodium acetate (NaOAc), 10 mM
magnesium acetate and 50 mM Tris (pH 7.5) using low-fluorescence glass
plates, as described previously (110). 10 pmol Cy3 labeled HP2 was allowed to
equilibrate with different combinations of Cy5 labeled HP1:Hfq RNA hairpin and
Hfq at room temperature for 5 minutes. Samples were loaded on preequilibrated
gel, and constant electric field of 6 V/min was applied immediately. After
electrophoresis at 4 °C, the gel was scanned with in glass plate in a Typhoon
Imager by exciting the donor with a 532 nm laser. The fluorescence emission of
the donor (Cy3) and acceptor (Cy5) were analyzed with Fluorsep program
(Amershan Bioscience).
6.8.4 Single-molecule experiments
The biotinylated HP2 (10 pM) was immobilized on a quartz slide (PEG
passivated for Hfq experiments) via a biotin-streptavidin interaction and smFRET
experiments were done in different buffer conditions in presence of 2 mM Trolox
as described in Chapter 2. The single-molecule experiments were carried out in
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large excess (35 nM) of the acceptor hairpin such that the association step can
be assumed to follow pseudo-first-order reaction kinetics, which greatly simplifies
the data analysis and allows dissection of the reaction mechanism. All the
experiments were performed at room temperature. After detection by total
internal reflection fluorescence microscopy, data processing and analysis were
done as described in Chapter 2.
6.9
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CHAPTER 7
Conclusions and future directions
RNA molecules can adopt different secondary and tertiary structures
creating a platform for interactions with a wide variety of ligands. These
secondary structures are recognized by various proteins to form protein-RNA
complexes (10). These protein-RNA complexes have a wide variety of structural,
catalytic and regulatory roles from transcription to pre-mRNA processing, nuclear
export, transport and localization (2-4). For example, during posttranscriptional
regulation of gene expression, RNA interacts directly with proteins to form
ribonucleoprotein particles (RNPs) (5) that are important for recognition and
function of the RNA molecule (6). Since there are many RNAs and a very large
number of RNA-binding proteins, the biogenesis of RNPs must be performed
with high fidelity. Incorrect formation of RNP complexes or aberrant expression of
RNA binding proteins can cause genetic disorders that may lead to diseases (7,
8). Therefore, understanding the molecular mechanism of protein-RNA
interactions and their applications to function is an important focus of structural
and biological research (9). Despite their functional importance in biology, the
actual mechanisms of protein-RNA interactions have yet to be fully understood.
Several biophysical methods have been used to characterize protein-RNA
interactions such as X-ray crystallography, cryo-EM, NMR, computational
modeling and so on. The development of single-molecule techniques has been
monumental in understanding the structural and dynamic behavior of proteinRNA complexes at the molecular level. In this work, several types of protein-
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RNA interactions were studied by using Fluorescence Resonance Energy
Transfer (FRET) in combination with Single-molecule FRET (smFRET). All of
these studied protein-RNA interactions have different biological applications from
gene splicing to RNA biogenesis and gene expression.
7.1

Splicing regulation through RNA looping
Alternative splicing (AS) plays an important role in generating different

protein isoforms from a single pre-mRNA. This is a highly regulated biological
phenomenon involving many small RNAs and proteins. Misregulation of AS has
been linked to several diseases from neurological disorders to cancers (8). There
are several factors involved in the direct or indirect regulation of alternative
splicing. These factors can be either splicing enhancers or suppressors
depending on how they interact with cis-acting elements on pre-mRNA. Several
models have been proposed to explain how alternative splicing factors control
this complex mechanism in the cell; however, most of these proposed models
were built from biochemical studies and lack details of the structural and dynamic
behaviors of these macromolecular assemblies.
The polypyrimidine tract binding protein (PTB) is a splicing regulator that
binds to CU-rich elements in pre-mRNA and represses N1 expression in nonneuronal cells as observed in c-src pre-mRNA. A structural model proposed that
domains 3 and 4 of PTB induce RNA looping after binding two polypyrimidine
tracts within the same pre-mRNA. Fox-1 protein is an important tissue-specific
splicing enhancer that binds to intronic enhancers to regulate alternative splicing.
This small protein, with only one RNA recognition motif (RRM), binds specifically
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to UGCAUGU RNA sequences in pre-mRNAs (200). It has been proposed that
Fox-1 binds the UGCAUGU element in the c-src gene downstream of the N1
exon and activates exon inclusion (203), creating an antagonistic effect between
Fox-1 and PTB to regulate alternative splicing of the N1 exon in neuronal cells.
The mechanism by which PTB and Fox-1 controls regulation of the N1 exon is
elusive and remains poorly understood. NMR studies of these proteins in
complex with RNA have proposed a model describing how these structures
relate to the splicing in vivo (15, 16, 41). Here, FRET was used to obtain a
deeper understanding of the molecular mechanism of the interactions between
these proteins and RNA. The experiments performed here are important and
innovative as they address key issues about the basic mechanism of alternative
splicing regulation.
Using FRET, we were able to observe the unique property of PTB34
(RRM3 and 4) to bring the 5’ and 3’ ends of RNA in close proximity upon binding,
forming an RNA loop as suggested previously (15). For efficient looping, the
separation between the two polypyrimidine-tracts must be greater than or equal
to 15 nucleotides. The stronger binding affinities (<50 nM) of PTB34 to these
RNAs of greater than 15 nucleotides imply the synergistic binding of the two
pyrimidine-tracts. Upon binding of PTB34, the distance between the two ends of
the RNA decreased with distances agreeing with PTB34-RNA complexes
previously characterized by NMR. In the case of a 15-nucleotide linker (PPT-15)
between RRM3 and 4, the 5’ and 3’ pyrimidine-tracts bound to RRM3 and 4,
respectively, demonstrating this protein’s specific directionality of RNA binding
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and looping, which was shown to be a result of the non-sequence specific
interactions between the positively charged residues in the protein and RNA
linker.
A mutant PTB34, which disrupts the important interactions between RRM3
and 4, decreased the binding affinity for PPT-15 by 10-fold; however, the mutant
PTB34 could still bind longer RNAs (30 nucleotides) with stronger affinity than
PPT-15. In-vivo splicing assays reported that this mutant actually enhanced the
exon expression as compared to WT. However, it is still unclear if the difference
in splicing repression for the mutant and WT is due to defective RNA looping or
weaker binding affinity. From time-resolved FRET and single-molecule
experiments on protein-RNA complexes, the structure of the mutant PTB34-RNA
complex was shown to be different from that of the WT. Therefore, the observed
increase in FRET of the mutant-RNA complexes are due to the formation of
higher order protein-RNA complexes, instead of the formation of an RNA loop.
The higher cooperativity coefficients observed from the mutant are added
evidence for this hypothesis. Stoichiometric RNA-protein complexes, which
should be formed at lower concentrations of the mutant PTB34, yield no apparent
FRET increase, indicating the lack of RNA looping. Based on these results, it
was proposed that the lower splicing repression for the mutant PTB34 is due to
the defective RNA looping rather weaker binding affinity as compared to the WT.
Therefore, the interactions between RRM3 and 4 of PTB34 are important for
efficient RNA looping and splicing in vivo.
Fox-1 is a splicing enhancer that has been proposed to compete with PTB
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for RNA binding. To further understand alternative splicing regulation by Fox-1
and PTB, a 15-nucleotide spacer RNA that mimics the DCS of c-src pre-mRNA
was used. Fox-1 was shown to have a higher affinity for its target UGCAUGU
sequence; furthermore, an increase in FRET upon binding of Fox-1 is consistent
with previous studies where Fox-1 induced a curvature of the RNA (41).
Competition experiments suggested that the tissue-specific Fox-1 competes with
domain 4 of ubiquitously expressed PTB34 for the same binding site in certain
cell types. Since the binding affinity of Fox-1 for PPT-15F (overlapping target
sequences with common U) is stronger than that of PTB domain 4, we proposed
that Fox-1 displaces domain 4 from the PTB-RNA complex. This supports the
hypothesis that Fox-1 disrupts the RNA loop and enhances splicing of N1 exon of
c-src pre-mRNA in neuronal cells in vivo. Moreover, competition experiments at
different PTB34 concentrations suggested that Fox-1 replaces PTB34 in a
concentration-dependent manner such that it is only an efficient competitor at
equal or less than 50 nM PTB34, resulting in a K1/2 lower than the Fox-1
dissociation constant. The formation of RNA secondary structure facilitated by
PTB34 binding or possible protein-protein interactions between PTB34 and Fox-1
may aid Fox-1 in identifying UGCAUGU elements more efficiently. On the other
hand, competition experiments, in which the downstream pyrimidine tracts and
Fox-1 binding sites were separated by additional adenine nucleotides, resulted in
K1/2 values slightly higher than those in the absence of separating adenines up to
20 nucleotides; when the binding sites were separated by 30 nucleotides, the K1/2
increased. This surprising result may be due to the formation of possible unusual
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secondary structures in cases where the PTB34 and Fox-1 binding sites are
separated that keeps the two binding sites in close proximity to enable Fox-1 to
replace PTB4 from the complex. An alternative explanation may be that possible
PTB34 and Fox-1 protein-protein interactions, rather than direct competition for
an RNA binding sites, actually allow Fox-1 to displace PTB34.
Even though several characteristic features regarding structural and
functional aspects of both PTB34 and Fox-1 in complex with RNA have been
explored, it will be interesting to investigate the competition between Fox-1 and
PTB34 in functional splicing assays. In addition, competition experiments in the
presence of neuron-specific PTB and U2AF splicing factors will be important for
understanding the assemblies of these factors and their influence on alternative
splicing regulation. Further understanding of PTB34-RNA looping and splicing
regulation at the molecular level in the presence of the spliceosome will also be a
worthy endeavor. For this purpose, it would be possible to perform a real time
single-molecule alternative-splicing assay of pre-mRNA in the presence of
PTB34 and Fox-1 along with splicing extract. This may lead to a better
understanding of the dynamics of assembly and their importance on splicing
regulation.
7.2

Protein-RNA dynamics in the central junction control 30S ribosome
assembly
The

ribosome

conformational

is

changes

a

macromolecular

during
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machine
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protein
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undergoes

synthesis.

The

conformations of ribosomal RNA are stabilized by ribosomal proteins to
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assemble into subunits (374). S15 is a primary binding protein that can bind and
stabilize the central junction into a closed conformation to allow additional
proteins to bind during 30S assembly. In addition to S15 binding, the junction
loop also must have the ability to bind Mg2+ and to be dynamic. This junction also
acts as a pivot point for helices 20, 21, and 22, which are important for the
dynamics of the junction. This study focused on identifying the key sequences
around the central junction that are important for S15 binding as well as the
stability of folded junction.
Interactions within the conserved region of bacterial junction, including
nucleotides 652-654 and 752-754, are very important for S15 binding and the
proper folding of the junction (334). Through saturation mutagenesis, the most
important interaction observed was the Watson-Crick base pairing between
nucleotides 654 and 754, which were stabilized by triple base pairing with 752
and base stacking of 588, 654, 655 and 753. Complementation between the
sides of the junction loop can restore the function with reestablishment of the
triple base pair. To determine whether S15 binding was affected by mutations in
the junction loop, S15 was cloned and over-expressed with the junction mutants.
S15 complemented mutations in the junction loop in each of the partially
functional mutants; however, nonfunctional mutants were not complemented by
over-expression of S15.
Since the formation of the closed conformation is important for proper
ribosome function, the loss in function of the junction mutants may be due to their
defect in S15 or Mg2+ binding. Single-molecule data suggested that S15 and
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Mg2+ play equivalent roles in folding of the wild-type (WT) but not the mutants.
Comparison of the structural dynamics of these mutants and WT sequences in
the presence and absence of S15 revealed specific sequence and structural
motifs in the junction loop that are important for S15 binding and successful
ribosomal assembly.
From original in vitro reconstitution experiments, primary binding proteins,
including S15, were thought to be important for ribosomal assembly. In recent
studies, deletion of S15 doesn’t affect 30S subunit assemble but association into
70S was inhibited since S15 is part of the intersubunit bridge B4. Alternatively,
primer extension assays showed that junction loop mutants have significant
defects in 30S assembly but not in the association with 50S. However, in cases
where the junction loop mutant is still able to bind S15, the 30S subunits that
assemble were able to associate with 50S without any noticeable additional
effects on association. This supports the hypothesis that there are several
assembly pathways, resulting in an assembled functional 30S subunit.
Mutations in the junction can prevent the helices 20, 21 and 22 from
forming the closed conformation by preventing S15 and Mg2+ binding as well as
assembly. However, both the junction loop and S15 do not have a direct role in
protein synthesis. The decrease in 30S assembly leads to decreased protein
synthesis making them an excellent target for antibiotics. Phage display can be
used to isolate a peptide library that binds the junction loop and, with the help of
single-molecule FRET assays, the ability of those peptides to prevent S15
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binding to the junction loop can be determined. Peptides that prevent S15
binding can be used in further studies as potential drug leads.
7.3

Kinetic analysis of an RNA kissing interaction and effect of Hfq on its
resolution into an extended duplex
Small non-coding RNAs (ncRNAs) regulate gene expression through RNA-

RNA interactions. When the loop sequences are complementary, they can form a
kissing intermediate that further rearranges into a stable structure. The
thermodynamic and kinetic details regarding RNA kissing interactions and their
importance for the regulation of gene expression have remained elusive.
Previous studies of the HIV-DIS kissing complex have proposed several factors,
including the closing base pair and the loop sequence, that are involved in the
stability of the kissing intermediates (348, 351, 364, 365). However, the
molecular dynamics of the formation of kissing intermediates and their resolve
into a stable structure have not been studied in detail.
In vivo, RNA binding proteins help to convert kissing complexes (KC) to an
extended duplex (ED) by lowering the high-energy barrier between the KC and
ED. For example, in the DIS system, a nucleocapsid protein, NCp7, facilitates the
formation of intermolecular base pairing (365, 367, 369, 370). Hfq is another
RNA binding protein that facilitates the binding of ncRNAs with their target mRNA
in many bacterial systems (62, 371). This study used single-molecule to
characterize the dynamics of the formation of a kissing complex and the effect of
Hfq to resolve the RNA into an extended duplex. The calculated thermodynamic
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and kinetic parameters were in agreement with the ITC and SPR data for the
same hairpins (347).
Single-molecule studies of RNA hairpins suggest only one rearrangement
step of strand displacement, contrary to the previously proposed two-step
rearrangement process for HIV-DIS strand displacement (366, 367). The single
kissing species observed in this study may be due to our inability to capture a
fast second step or a lack of a significant FRET change between two
conformations with the current fluorophore positions. Kissing interactions could
be formed and broken several times before the hairpins dissociate or resolve into
an extended duplex at room temperature. From kinetic analysis, the kissing
interaction is quite stable at room temperature that depends on the loop
sequence. This information from smFRET was further supported by the
thermodynamic data from ITC experiments (347).
Only a few molecules were observed that resolved into an extended duplex
at room temperature. However at an elevated temperature (67°), previous
experiments have shown that nearly 25% of the RNA molecules refold into the
extended duplex from the KC (368). This can be attributed to a huge energy
barrier between the KC and the ED at room temperature. Since the progression
from the kissing interaction to the extended duplex is very rare, they were not
enough transitions to measure the kinetic parameters at room temperature.
Hfq accelerates the association of the RNA hairpins into an extended
duplex. The chaperone activity helps to form intermolecular base pairs to anneal
the RNAs, consistent with previous studies on DsrA and rpoS systems (356,
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359). The transition from the hairpin to the extended duplex conformation through
the kissing complex was never observed, suggesting that the kissing complex
may not an obligatory intermediate for the strand displacement mechanism
further supporting our thermodynamic data (347). None of the RNAs in the
extended duplex dissociated back to free hairpins within the experimental time
frame, more than 30 minutes. This is in contrast with previous findings in which
Hfq helps to break the intermolecular base pairing between DsrA and rpoS (359).
Our data suggests that Hfq acts as a chaperone to facilitate the progression of
strand displacement and extended duplex formation, thereby preventing the
dissociation of free hairpins.
It is not yet clear whether Hfq stays bound with RNA duplex or dissociates
leaving behind a stable RNA-RNA interaction as proposed earlier (58, 356, 359,
372). It is difficult to address this question with the previously used experimental
setup using labeled RNA and unlabeled protein. By fluorophore labeling Hfq,
where a decrease in fluorophore signal would correlate with the dissociation of
Hfq from the protein-RNA ternary complex, it may be determined whether the Hfq
remains bound or not. The studies discussed above were conducted using
engineered RNA hairpin sequences and might not reflect the properties of real
RNA sequences in cell; therefore, future studies with native sequences are
necessary to fully understand how Hfq functions in vivo. Further, the singlemolecule assay described above can be adapted to study other ncRNA/mRNA
interactions, such as the interaction between the ncRNA, DsrA, and its mRNA
partner, rpoS.
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Overall, FRET and single-molecule FRET has been successfully used to
study protein-RNA interactions. Here, we have characterized three different types
of ribonucleoprotein systems with very different biological roles in the cell from
splicing

to

ribosomal

biogenesis

and

regulation

of

gene

expression.

Understanding the molecular mechanisms of such interactions will help to
generate platforms for further study on drug design for the treatment and
prevention of many diseases, as well as understanding the mechanisms with
which those diseases occur.
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In the cell, RNA and protein, interact to form ribonucleoprotein complexes
(RNPs) that have vital structural, catalytic and regulatory roles. Despite their
functional importance, the mechanistic details and dynamics of RNPs are poorly
understood.

Single-molecule

Fluorescence

Resonance

Energy

Transfer

(smFRET) techniques that provide information about heterogeneity and dynamic
behaviors of molecules have been developed to investigate inter- and intramolecular interactions. Here we have used FRET in combination with smFRET to
study three very different RNP systems.
Alternative splicing is a highly regulated biological process that plays a
crucial role in proteomic diversity in eukaryotes. One splicing regulator, PTB, has
been proposed to repress splicing by looping RNA between two binding sites.
Here, we examined the looping activity of a minimal PTB construct (PTB34) on
various RNA oligonucleotides and found that PTB34 requires at least a 15
nucleotide linker between binding sites for efficient looping. A PTB antagonist,
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Fox-1, has been hypothesized to compete with PTB to reduce looping and
promote exon inclusion. Our data suggest that Fox-1 indeed disrupts PTB
binding and looping, supporting the hypothesis that Fox-1 breaks RNA looping to
enhance splicing of alternative exons.
Interactions between ribosomal proteins and ribosomal RNA facilitate the
formation of functional ribosomes. Studies of a central junction in 16S rRNA and
the primary binding protein that triggers a conformational change, S15, show that
mutations that alter the junction dynamics affect 30S assembly. Although partially
functional mutants are complemented by over-expression of S15, nonfunctional
mutants are not. Comparison of the structural dynamics of these mutants and
WT sequence in the presence and absence of S15 revealed specific sequence
and structural motifs in the junction that are important for ribosome function.
Small non-coding RNAs regulate gene expression in response to
biological stimuli through a mechanism that relies on changes in RNA-RNA
interactions, for instance switching between two hairpins and an extended
duplex. In the cell, proteins, such as Hfq, facilitate the formation of functional
RNA structures. Here we show that Hfq acts as a chaperone to overcome highenergy barriers and promote the progression of kissing hairpins through strand
displacement to an extended duplex formation.
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